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1. INTRODUCTION 
Siddha system of medicine is one of the ancient system which are being practiced 
any other system in the world. The system is the mother system of Varma Maruthuvam, 
yoga Maruthuvam, acupuncture, acupressure, naturopathy, Reiki, etc,...  Siddha system is 
the Unique system that definites total number of diseases that is 4448 in number which 
includes birth and death.1 
The WHO defines that “health is a state of complete physical, mental, and social 
well-being and not merely the absence of disease or infirmity”                                   
The Siddha system of medicine differs from any other system of medicine when 
approach to patient not only deals with physical character but also deals with psychosocial 
activity.  
In Siddha system parts of plants, ores of minerals, poisonous elements 
(paadaanam), animal products are used to prepare the medicines.2 .Addition to these the 
water, the air, the sand particles, the sunlight 3 and the cosmic energy also used to treat the 
patient.  
Siddha system of medicine having the unique pharmacological aspect through the 
drug delivery system. The significance of drug delivery system mainly due to the particle 
size found in the higher order medicine like parpam and chendhooram.  Most of the particle 
distribution found in higher order medicine nearly micro / nano in size.4 Because of the 
micro / nano particle size of higher order medicine leads to the rapid solublity during the 
process of absorption and also enhances the ion channel mechanism.5 After metabolism of 
the drug, the waste end product easily excreated by the excretory system of our body. 
Because of this, minimal dose of medicine that is more efficient to cure diseases and also 
nullifies the side effect during prolonged usage.  So much of pollutant and 
environmental changes, our Lifestyle altered and human beings are faced the stressful and 
mechanical life. Because of this changes so many Lifestyle disorders may come. Obesity 
and Diabetes are come under this category and have the major and important role.6 
The global prevalence of diabetes among in 2014 8.5%, in 2016, an estimated 1.6 
million deaths where directly caused by diabetes. India had 69.2 million people living with 
diabetes as per 2015 data. In 2017 there are 451 million people with diabetes worldwide. 
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It was estimated that almost half of the people (49.7%) living with diabetes are 
undiagnosed. In 2017 approximately 5 million death worldwide were attributable in 
diabetes in the 20-99 years age range. The global health care expenditure on people with 
diabetes was estimated to be USD 850 million in 2017.7 
Worldwide over 3 million Children's and 600 million adults are obesed. In United 
States 7.94 % million people are obesed and toped in the list. China got second place with 
57.3 million people in this 15.3 million or children. India is the third most obese country 
in the world with 30 million people among this 14.4 million for children.8 
Globally 422 million adults are living with diabetes mellitus the diabetes mellitus 
was classified into two major ocategories type 1 type 2. Some patient has high blood sugar 
level by the defects of insulin secretion. They need insulin to maintain the sugar leve. These 
people are in Type 1 Diabetes (or) Insulin dependent diabetes. 
Some patient has high blood sugar level by the defects in action of insulin. Their 
body have some insulin which is not properly functioned. They were maintain the blood 
sugar level by the oral drugs are in type 2 diabetes (or) Non-insulin dependent diabetes. 
This is the most common type of diabetes nearly 85 to 90% of all cases.Type 2 diabetes 
was more common in males 11.4 percentage then in females 9.2 percentage in the elderly 
population greater than or equal to 65 year.9 
In youngsters, less than 50 year in Urban population 12.8 % more prone to diabetic 
compared to rural population. 5.2 % the incidence of diabetes was higher among patient 
16.9 % with hyperlipidemia.10 
 In Siddha system of medicine Diabetes mellitus was known as” Madhu Megham". 
  இருமியே வாதமும் பித்தமும் கூடி  
மருவு சலயமக வாநதி ய ாலாகும்  
உருவம் யவராகும் உண்டவுடல் காந்திடும் 
 உருகயவ உன்யனாடு உறிஞ்சி இனிக்கும்  
                                                        -திருமூலர ்நாடி 11 
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 ாரத்்திடு மூன்றும் திந்து மமலிந்து நிற்கில்  
யதரந்்மதடு யமகம் உள்யள  
யதான்றியே ம ாருந்தி மமே்யில்  
                                                     -சித்த மருத்துவம் 12 
The above versus says that the vatha dhodam merge with the pitha dhodam large 
amount of urine may void like the stream. Hunger may come again and again. Our body 
tissues are excreated through urine and sweet in taste.  
When discuss about the complication of Mathu megham the Saint yugimuni list out 
10 major issues. 
 காணயவ முதலவத்ததச ்சரீரந் தானுங் 
 கனமாக ருத்து …………. …………. 
                -சித்த மருத்துவம் 13 
Above mentioned complication types of diabetes, first one was the bulky mass 
body. It was known as “Adhithoolarogam” that is obesity. Obesity is calculated by the body 
mass index. 
             A person’s body weight in kg 
BMI =               
  A person’s body height in m2 
Tabele No: 1.1 BMI Table 
     BMI RANGE INDICATION 
Upto 18.5 Under weight 
18.5 to 25.0 Normal 
25.0 to 30.0 Over weight 
30.0 to 35.0 Class 1 obesity 
35.0 to 40.0 Class 2 obesity 
Above 40.0 Class 3 obesity 
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Some market available drugs are act on lipid metabolism and reduce the level of lipids in 
blood. They are, 
1.Statins  
2. Fibrates  
3. Probucol. 
Similarly, some drugs are acts on carbohydrate metabolism and control the sugar 
level and also available in the market. They are, 
  1. Various type of insulin  
2. Glucagon  
3. Sulphonyl ureas  
4. Biguanides  
5. Alpha glucosidase inhibitors 
6. Glitazones 
Regular usage of these drugs may require high dose to maintain the normal range 
a(or) maybe have resistant to the particular drug. So, we want to increase the dose (or) 
change the superior drug depends upon the patients need. In this way this drug is not active 
in all conditions. So, there is a need to discover a drug that will be used in long term aspects 
without (or) minimal adverse side effects. 
In Siddha system of medicine, so many dogs are there to treat this condition. The” 
Indhirani Maathirai” comes under above category of medicines. 
The Indrani Maathirai constitutes the equal ratio of  
1.purasan ver,   
       2.kalli ver,  
       3.Kalarchi ver,  
       4.Kadugu,  
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       5.Milagu,  
      6.perungayam and  
      7.vediyuppu. 
All these purified ingredients would be e ground with karungali Kudi Neer to obtain 
mezhugu padham then rolled in to Maathirai. Most of the ingredients in this list have the 
the hypoglycemic activity and/or anti hyperlipidemic activity. 
Still now proper evaluation on the drug “Indhirani Maathirai” was not done. So, 
the auther is interested to study the antidyslipidemic, antidiabetic and antioxidant properties 
of the drug in animal model. 
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 AIM AND OBJECTIVES 
AIM: 
        Obesity (Adhithoola Aogam) and diabetes mellitus (Madhu Megham) are the 
metabolic disorder oriented to our lifestyle changes Globally obesity and diabetes are 
the most common and fast growing health issue both on a deer prolong medication and 
the lifestyle modification regular usage of medicines may cause some adverse side 
effects. The side effects should be minimised then only we improve the health care of 
our society this may achieve by Siddha system of medicine Indhirani Maathirai is one 
of the drug side in Siddha literature to treat obesity which is not properly ever with 
previously the name of the study was to validate the safety and efficacy of the drug 
Indhirani Maathirai for Antidyslipidemic activity in triton wr 1339 induced albino 
rats. 
OBJECTIVES: 
In this study the following methodology was done to evaluate the safety and 
efficacy of the trial drug 
➢ Various Siddha and modern references relevant to the study are collected. 
➢ The trial drug was prepared honestly according to classical Siddha text. 
➢ Validate of the physico chemical and phytochemical properties of the trial drug 
were done. 
➢ To evaluate the acidic and basic radicals of the trial drug by means of 
biochemical analysis were done. 
➢ Instrumental analysis of the trial drug was done to estimate the particle size of 
the molecule functional groups and elements which were present in it. 
➢ According to OECD guidelines acute toxicity study and repeated oral toxicity 
study of the trial drug were done. 
➢ To evaluate the pharmacological activity  
1. Antidyslipidemic activity-Triton WR 1339 induced model. 
2. Anti-Diabetic activity strip mm induced model in wistar Albino rats.  
3. Anti-oxidant activity DPPH assay were done.  
➢ Interpret the all data which are collected through the above studies to establish 
the activity and potency of the drug Indhirani Maathirai. 
REVIEW OF LITRATURE 
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   3. REVIEW OF LITRATURE 
3.1. DRUG REVIEW 
This chapter deals with the scientific and gunapadam aspect of the ingridiants of 
the Indhirani maathirai.     
INGIRIDIANTS OF THE INDHIRANI MAATHIRAI 
purasan ver (root of beautea monosperma)      
Milagu (Piper nigrum)        
Kalli ver ( root of Euphorbia antiquorum)    
Kalarchi ver ( root of Caesalpinia bonduc )     
Kadugu (Brassica juncea)      
Kambiccharam (potassium nitrate)      
Perungayam (ferula asafoetida)                
Karungali kudineer ( Acacia catechu stem decoction)                    
3.1.1. PURASAN VER (Butea monosperma) 
SYNONYMS 
Butea monosperma(Lam) 
Butea frondosa Roxb ex Wild 
Eeythrino monosperma Lam 
Plaso monosperma 
OTHER NAMES                                        Fig.No-3.1:Beautea monosperma flower 
Palaasu, Bramathervu, Murukku, Kinguki, Kiruminasam, Seera, Palasam, Puraisu, 
Purosu, Punarmurukku, Vaadhabothem. 
VERNACULAR NAME 
Eng-Bastard Teak,Flame of forest 
Tel-Moduga 
Mal-Murukka maram 
Pers-Dharakhte-palasina 
Hin-Dhara 
Kan-Muttagamara   Fig.No-3.2: Beautea monosperma plant 
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BOTANICAL ASPECT 
CLASSIFICATION 
            Kingdam-Plantae 
Class-Dicotyledonae 
Subclass-Polypetalae 
Series-Calyciflorae 
Order-Rosalae 
Family-Leguminosae 
Subfamily-Febaceae 
Genrae-Butea 
Species-monosperma       Fig.No-3.3: Beautea monosperma root 
HABIT 
 Tree 
DISTRIBUTION 
It is a medium sized tree native of the mountainous regions of India and Burma and 
now grows wild throughout India. 
DESCRIPTION 
Leaves are pinnate, three leaflets, each leaflet ovate-lanceolate. Flowers racemes 
densely brown velvety on bare branches. Calyx is dark, olive green to brown in colour and 
densely velvety outside. The corolla is long with silky silvery hairs outside and bright 
orange red. Stamens are diadelphous, anthers uniform. carpel l; style filiform, curved and 
stigma capitate. Pods are narrowed, thickened at the sutures, splitting round the single 
apical seed, lowest part indehiscent. The seeds are flat, reniform, curved.14 
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SIDDHA ASPECT 
GENERAL PROPERTIES 
வயிற்று கிருமி கணம் வாதமமாடு சீதம் 
நியத்தபடர ்தாமரரயும் நீங்கும்-வயிற்று 
வலியிரரசச்ல் வன்கரப்பான் மாறும்பித ்துண்டாம் 
மலிபுரசங் மகாட்ரடதரன வாழ்தத்ு. 
 -அகத்தியர ்குணபாடம் 15 
புரசுவா தம்பித்தம் மபாங்குகபங் குன்மம் 
கிருமி யுடனன கிராணி-மபருவலி னநாய் 
ஓட்டுமதி தீபத்ரத உண்டாக்கு அப்மபாழுனத 
தீட்டியனவற் கண்ணாய்! மதளி. 
                                        -அகத்தியர ்குணபாடம் 16 
சந்திகட்கு நாடிகட்குந் தங்குசுக்கி லந்தனக்கும் 
புந்தியுரங் கட்குமுரம் பூடட்ுங்கா-ணுந்து 
சரமதனுக் காகமநூல் சாற்றுமலர ்மானத! 
பிரமதரு விற்சம்பி சின், 
  -அகத்தியர ்குணபாடம் 17 
EXPLANATION 
 Purasu regulates the three doshas.It controls the worm infection and abdominal 
pain.It has stomachic activity also. Butea frondosa gums have the tonic property to joints, 
nerves and chest region.The gums have the antrogenic property too.The seed of Butea 
monosperma cures the worm infestation, body achae, ring worm, eczema and peptic 
ulcer.The seed enhances the piththa thodam. 
MODERN ASPECT 
CHEMICAL CONSTITUENT:  
Butin, butein, butrin, isobutrin,palasitrin, coreopsis, isocore epson, chalcones and 
aurones have been isolated from the flowers . The antifungal compound -medicarpin, kino-
tannic acid, gallic acid, proanthocyanidins, stigmasterol,stigmasterol-D glucopyranoside 
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and nonadecanoic acid have been isolated from the stem bark and gum. A new lectin N-
Acetyl galactosamine was isolated from the seed.18 
MEDICINAL USES:  
The flower decoction is widely used in the treatment of hepatic disorders and viral 
hepatitis, diarrhoea and possess anti-inflammation activity. Root combines with Pippali to 
be useful in the treatment of filariasis, night blindness, helminthiasis, piles, ulcers and 
tumours. The stem bark is used in indigenous medicine for the treatment of dyspepsia, 
diarrhoea, dysentery, diabetes, ulcers, sore throat and snake bites. The root bark is used as 
an aphrodisiac, analgesic and anthelmintic whereas the leaves possess antimicrobial 
property. Seed combined with honey is internally used in the case of intestinal worms 
especially tapeworm.19 
3.1.2.MILAGU-PIPPER NIGRAM 
OTHER NAMES: 
 Kalinai, Kari, Kayam, Kolagam, Thirangal, Miriyal, Sarumavandham, Vaalism, 
Kurumilagu, Malayali. 
           -  குணபாடம் மூலிரக 18 
  
 மசால்லியனதார,் அருடம்டன்றி ' அதற்குப் மபயர-் 
மசாற்மபரிய, மதங்க மனன்றும் னபருண்டாசச்ு 
அதுலியனதார,் மரலத்திருக்கமலன்றும் னபரு 
அட்டமா சாதி என்று மிதற்குப் னபரு 
கல்வியனதார ்கத்திசன் என்றும் னபரு 
கத்துரும் பயனன்று னநர ்வனந்தா மனன்றும் னபரு 
மல்லியனராரக்்கு தாயன்றி தற்குப் னபரு 
வசனித்தும், மிளகினிட அதீதப் னபனர  
- பஞ்சகாவிய நிகண்டு 19 
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EXPLANATION 
Arutendru, Mathangan, Malaiththirukkal, Attamasaathi, Katheesan, Kathurupayan, 
Thaai, Kalinai, Kari, Kayam, Kolagam, Thirangal, Miriyal, Sarumabandham,Valliam, 
Kurumilagu, Malayali. 
VERNACULAR NAME 
 Eng-Black Pepper 
Tel-Miriyalu 
Mal-Kurumilagu 
Kan-Menasu 
Sans-Mariche 
Hin-Kali-Mirch            Fig.No-3.4:Pipper nigram 
BOTANICAL ASPECT 
Classification  
 Kingdam-Plantae 
 Class-Dicortyledane 
 Subclss-Monochlamidae 
 Series-Microembryeae 
 Family-Pipraceae 
 Genera-Pipper      
 Species-nigram    Fig.No-3.5:Pipper nigram 
HABIT  
It is a twiner. 
DISTRIBUTION 
It is native to Malabar, a region in the Western Coast of South India.20  
DESCRIPTION 
Stems are stout climbing and very flexible. Leaves are elliptical to orbicular-ovate, 
younger leaves are cordate and all are palmately veined with 5-7 veins. Flowers are small 
and borne on long pendulous spikes from each node, The flowers are not showy.The berries 
first turn green, then red, finally turning black.21 
REVIEW OF LITRATURE 
 
ANTIDYSLIPIDEMIC ACTIVITY OF INDHIRANI MAATHIRAI                  12 
 
PART USED  
Seed, plant  
SIDDHA ASPECT 
PROPERTIES  
Taste - bitter, pungent  
Character - hot  
Division - pungent  
A GREEN VARIETY OF PEPPER 
  அளரவயுறாக்காரம் அரடந்திருக்கும் வாத 
விரளரவமயல் லாமறுக்கும் மமய்னய - மிளகின்காய் 
கண்டவரக்்கும் இன்பமாம் காரிரகனய! சீழ்மூலம் 
மகாண்டவரக்்கு நன்மருந்தாங் கூறு.  
-அகத்தியர ்குணபாடம் 22 
 
            சிதகரம் பாண்டு சினலத்துமம் கிராணி குன்மம் 
வாதம் அரூசிபிதத்ம் மூலம்-ஒதுசன்னி 
யாசமபஸ் மாரம் அடன்னமகம் காசமிரவ 
நாசங் கறிமிளகினால்  
             -அகத்தியர ்குணபாடம் 23 
னகாணுகின்ற பக்கவலி குய்யவுனரா கம்வாத 
னசாணிதங்க ழுத்திற்குள் னதான்றுனநாய் - காணரிய 
காது னநாய் மாதரக்ுன்மங் காமாரல மந்தமமன்றீர ்
ஏதுனநாய் காயிருக்கில் ஈங்கு. 
-அகத்தியர ்குணபாடம் 24 
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EXPLANATION 
The peper cures the vadha diseases and the apses.It cures the fever with severing, 
anaemia, cough with expectoration, piles, anohrexia, epilepsy, urinary disorders, stroke, 
indigestion, jaundice. 
மிளகின் மபருரம 
தீயாகி எங்கும் திரியுமரத யாவத்து 
னமாயாம மலப்படியு முண்டாக்காற்-பாயாது 
னபாந்திமிரவ்ா தங்கிரந்தி புண்ணிரும் மண்ணவரக்்கும் 
காந்திமமய்வா தசச்லுப்ரபக் காய்,  
-னதரன் மவண்பா 25 
EXPLANATION  
The peper regulates the vadha,piththa and kabha. 
MODERN ASPECT 
Chemical Constituent: 
 Pyrrolidine alkamide, Isopiperolein B,retrofractamide A, pipercide, 
piperchabamide , pellitorin,dehydropipernonaline, 2E, 4E, SIZE-N-isobutyl 
eicosatrienoic,pellitorine, trachyone, pergumidiene and isopiperolein B have been isolated 
from fruit.Essential oil contained.mono-terpene hydro-carbons, sabinene, B-pinene, 
limonene,furthermore terpinene, B-pinene, myrcene,3-carene, borneol,carvone, carvacrol, 
1, 8-cineol, linalool, sesqui-terpenes, B caryophyllene, humulene-bisabolol, caryophyllene 
oxideketone, phenyl ether, eugenol,myristicin and safrole,bis alkaloids, pyramides D and 
E.26 
Medicinal Uses:  
The fruit is an important spice and flavouring agent and has also been used in the 
treatment of cholera a dyspepsia, as well as a variety of gastric ailments and arthritic 
disorders. Black pepper oil can be used to help in the treatment of pain relief, rheumatism, 
chills, flu, cold, increase circulation, exhaustion, muscular ache, physical and emotional 
coldness, nerve tonic and fevers. According to Ayurveda, fruit is useful in treatment of 
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asthma, chronic indigestion, colon toxins, obesity, sinus congestion, fever, intermittent 
fever, cold extremities, colic pain, piles, worms and sore throat. Externally, fruit paste 
extract can be applied to boils and other skin diseases. A pinch of pepper powder mixed 
with clove oil can be put in the caries to alleviate toothache. The finely ground pepper 
mixed with honey taken twice a day is beneficial in amnesia or dullness of intellect.27 
3.1.3. KALLI VER-EUPHORBIA ANTIQUORUM 
OTHER NAMES: 
  தாபித்னதாம், கண்டிமயன்று, உசச்ிரமமன்றும்  
தருவான, கானமாதக மமன்றும் னபரு 
தாபிந்னதாம், கற்கடக மாத மரன்றும் னபரு 
நலமான, கருவு மறப்பளி மயன்றும் னபரு 
வாபித்னதாம், கங்ரகப் பாவிரல என்றும் னபரு 
வாசிட்ட தி மூவி என்றும் னபரு 
யாபித்த, மாக்னுரடயாள மூலி என்றும் னபரு 
ஆகிதமாய் மசால்லிவிட்னடாம், சதுரக்கள்ளியின் னபர ்
-பஞ்சகாவிய நிகண்டு 28 
EXPLANATION: 
Sithiram, Komothagam, Kadarkatchi, Maadhar, Marapali, Gangaipaal, Idaivel 
Mooli, Mugamudaiyal Mooli. 
VERNACULAR NAMES: 
Eng- Quadrangular Spurge 
Hind- Tidahara, Sehund, Tin-dhari-send 
Te- Bont-jemudu, Bedda-yemudu  
Duk,- Tidharl•sound 
Sans- Vajratundi, Vajradathtaka, Mahasunhi 
Mal- Chathura-kali          Fig.No-3.6:Euphorbia antiquorum 
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BOTANICAL ASPECT 
Classification  
 Kingdam-Plantae 
 Class-Dicortyledane 
 Subclss-Monochlamidae 
 Series-Unisexuales 
 Family-Euphorbiaceae 
 Genera-Euphorbia 
 Species-antiquorum 
Habit             Fig.No-3.7: Euphorbia antiquorum 
root 
   It is a shrub 
 
Description 
    It is a small armed tree with whorled fleshy branches branchlets thick and broad, 
3-5 winged, having sharp stipular spines leaves are small, sub-sessile, soon deciduous; 
involucres 3-nate, the central, flower sessile, female, the two laterals on long stout pedicles, 
glands 5, style bifid; fruit capsule.29 
Part used  
Stem, latex, root, root bark 
SIDDHA ASPECT 
Properties  
Taste - pungent 
Character - hot 
Division - pungent 
Action:  
Thermogenic  
Anodyne 
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Purgative 
Emetic  
Stomachic 
Rubefacient  
General properties  
கரப்பான் மசாறியுங் கடியுங் கபமும் 
உரப்பன் குன்மம் கிழிக்கும்-நிரரப்பான 
னபதிதருஞ் சீதமமன்ற னபசச்கற்றும் பூவுலகிற் 
ஓத்து சதுரக்கள்ளி தான்.  
-அகத்தியர ்குணபாடம் 30 
EXPLANATION 
 This plant cure eczema, scabies, urticaria, peptic ulcer and excess kabam.It cures 
diahroea also. 
Latex  
குட்டங் கடிசூரல குன்மனம தம்வாயு ! 
துட்டக் கிருமினயாடு தூறுபுண்ணு - முட்ட 
முதிரக் கரப்பனும்னபா மமாய்குழனல! நாளுஞ் 
சதுரக்கள் ளிப்பாற்குத் தான்.  
-அகத்தியர ்குணபாடம் 31 
EXPLANATION 
 The latex cures leprasy, urticaria, peptic ulcer, vaadha diseases, 
leucorhoea, non-healing ulcers megguts and eczema. 
 
MODERN ASPECT 
Chemical constituent:  
Diterpene, antiquorin, friedelan-3-B-ol, B-taraxerol, triterpenes, euphol 3-0-
cinnamate, antiquol A and antiquol B, euphol, 24-methylenecyeloartanol, cycloeucalenol, 
(Z)-9-Nonacosene, sistosterol and p-acetoxyphenol were isolated from the latex.32 
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Medicinal uses:  
The juice is acrid, anti-inflammatory, deobstruent, purgative and is useful in 
rheumatism, dropsy, gout, neuropathy, deafness, cough and cutaneous diseases.33 
3.1.4KALARCHI VER 
SYNONYMS 
 Caesalpinia bonduc (L) Roxb 
 Caesalpinia bonducella 
 Caesalpinia crista  
OTHER NAME 
 Kaai, Vajjirapeejam, Kalar Kaai, Kacchakkaai, Guberapatchi. 
VERNACULAR NAME 
 Eng-Bonduc Nut,Moloucca bean,Pysic nut 
 Tel-Gach-chakaya 
 Mal-Kazhanchikkara,Kalanchikkuru 
 Kan-Gajjaga-Kay 
 Sans-Kuberaleshi,Serakaraja 
 Arab-Akitnakit 
 Pers-Sagar Ghota 
 Hin-Kalkaranj,Katkaliji 
 Duk-Guchhe      Fig.No-3.8:Caesalpinia crista 
BOTANICAL ASPECT                                                   
CLASSIFICATION    
 
 Kingdam-Plantae 
Class-Dicotyledonae 
Subclass-Polypetalae 
Series-Calyciflorae 
Order-Rosalae    Fig.No-3.9:Caesalpinia crista root          
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Family-Leguminosae 
Subfamily-Caselpinasceae 
Genrae-Caesalpinia               
Species-crista 
HABBIT 
 Caeselpinia crista is a thorn straggling shrub. 
DISTRIBUTION 
 Wildely distributed in tropics.It was cultivated in India by means of seeds.34 
DESCRIPTION 
It is a large straggling, thorny shrub. The branches are armed with straight, yellow 
prickles. The leaves are pinnate, stipules foliaceous, pinnae 7 pairs, leaflets 3-8. The 
flowers are pale yellow in color, in supra-axillary racemes at the top. The fruits are inflated 
pods, covered with prickles, 6 cm long, 1-2 seeds per pod. The seeds are globular, hard, 
bluish grey with a smooth shiny surface.35 
SIDDHA ASPECT 
PROPERTIES 
 Taste-Bitter 
 Character-Hot 
 Division-Pungent 
ACTION 
 Anti-periodic 
Anti-spasmodic 
Tonic 
Febrifuge 
Anthemintic 
Deobstrecent 
Emmenogue 
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GENERAL PROPERTY 
விரரவாதம் சூரலயரும் மவட்ரடயனல் ஏகும் 
 நிரரனசரந்்த குன்மம் நிரலயா -துரரனசர ் 
அழற்சி விலகும் அருந்திற் கசப்பாம்  
கழற்சியிரல என்றுரரக்கும் கால் 
 -அகத்தியர ்குணபாடம் 36 
ஏரண்ட னதானட இரங்கண்ட மமதத்வுனம  
வீறண்ட மமல்லாம் விலகுங்கான்  
தூரண்ட வள்ரள குரழயடினபாம் வாள்விழிமானத!  
நல்ல மவள்ரள கழற்சிஇரல விள். 
             -அகத்தியர ்குணபாடம் 37 
னகாசம் சுருங்கத் குடிலமிகு மன்னவனால்  
வீசன் சுருங்காது னமலிட்ட - னமாசம்  
ஒழிய மருந்தாகி ஒதத்ாரச மசய்யும்  
கழலாகிய கழற்சிக் காய் 
- னதரர ்மவண்பா 38 
EXPLANATION 
 The leaves of black type of Kalarchi reduces the orchitis,leucorrhoea and the types 
of peptic ulcers.The leaves of white type also reduces the orchitis. 
 
MODERN ASPECT 
CHEMICAL CONSTITUENTS 
 Seeds contain amino acid, Caesalpinia, bounducin, fatty oils, glycerols, palmitic 
acid, norcassane-type diterpenes, cassane-type diterpenes namely Norcaesalpinin A B and 
C were isolated from the seed kernel,Taepeenin A-I, nortaepeenin A-B and three diterpenes 
vinhaticoic acid, methyl vinhaticoate and ent-115-hydroxy-osa 5,15-diene were isolated 
from the stems and root.39 
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Medicinal Uses 
 Roasted seeds with castor oil is externally applied for hydrocele. Roasted seeds are 
internally given for hydrocele, leprosy, mitigates the condition and relieves the pain. 
Leaves areinternally used for liver diseases.Decoction of roots with honey is given for 
leucorrhoea. Leaves and stem bark considered as an anthelmintic, emmenogogue. Roasted 
seed powder combined with asafoetida, ghee and little amount of salt is recommended in 
postpartum period especially the abdominal pain. The seeds powder mixed with milk used 
in the case of diarrhoea.40 
3.1.5. KADUGU (BRASSICA JUNCEA) 
OTHER NAMES 
Iyavi 
-குணபாடம் மூலிரக வகுப்பு 
விட்ட வலி விண்மணன்று இதற்கு னபரு 
விளக்கினனாம், அய்யாலு சீன மமன்றும் னபரு 
எட்டமவன்றும், பள்ள மனன்று இதற்குப் னபரு  
எனது, மகத்தான துருஞ்சி எறிதற்குப் னபரு 
நடராஜ் சிதறி எறிதற்குப் னபரு 
நல்ல பத்தரவமமன்றிதற்குப் னபரு 
அட்டவத்தனாதி என்று, இதற்குப் னபரு 
அருளினனாம், புலதத்ியனன கடுகின் னபனர 
-பஞ்சகாவிய நிகண்டு 41 
EXPLANATION 
 Vitta vali, vin, iyyalu, seenam, ettam, pallan, thurunji, naattaraasa sithari, nalla 
paththaravam. 
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VERNACULAR NAMES 
Eng-Indian mustard 
Hin-Rayi 
Kan-Sassiv 
Mal-Katuku 
San-Sarsapah 
Tel-Avalu 
BOTANICAL ASPECT  Fig.No-3.10:Brassica juncea 
CLASSIFICATION         
            Kingdam-Planta 
 Class-Dicortyledane 
 Subclss-Polypetalae 
            Order-Thalamiflorae 
 Series-Parietales 
 Family-Brassicaceae 
 Genera-Brassica  
 Species-juncea 
HABIT 
 Shrub      Fig.No-3.11:Brassica juncea 
DISTRIBUTION 
Cultivated throughout india. 
DESCRIPTION 
A glabrous annual with a few bristles at the base upto 1.5m in height, basal leaves 
long, broadly ovate, coarsely denate, persistant middle leaves oblong, 8 denate, upper 
leaves broadly linear, entire.Flowers yellow in racemes, fruits siliqua, breaking away from 
below upwards.Seeds attached to the replum.42 
PARTS USED 
Seed, seed oil. 
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SIDDHA ASPECT 
PROPERTIES 
Taste - Sour 
Character - Heat 
Division – Sour 
ACTION 
Emetic 
Digestive 
Stimulant 
Rubefacient 
GENERAL PROPERTIES 
 கடிப்பரக மயனவரு கடுகிரன நாளு 
மிளகில வணதம்தாடு மூன்றுமமான் றாக்கி 
யடுபுன லருந்துமு னயிலரவ கரறமதாறும் 
வளிமுதன் மூலிரக வலிமயலா மகனும் 
பசச்டி முதற்கறி பண்பினா லயிலினு 
நிசச்ய மாயுணி கழப்பிணி யறுக்குனம 
-னதரன் காப்பியம் 43 
இடிகாச நாசிசச்ூ ரரீளதபம் பித்தங் 
கடிவாத சீதங் கடுப்னபாட்டுடலிற் 
படுனகாட்டு னநாமயன்னும் பங்கிரவக ரளப்புண் 
கடுனகாட்டு னமன் மருந்து காண், 
             -அகத்தியர ்குணபாடம் 44 
மந்தமயக் கம்வாதம் வாய்நீரச் ்சுழற்றலறு 
முந்து சுகப்பிரச வங்களுண்டா -மிந்துநுதன் 
மானன! கிராணிகுன்ம மாறுமுத ்னதாட்டமும்னபாம் 
தானன கடுகிற்குத் தான். 
             -அகத்தியர ்குணபாடம் 45 
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மவண் கடுகு 
பாலக்கிர கம்பூத ரபசாச னமாட்டிவிடும் 
ஆல விஷங்கடிக ளாற்றுங்காண்-னகாலமிகு 
மவள்ரளச ்மசவிமானத மாபங்க னநாய்விலக்கும் 
மவள்ரளக் கடுகின் விதி 
 -அகத்தியர ்குணபாடம் 46 
EXPLANATION 
• It cures with expectoration rainy days urticaria myalgia laziness concentrated saliva 
diarrhoea abdominal pain and delirium.Excuse dysentery joint disease indigestion 
and hiccup. Every day we take mustard with salt and pepper along with hot water 
that that will cure 3 dhodam. 
• It is the diuretic and emitec property also.  
• We take 2 gram mustard and titrated with water and have vomit may come.The 
paste applied in cloth.  When the cloth applied in ARM legs that will be cured 
inflammation present in the site. The cloth was applied on the chest that will be 
cured hiccups. 
3.1.6. KAMBICHARAM 
  Six times processed (distilled) vediyuppu is known as kambicharam.47 
VEDIYUPPU (POTTASIUM NITRATE) 
OTHER NAMES:  
Pottiluppu, Inangan, Padairasan, Boomikoorma Navachara mithru 
PREPARATION: 
  The sand containing the crude salt is placed in a mud pot. Water is added into it and 
mixed well. and a straw is placed inside the pot and filtered. The filterated mixture is heated 
to get the salt. 
The potassium nitrate salt is used for the preparation of explosives It is also used 
for cooling alcohol and to polish the gold ornaments. 
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Purification: 
1. Salt    - 100g 
2. Water   - 400g  
3. Fermented butter milk - 100g 
4. Lime juice   - 100g 
             Fig.No-3.12:Potassium nitrate 
Water is added to the salt and boiled on a hearth with mild flames The white of 
eggs (4 Nos.) is added to every 1,400 gm of salt and the bubbles appearing with impure 
substances are removed with a wooden spoon 
The ingredients are then transferred to another pot sealed with mud pasted cloth, 
filtered and kept in places without aeration. Next day the water is filtered and the salt is 
dried in sun shade. This process is repeated for seven times to get it purified. 
OTHER METHOD 
Potassium nitrate (1part), sea water or water (2 parts) are taken Potassium nitrate is 
finely powdered and dissolved in water. The clear fluid is poured in white coloured iron 
pot and heated till a semi-solid consistency is obtained. This is then poured in a copper pot 
and placed in a cool place; now the salt will form; the salt is taken out and dissolved in 2 
parts of water and heated as mentioned above, this process is repeated for five to seven 
times to get it purified 
The purified salt will appear as white thin rods. When placed in the tongue, it gives 
a cooling effect. 
PROPERTIES AND USES  
"மல்லாரு மட்டகுன்ம மாருத ரக்கட்டி 
கல்லா மரதப்புநீரக்் கட்டருக - மலல்லானம 
கம்பிகம்பி மயன்றுங் கருவுண்டா மங்கிநின்ற 
கம்பிகம்பி மயன்றுரரக்குங் கால். 
-குணபாடம் தாது சீவம் 48 
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"சூதக வாயுமவாடு னசாணிதத்தின் வாதமும்னபாம் 
வாத வலி குன்மம் மாறுங்கண்-மீதாங் 
மகாடிய வயிறிழியுங் னகாரழகப னமகும். 
மவடியுப்பு தன்ரன விளம்பு.” 
-குணபாடம் தாது சீவம் 49 
EXPLANATION 
• Potassium nitrate salt has got demulcent, diuretic and diaphoretic 
properties. This should be given by dissolving in large quantities of water 
• The salt is also useful in the treatment of eight types of gunman, uterus fibroids, 
anorexia, anaemia, urinary tract infections, dysuria, strangury, ascites, 
menopausal disorders, abdominal distention and asthma 
• It improves fertility in women. 
• The salt is also effective in fever, swellings, rheumatic disorders haemorrhage, 
gonorrhoea, eye diseases and sore throat. 
DOSAGE:  
650 mg - 1300 mg. 
MEDICINAL USES 
• Equal ratio of salt and tamarind are dissolved in water and boiled and the mixture 
is taken in semi-solid consistency and applied over the swelling and sprain by which 
haematoma will subside. 
• The salt is also used as one of the ingredients in tooth powders 
• Insects entered in the ear, generative organs, anus will come out on spraying the 
salt water 
• Dissolved salt water is given through the rectum to remove the worms in the large 
intestine 
• The salt is also used as a preservative for fish, mutton and vegetables 
• The salt is dissolved in water and given for the silver nitrate poisoning 
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3.1.7. PERUNGAYAM (Ferula asafoetida) 
OTHER NAMES 
Valeegam, Abhiyagraham, Ramadem, Gandhi, Kayam, Sandenasam, 
Boodhanasam. 
- குணபாடம் மூலிரக வகுப்பு 
 
அருளினனாம், னசாம நாதி என்றும் னபரு 
ஆட கண்டகாரி யாதி என்றும் னபரு 
எருளினனாம் இந்தத ்தூனி என்றும் னபரு 
இறங்கு ராமமன்ற  தற்குப் னபருண்டாசச்ு 
உருளினனாம் உக்கித மமன்றிதற்குப் னபரு 
உசிதமுள்ள குந்ததமமன்றதற்குப் னபரு 
குருளினனாம் குட்டாமமன்றதற்குப் னபரு 
கூறினனாம் மபருங்காய அதீதப் னபனர 
- பஞ்ச காவிய நிகண்டு50 
EXPLANATION 
Somanathi, Aadakanda kaari, Aadhi,Indhuli, Kooraam, Ukkitham, Kunthatham, 
Kuttaam. 
VERNACULAR NAMES 
Tam-Perungayam 
Eng-Asafoetida 
Tel-Inguva 
Mal-Perungayam 
Kan-Ingu 
Hin-Hing 
 
Fig.No-3.13:Ferula asafoetida 
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BOTANICAL ASPECT 
CLASSIFICATION 
 Kingdam-Plantae                                          
 Class-Dicortyledane 
 Subclss-Polypetalae 
 Series-Calyciflorae 
 Order-Umbellales 
 Family-Apiaceae 
 Genera-Ferula 
 Species-asafoetida 
HABIT 
 It is a shrub.             Fig.No-3.14:Ferula asafoetida 
DISTRIBUTION 
Cultivated in the north west part of india. 
DESCRIPTION 
A tree attaining height of 2-4 m.Stem stout and much branched.Leaves puberulas 
and minutely olandrelar or somewhat termantoce, the eaotical ones large and 
teenatisect,with segements oblongand ofuse.Umbels are fleshy peduncles, 20-30, flowers 
yellow.51 
PARTS USED 
Leaves,stem,root and gum resin. 
SIDDHA ASPECT 
PROPERTIES 
Taste-Bitter,Pungent 
Character-Hot 
Divison-Pungent 
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ACTION 
Expectorant 
Carminative 
Anthelmintic 
Diuretic 
GENERAL PROPERTIES 
தந்தனவ தந்த மூலதம்தழும்பிணி 
பருவகாலம் விருசச்ிகங்கீடம்மா 
மந்தம் வாதம் உதாவரத்்தம் அல்குல் னநாய் 
மாரப்ணங்கட்ட குன்மம் மனகாதரம் 
உந்து கரப்்பத்தின் வித்திரஞ்சூரலசச்ூர ்
உதிரப்பூசச்ி சினலதத்ுமத்துறும் வலி 
வந்தமமய்க்கடுப் னபாடிரவமுற்றுனம 
மாயுநாறுநற் காயங்கிரடக்கினன. 
- னதரரயர ்குணபாடம் 52 
 
INDICATION 
  Cures gastritis, uterine disorders, ascites,worms,vatha diseases. 
MODERN ASPECT 
CHEMICAL CONSTITUENTS 
Luteolin and its 7-O-B-D-glycopyranoside(fruits) seven S containing compound in 
essential oil. Ferrasiferol A,gummosin, kamolonol, mogoltaclone, polyanthia, 
umbelliferone (gum), foetidin.53 
MEDICINAL USES 
• Asafoetida given along with egg to cure dry cough. 
• Equal quandity of aloe juice,pepper,asafoetida cures amenorrhoea. 
• Asafoetida heated with gingely oil and used as a ear drops cures ache. 
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• It is used as anti-spasmodic,aphrodisiac,carminative, diuretic, expectorant, 
emmanogogue and nerve tonic. 
• It is remedy for historia and nerve disorders of women and children and in the 
advanced stages of whoophing cough. 
• It is used in colic pain,spasmodic movements of the bowels, infantile convulsions, 
aasthma and bronchitis 
3.1.8. KARUNGAALI (Accasia catechu) 
SYNONYMS 
Acacia catechu (L) Willd, Oliv. 
Senegalia catechu  
catechuoides (Roxb.)Prain 
Acacia catechuoides (Roxb.) Benth. 
Acacia sundra (Roxb.) Bedd. 
Acacia wallichiana DC 
Mimosa catechu Lif.    Fig.No-3.15:Acacia catechu 
Mimosa catechu uses Roxb. 
VERNACULAR NAMES  
Eng - black catechu, cutch tree  
Tel - chandra  
Mal - karungali  
Kan - ladies  
Sans - chandiran  
Hind - katha  
Duk - kher 
BOTONICAL ASPECT 
CLASSIFICATION 
Kingdom - plantae  
Class - dicotyledonae      Fig.No-3.16: Acacia catechu  
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Sub class - polymerase  
Series - calyciflorae  
Order - rosales  
Family - leguminaceae  
Sub family - mimosaceae  
Genera - Acacia  
Species - chetachu 
HABIT  
It is a deciduous shrub or tree, grows to 2-6 m tall with a flat to rounded crown. 
DISTRIBUTION 
 Widly distributed in tropics and sub tropics espectually in india and burma. 
DISCRIPTION 
The tree has many branches and erect twigs spreading within the upright part. The 
branchlets have thorns just below the nodes: either three thorns with the central one hooked 
downwards and laterais curved upwards, or a single thorn with laterals absent. Leaves are 
small, grey-green, alternate and bipinnate. Pinnae occur in (2-) 3-8 (-12) pairs, and leaflets 
in 7-25 pairs. The rachis sometimes has prickles. The white or cream-colored flowers occur 
on spikes. Pods are indehiscent, yellowish to brown, flat papery and oblong; seeds are 
nearly round.54 
PART USED:  
Gum and stem bark, root 
ACTION:  
Demulcent and emollient. 
SIDDHA ASPECT 
PROPERTIES  
Taste - astringent  
Character - cold  
Division - pungent 
REVIEW OF LITRATURE 
 
ANTIDYSLIPIDEMIC ACTIVITY OF INDHIRANI MAATHIRAI                  31 
 
GENERAL PROPERTIES 
Aquous extract of root 
குட்டங் கயனராகங் குன்மம் மபருவயிறு 
மநட்ரட புழு திமிரு நீரிழிவும்-விட்னட 
யருங்கான கத்னதகு மஞ்சுகனம! நல்ல 
கருங்காலி நீரதரனக் கண்டு. 
             -அகத்தியர ்குணபாடம் 55 
Bark 
            னமகநீ ரரக்மகடுக்கும் வீறுதந்த மூலத்துள் 
ஆகிய னவதரனரயயாற்றுங்காண்-னசாகம் 
தருங்காச மீரளயிரவ சாரா தகற்றுங் 
கருங்காலிப்பட்ரடயது காண் 
       -அகத்தியர ்குணபாடம் 56 
Gums 
கருங்காலி யின்பிசின்றான் காரார ்கரப்பான் 
வருனமக நீரிழிரவ மாற்றும் விரரவாய்ப் 
மபரும்பாடரடப நீக்கும் மபருந்தாது விருத்தி 
அரும்பு மமனக்கண் டறி. 
                -அகத்தியர ்குணபாடம்57 
Root 
ரகப்புற் றிருக்குங் கருங்காலி னவருக்கு 
ரமப்புழுவும் பாகம் மதுநீரும்-மமய்க்குமளழு 
குஷ்டுமுதி ரப்னபாக்குங் கூவியழு தகலும் 
மட்டுறுபூங்னகாதாய்! வழுதத்ு. 
-அகத்தியர ்குணபாடம்58 
EXPLANATION  
• Across accept of root of karungali cures leprosy Ascites worm infestation diabetes 
and peptic ulcer numbness due to anaemia  
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• The seed of hydnocarpus laurifolia boil in decoction of bark of karungali, the oil 
may come. The oil is used to leprosy internal and externally 
• The decoction is used 2 diabetes and blood purification and also strengthens the 
body  
• The gum of karungali used in Eczema diabetes menorrhagia the gum has 
spermatogenic activity  
• The root of karungali used in diabetes CA tongue worm infestation can amoebic 
dysentery 
MODERN ASPECT 
CHEMICAL CONSTITUENT:  
The naturally occurring association of the smaller molecular weight of 
arabinogalactan and glycoprotein were from isolated gum.59 
MEDICINAL USES:  
Gum is used externally for burns, sore nipples, cough, diarrhoea, dysentery, 
haemorrhage and externally to cover inflamed areas. Gum arabic is used in the food 
industry as a flavour fixative and emulsifier, to prevent crystallization of sugar in 
confections, as a stabilizer in frozen dairy products, for viscosity. 
3.2. DISEASE REVIEW 
3.2.1. SIDDHA ASPECT OF THE DISEASE 
ADHI THOOLA ROGAM 
In Siddha system of medicines, dyslipidaemia condition is correlated with Adhi 
thoola rogam. 
Adhi – Excess 
 
Thoola - Body (muscle mass) 
 
Rogam - Ailment 
SYNONYMS 
Mikkakozhuta udambu - Excessive accumulation of fat in the body. Athitoolam, 
Mikkaparithauambu - Excessive development of muscular tissues.60 
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SYMPTOMS 
Adiposity in abdomen, thigh, breast and gluteal regions. decrease in happiness, 
increased fatigue, tiredness, decrease in intelligence, shaking of the body parts while 
walking, increased kapha-pitha disorders.it also brings dosham of sperm and ovum result 
in in distribution of conception. 
DYSLIPIDEMIC DRUGS USED IN SIDDHA MEDICINE 
▪ Ekku chendooram 
 
▪ Amukkura podi 
 
▪ Thuthuvalai Karpam 
 
▪ Saccharum spontaneum 
 
▪ Bauhinia purpurea 
 
▪ Shuddha guggulu 
 
▪ Vrikshamla 
   
3.2.2. MODERN ASPECT OF THE DIESASE  
LIPIDS 
Lipids {Greek: lipos-fat} are of great importance to the body as the chief 
concentrated storage form of energy, besides their role in cellular structure and various 
other biochemical functions. As such, lipids are a heterogenous group of compounds and, 
therefore it is rather difficult to define them. 
Lipids may be regarded as organic substance relatively insoluble in water, soluble 
in organic solvents (alcohol, ether etc.), actually or potentially related to fatty acids and 
utilised by the living cells. 
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CLASSIFICATION OF LIPIDS 
Lipids are broadly classified in to simple, complex, derived and miscellaneous lipids, 
which are further divided in to different groups. 
1. SIMPLE LIPIDS: Esters of fatty acids with alcohols. These are mainly of two 
types. 
(a) FATS AND OILS (Triacylglycerlols) 
(b) WAXES 
2. COMPLEX OR COMPOUND LIPIDS: 
These are esters of fatty acids with alcohols containing additional groups such as 
phosphate, nitrogenous base, carbohydrate, protein etc. They are further divided as 
follows 
(a) Phospholipids: It is further classified into: 
1. Glycerophospholipids 
2. sphingophospolipids 
(b) Glycolipids 
(c) Lipoproteins 
(d)  Other complex lipids  
3.DERIVED LIPIDS 
4.MISCELLANEOUS LIPIDS 
5.NEUTRAL LIPIDS 
 FUNCTIONS OF LIPIDS: 
➢ They are the concentrated fuel reserve of the body (triacylglycerols). 
➢ Regulate the permeability of membrane (phospholipids and cholesterol). 
➢ They serve as a source of fat-soluble vitamins (A, D, E and K). 
➢ Lipids are important as cellular metabolic regulators (steroid hormones and 
prostaglandins). 
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➢ Lipids protect the internal organs, serve as insulating materials, and give shape 
and smooth appearance to the body.61 
LIPOPROTEINS 
Lipoproteins consists of lipids and proteins. The function as transport vehicles 
lipids in blood plasma.  
STRUCTURE OF LIPOPRTEINS 
Neutral lipid core surrounded by a coat shell of phospholipids, apoproteins and 
cholesterol.  
CLASSIFICATION OF LIPOPROTEIN 
Five major classes of lipoproteins are identified in human plasma, based on 
their separation by electrophoresis. 
1) Chylomicrons 
2)   Very low-density lipoprotein 
3)   High density lipoproteins 
4)   Low density lipoproteins 
5)   Free fatty acids—albumin 
Table No:3.1. Lipoprotein Patterns (Fredrickson Phenotypes) 
 
  
Elevated Lipoprotein(s) 
 
Elevated Lipids 
I Chylomicrons TGs 
IIa LDL Cholesterol 
IIb LDL and VLDL TGs and cholesterol 
III VLDLand chylomicron remnants  TGs and cholesterol 
IV VLDL TGs 
V Chylomicrons and VLDL TGs and cholesterol 
LDL = low-density lipoprotein; TGs = triglycerides; VLDL = very-low-
density lipoprotein.62 
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METABOLISM OF LIPOPROTEIN 
A general of lipoprotein metabolism is depicted. Chylomicrons are synthesized in 
the small intestine during the course of fat absorption. They contain apoprotein B48 name 
is given since this apoprotein contains 48% of protein coded by apo B gene. Chylomicrons 
are produced when nascent particles combine with apo C II and apo E, derived from HDL. 
ROLE OF LIPOPROTEIN LIPASE: 
It hydrolyses a portion of triacylglycerols present in chylomicrons and VLDL to 
liberate free fattyacids and glycerol. Lipoprotein lipase is activated by apo C II. 
UPTAKE OF CHYLOMICRON REMNANTS BY LIVER: 
The chylomicron remnants are taken uo by receptors present on the hepatocytes of 
liver. 
CONVERSION OF VLDL TO LDL 
During the course of VLDL metabolism intermediate density lipoprotein is formed 
which lose apo-E and get connected to LDL. 
Cholestrol Ester Transfer Protein 
CETP is synthesized in the liver and it facilitates the exchange of components 
between different the exchange lipoproteins. 
  LDL Receptors and Supply of Cholesterol to Tissues 
The most important function of LDL is to supply cholesterol to the extrahepatic 
tissues.  
DEFICIENCY OF LDL RECEPTORS: 
A defect in LDL receptor results in the elevation of plasma LDL, hence plasma 
cholesterol. However, plasma triacylglycerol concentration remains normal. Deficiency 
LDL receptors is observed in a type IIa hyper beta lipoproteinaemia. This disorder is 
associated with a very high risk of atherosclerosis. 
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The evidence implicating hypercholesteremia in atherogenesis includes the following 
observations: 
1. The dominant lipids in atheromatous plaques are cholesterol esters. 
2. Genetic defects in lipoprotein uptake and metabolism that because 
hyperproteinaemia is associated with accelerated atherosclerosis. 
                    3.Lowering serum cholesterol by diet or drugs slows the rate of progression of 
atherosclerosis, causes regression of some plaques, and reduces the risk of cardiovascular 
events. 
The mechanisms by which hyperlipidaemia contributes to atherogenesis include the 
following: 
Oxidised LDL is indigested by macrophages through a scavenger receptor, distinct 
from the LDL receptor, resulting in foam -cell formation. In addition, oxidised LDL 
stimulates the release of growth factors, cytokines, and chemokines by ECs and 
macrophages that increase monocyte recruitment into lesions. Finally, oxidised LDL is 
cytotoxic to ECs and smooth muscle cells (SMCs) and can induce EC dysfunction. 
The importance of oxidised LDL in atherogenesis is suggested by its accumulation 
within macrophages at all stages of plaque formation. Moreover, antioxidant therapy (β-
carotene and vitamin E) protects against atherosclerosis in animal models, but it does not 
appear to be effective for preventing IHD. 
DYSLIPIDEMIA 
Dyslipidemia is elevation of plasma cholesterol, triglycerides (TGs), or both, or a 
low HDL cholesterol level that contributes to the development of atherosclerosis. Causes 
may be primary (genetic) or secondary. Diagnosis is by measuring plasmalevels of total 
cholesterol, TGs, and individual lipoproteins. Treatment involves dietary changes, 
exercise, and lipid-lowering drugs. 
CLASSIFICATION 
Dyslipidemias were traditionally classified by patterns of elevation in lipids and 
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lipoproteins. A more practical system categorizes dyslipidemias as primary or secondary 
and characterizes them by, 
 Increases in cholesterol only (pure or isolated hypercholesterolemia) 
 Increases in TGs only (pure or isolated hypertriglyceridemia), 
 Increases in both cholesterol and TGs (mixed or combined hyperlipidemias) 
Both primary and secondary causes contribute to dyslipidemias in varying degrees. For 
example, in familial combined hyperlipidemia, expression may occur only in the presence 
of significant secondary causes. 
PRIMARY CAUSES 
Primary causes are single or multiple gene mutations that result in either 
overproduction or defective clearance of triglycerides and LDL or in underproduction or 
excessive clearance of HDL. 
The names of many primary disorders reflect an old nomenclature in which 
lipoproteins were detected and distinguished by how they separated into alpha (HDL) and 
beta (LDL) bands on electrophoretic gels. 
SECONDARY CAUSES 
Secondary causes contribute to many cases of dyslipidemia in adults. 
The secondary cause of dyslipidemia in developed countries is sedentary lifestyle with 
excessive dietary intake of saturated fat, cholesterol, and trans fats. 
Trans fats are polyunsaturated or monounsaturated fatty acids to which hydrogen 
atoms have been added; they are used in some processed foods and are as atherogenic as 
saturated fat. 
       Other common secondary causes of dyslipidemia include 
 Alcohol overuse 
 Hypothyroidism  
 Primary biliary cirrhosis and other cholestatic liver diseases 
 Drugs, such as thiazides, beta-blockers, retinoids, highly active antiretroviral 
agents, cyclosporine, tacrolimus, estrogen and progestins, and glucocorticoids 
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 Secondary causes of low levels of HDL cholesterol include cigarette smoking, 
anabolic steroids, HIV infection, and nephrotic syndrome. 
 chronic kidney disorders 
SIGNS AND SYMPTOMS: 
 Dyslipidemia itself usually causes no symptoms but can lead to symptomatic 
vascular disease, including coronary artery disease (CAD), stroke, and peripheral 
arterial disease. 
 High levels of triglycerides (> 1000 mg/dL [> 11.3 mmol/L]) can cause acute 
pancreatitis. 
 High levels of LDL can cause arcus corneae and tendinous xanthomas at the 
Achilles, elbow, and knee tendons and over metacarpophalangeal joints. Other 
clinical findings seen in patients with high LDL (eg, in familial 
hypercholesterolemia) include xanthelasma (lipid rich yellow plaques on the 
medial eyelids). 
 Xanthelasma can also occur in patients with primary biliary cirrhosis and normal 
lipid levels. 
 Patients with the homozygous form of familial hypercholesterolemia may have 
arcus corneae, tendinous xanthomas and xanthelasma plus planar or tuberous 
xanthomas. 
 Planar xanthomas are flat or slightly raised yellowish patches. Tuberous 
xanthomas are painless, firm nodules typically located over extensor surfaces of 
joints. 
 Patients with severe elevations of TGs can have eruptive xanthomas over the 
trunk, back, elbows, buttocks, knees, hands, and feet. Patients with the rare 
dysbetalipoproteinemia can have palmar and tuberous xanthomas. 
 Severe hypertriglyceridemia (> 2000 mg/dL [> 22.6 mmol/L]) can give retinal 
arteries and veins a creamy white appearance (lipemia retinalis). 
Extremely high lipid levels also give a lactescent (milky) appearance to blood plasma. 
Symptoms can include paresthesias, dypsnea, and confusion.  
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BILE ACID SEQUESTRANTS 
Bile acid sequestrants block intestinal bile acid reabsorption, forcing up-regulation of 
hepatic LDL receptors to recruit circulating cholesterol for bile synthesis. They are proved 
to reduce cardiovascular mortality.  
Cholestyramine, colestipol, and colesevelam (but to a lesser degree), interfere with 
absorption of other drugs—notably thiazides, beta-blockers, warfarin, digoxin, and 
thyroxine—an effect that can be decreased by administration at least 4 h before or 1 h after 
other drugs. Bile acid sequestrants should be given with meals to increase their efficacy. 
CHOLESTEROL ABSORBATION INHIBITORS 
Cholesterol absorption inhibitors such as ezetimibe, inhibit intestinal absorption of 
cholesterol and phytosterol. Ezetimibe usually lowers LDL cholesterol by 15 to 20% and 
causes small increases in HDL and a mild decrease in triglycerides. 
PCSK9 MONOCLOAL ANTIBODIES 
PCSK9 monoclonal antibodies are available as subcutaneous injections given once 
or twice per month. These drugs keep PCSK9 from attaching to LDL receptors, leading to 
improved function of these receptors. LDL cholesterol is lowered by 40 to 70%. A 
cardiovascular outcomes trial with evolocumab showed a decrease in cardiovascular events 
in patients with prior atherosclerotic cardiovascular disease. 
DIETARY SUPPLIMENTS 
Dietary supplements that lower LDL cholesterol levels include fiber supplements 
and commercially available margarines and other products containing plant sterols 
(sitosterol and camphesterol) or stanols. The latter reduce LDL cholesterol by up to 10% 
without affecting HDL or TGs by competitively displacing cholesterol from intestinal 
micelles. 
 
 
REVIEW OF LITRATURE 
 
ANTIDYSLIPIDEMIC ACTIVITY OF INDHIRANI MAATHIRAI                  41 
 
FUTURE THERAPIES 
Future therapies to reduce LDL include peroxisome proliferator–activated receptor 
agonists that have thiazolidinedione-like and fibrate-like properties, LDL-receptor 
activators, LPL activators, and an adenosine triphosphate-citrate lyase/adenosine 
monophosphate activated kinase modulator. 
Cholesterol vaccination (to induce anti-LDL antibodies and hasten LDL clearance 
from serum) and gene transfer are conceptually appealing therapies that are under study but 
years away from being available for use. 
ELEVATED LDL CHOLESTEROL IN CHILDREN 
 Dietary treatment for children with LDL cholesterol > 110 mg/dL (> 2.8 mmol/L). 
Drug therapy is recommended for children > 8 yr and with either of the following: 
 Poor response to dietary therapy, LDL cholesterol ≥ 190 mg/dL (≥ 4.9 mmol/L), 
and no family history of premature cardiovascular disease 
 LDL cholesterol ≥ 160 mg/dL (> 4.13 mmol/L) and a family history of premature 
cardiovascular disease or ≥ 2 risk factors for premature cardiovascular disease. 
HIGHER HDL 
            Treatment includes lifestyle changes such as an increase in exercise and weight 
loss. Alcohol raises HDL cholesterol but is not routinely recommended as a therapy 
because of its many other adverse effects. Drugs may be successful in raising levels when 
lifestyle changes alone are insufficient, but it is uncertain whether raising HDL levels 
reduces mortality. 
TREATMENT FOR SECONDARY CAUSES OF DYSLIPIDEMIA 
➢ Treatment of diabetic dyslipidemia should always involve lifestyle changes and 
statins to reduce LDL cholesterol.  
➢ To decrease the risk of pancreatitis, fibrates can be used to decrease TGs when 
levels are > 500 mg/dL (> 5.65 mmol/L).  
➢ Metformin lowers TGs, which may be a reason to choose it over other oral 
antihyperglycemic drugs when treating diabetes. 
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➢ Some thiazolidinediones (TZDs) increase both HDL cholesterol and LDL 
cholesterol. Some TZDs also decrease TGs.  
➢ These antihyperglycemic drugs should not be chosen over lipid-lowering drugs to 
treat lipid abnormalities in patients with diabetes but may be useful adjuncts.  
➢ Patients with very high TG levels and less than optimally controlled diabetes may 
have a better response to insulin than to oral antihyperglycemic drugs. 
MONITORING TREATMENT: 
Lipid levels should be monitored periodically after starting treatment. No data 
support specific monitoring intervals but measuring lipid levels 2 to 3 mo after starting or 
changing therapies and once or twice yearly after lipid levels are stabilized is common 
practice. 
If statin-induced muscle damage is suspected, statin use is stopped and CK may be 
measured. When muscle symptoms subside, a lower dose or a different statin can be tried. 
If symptoms do not subside within 1 to 2 wk of stopping the statin, another cause should 
be sought for the muscle symptoms (eg: polymyalgia rheumatica) 65 
Treatment of dyslipidemia in patients with hypothyroidism, chronic kidney 
disease, liver disease, or a combination of these disorders involves treating the underlying 
disorders primarily and lipid abnormalities secondarily. Abnormal lipid levels in patients 
with low-normal thyroid function (high-normal TSH levels) improve with hormone 
replacement. Reducing the dosage of or stopping drugs that cause lipid abnormalities 
should be considered. 
3.3. PHARMACEUTICAL REVIEW 
Purification processes in Siddha system (suddhiseithal) 
The process of detoxification or purification of the drug is called ‘suddhiseithal’ 
in Siddha medical terminology. 
Nature has created innumerable plant, herbs, metals, poisonous substances, 
minerals, salts and other organic substances. The Siddha had selected such of those things 
which can render relief to innumerable ailments of mankind suffered. Any matter in nature 
has to be utilized for medicine purposes the properties which may cause bad effects should 
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be neutralized or eliminated. That’s why every raw drug used in Siddha medicine is 
purified before preparing it as a medicine. 
Purification 
The exact part of the herb which has been prescribed should alone be taken for 
medicine. There should not be other impurities like mud, sand or any such thing. If it is 
green leaf, dried or decomposed leaves or insects should be eliminated. Care should be 
taken in identifying the herbs properly. 
As a general rule, when anything is subjected to be processed by using heat, 
soaking either alone or with some other substance, some chemical reaction may take 
place.  In these process impurities, toxins would be eliminated and the substances become 
purified. Hence some of the poisonous herbs which are purified by using heat. 
Importance of purification 
The drugs when subjected to heat like roasting or soaked in liquids undergo some 
chemical reactions. Such as oxidation of toxic substances to non-toxic substances, 
elimination of certain poisonous chemicals to non- poisonous substances. In these ways 
not only the toxicity, impurities or removed but also enhance the potency of the drugs.  
Mathirai :( 57) 
 The ingredients should be first purified and powdered into a fine powder and 
then macerated with the prescribed juices or liquid one after the other in their order. 
Each time it must be grinded till it becomes waxy in consistency does not adhere to the 
fingers or mortar and pestle; lastly it must be made into pills as prescribed and dried in 
shade.  
Other names : Kuligai 
Rule of tablet preparation 
➢ Before preparing mathirai, the raw drugs required are powdered separately and 
then mixed to attain homogeneity, then grinded together until it reaches waxy in 
consistency. 
➢ The fine paste which does not stick to the mortar should be considered as the right 
consistency for rolling pills. 
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➢ If any of the preparation of pills, if mercury and sulfur are the key ingredients, 
mercury should be grinded first and sulfur is added to it and grinded and further 
continued. 
➢ In case of inclusion of hard raw drugs, they should be grinded first; the reason 
behind this if hard substances are added to smooth substances, they will not be 
grinded finely.  
➢ Croton seeds if included can be grinded at the last: because croton on grinding 
releases oil; if added early the effect of medicine will be suppressed, so it should 
be added finally. 
➢ Aromatic substances like camphor, lac, musk, are added just before 24 minutes 
the paste reaches waxy consistency. 
➢ The paste should not adhere to the mortar nor does it adhere to the pestle. 
Storage 
They should be stored in well stopper glass vials, with relevant labels and 
instructions.  
Shelf life of medicines 
Medicines can be classified into internal and external medicines. They are each in 
32 types. Mathirai comes under the category of internal medicines. The shelf life of 
medicines indicates the potency of medicines. The medicines even though seems to be 
fresh is not efficacious after sometime. So, the medicines should not use after certain 
period. 
THE SHELF LIFE OF MATHIRAI, 
As per Siddha literature Agamarunthu padal in Gunapadam Thathu-seevam text 
“உயரச்ூர ணம்பிடட்ு வடகம் வவண் வணய்நான்கி 
         னுயிரம்ூன்று திங்கவெண்வணய் 
விரலிடுமு யரந்்தமாத்  திரரகடுகு பக்குவம் 
         ......................................................................... 
 வகாெ்ொறு  மமாராண்டு..........................................  
      - குணபாடம் தாது சீவம் வகுப்பு 
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  From above the quote the shelf life of Mathirai is 1 yr. But according to Ayush 
guidelines the shelf life is 2 yr.  
 Traditional tests for Mathirai  
 Characters  
• Non sticky on rolling 
• No cracks over the surface after drying 
• Shall be rolled uniformly over the plane surface.  
Based on these characters the drug is assessed as the appropriate one for medication. 
Table No 3.2: Testing parameters for Mathirai-AYUSH guidelines 
S.No Tests 
  1 Description, Colour, Odour 
  2 Weight Variation 
  3 Disintegration Time (Not more than 15 minutes) 
  4 Identification TLC/ HPTLC/GLC 
  5 Assay 
  6 Test for heavy/toxic metals 
Mercury 
Arsenic 
Cadmium 
Lead 
    7 Microbial Contamination 
Total Bacterial count 
Total Fungal count 
     8 Test for specific pathogen 
E.coli 
Salmonella species 
Pseudomonas aeruginosa 
Streptococcus aureus 
    10 Test for aflatoxins B1, B2, G1, G2 
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 Modern Aspect of the formulation: 
Tablet (Pill)-Mathirai 
A tablet is a pharmaceutical dosage form, it otherwise called as caplet. Medicinal 
tablets are called as "pills". Originally "pills" referred specifically to a soft mass rolled 
into a ball shape, rather than a compressed powder. (58)  
As per Indian Pharmacopeia 2007 defined the Tablets are solid dosage forms each 
containing a unit dose of one or more medicaments. They are anticipated for oral route. 
A tablet consists an active medicament with excipents which are in powder form are 
compressed or pressed into a solid dosage form. About two third drugs prescribed are in 
solid dosage form and tablets include half of them. 
Classification: 
 As per IP2007 tablets are majorly classified into following categories (Indian 
pharmacopoeia 2007) 
1. Uncoated Tablets: 
 This type of tablets contains single layer or more than one-layer tablet consisting 
of active ingredient with the excipents, no additional cover is applied on to it after the 
compression. 
2. Coated Tablets: 
 Coated types of tablets have an additional coating layer on it after the tablet was 
compressed, the coating layer of tablets formed with sugar, gums, resins, inactive or 
insoluble fillers, plasticisers, polyhydric alcohols, waxes. 
3. Dispersible Tablets:  
 These are the film coated or uncoated tablets because a uniform dispersion when 
suspended in water 
4. Effervescent Tablets:  
These type of tablets which are uncoated and are planned to be dissolved and 
produce an dispersion before they are administered the dissolution is achieved by the 
reaction between an organic acid and bicarbonate which produce CO2, thus produced CO2 
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will disintegrate the tablet so which dissolves in the solution to produce an suspension 
which was rapidly absorbed. 
5. Modified-release Tablets:  
 These types of tablets are the coated or uncoated tablets which are designed in 
such a way that the rate or location of the active ingredient released is modified. It includes 
enteric coated tablets, prolong release tablet or delay release tablet.  
A) Enteric-coated Tablets:  
 These are also called as gastro resistant tablets as they resistant to the gastric 
juices; these are formulated by coating the tablet with anionic polymer of methylacrylic 
acid and their esters or by coating with cellulose acetyl pthylate. 
 E.g: erythromycin, NSAIDS 
B) Prolonged- release Tablets:  
These types are otherwise called as sustain release tablets or extended release 
tablets was formulated in such a way that the active ingredient is released for a prolong 
duration of time and is available in systemic circulation after administration. 
C) Delayed-release Tablets:  
This dosage form was planned to release the drug after some time delay or after 
the tablet has passed one part of the GIT into another. All enteric coated tablets are type 
of delayed action tablet but all delayed action of tablets was not enteric or not intended to 
produce enteric action. 
6. Soluble Tablets: 
These are coated or uncoated tablets which are planned to dissolve in water before 
they are administered. 
7.  Tablets for Use in the Mouth: 
These are the tablet formulations which are planned to be show local action in the 
buccal cavity. These include buccal tablet, Sublingual Tablets and Troche or lozenges. 
Buccal tablets are placed in between the cheek and gingival. Sublingual tablets are placed 
below the tongue E.g: glyceryl trinitrate. 
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8. Tablets for other routes of administration:  
These include implantable tablets and vaginal tablet. These are inserted in to the 
rectum or vagina for their local or systemic action. 
Tablet Ingredients: 
A tablet consists of active medicament with excipents which are in powder form are 
compressed or pressed into a solid dosage form. In addition to active ingredients, tablet 
contains a number of inert materials known as additives or excipents. (59) 
• Diluent  
• Binder and adhesive  
• Disintegrents  
• Lubricants and glidants  
• Colouring agents  
• Flavouring agents  
• Sweetening agents  
1. Diluent:   
Diluents are fillers are used to make bulk of the tablet when the drug dosage itself 
was inadequate to produce the bulk these are used. Secondary reason is to provide better 
tablet properties such as improve cohesion, to permit use of direct compression 
manufacturing or to promote flow. 
2.Binders and Adhesives:These materials are added either dry or wet form granules or 
to form cohesive compacts for directly compressed tablet. Ex: Acacia, tragacanth-solution 
for 10-25% concentration.  
3. Disintegrents:  
It added to the tablet formulations to facilitate its breaking or disintegration, when 
it contacts in water in the GIT.  Example: Starch- 5-20% of tablet weight. Super 
Disintegrents: Swells up to ten-fold within 30 seconds when contact water. Example: 
Crosscarmellose- cross-linked cellulose. 
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4. Lubricant and Glidants:  
Lubricants are planned to prevent adhesion of the tablet materials to the surface 
of dies and punches, reduce inter particle friction and may improve the rate of flow of the 
tablet granulation Example: Lubricants- Stearic acid, stearic acid salt - Stearic acid. 
5. Coloring agent:  
The use of colors and dyes in a tablet has three purposes:  
• Masking off colour drugs  
• Product Identification  
• Production of more elegant product  
 All coloring agents must be approved and certified by FDA. 
1. Flavoring agents: 
For chewable tablet- flavor oil is used  
2. Sweetening agents: 
 For chewable tablets: Sugar, mannitol. Saccharine (artificial):500 times sweeter 
than sucrose. 
Advantages: 
• These are very easy and handy to use. 
• As these are unit dosage form fixed dose was administered. 
• Modified drug release rate and duration of tablets be able to increase their 
therapeutic effect and increase the patient compliance by reducing the frequency 
of drug administration. 
• These are cost-effective dosage forms when compared to other dosage forms 
• The physical, microbial and chemical stability of tablet are superior to other 
dosage forms. 
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Disadvantages: 
• The systemic availability of the drug depends on many physiological factors 
• The onset of action was lesser when compared to Intra Venous route. (except 
sublingual tablets) 
• Geriatric and children of small age cannot swallow the tablets easily. 
3.4.PHARMACOLOGICAL REVIEW 
I. ANTIDYSLIPIDMIC ACTIVITY 
1.TRITON- INDUCED HYPERLIPIDEMIAPURPOSE AND RATIONALE 
The systemic administration of the surfactant Triton to mice or rats results in a 
biphasic elevation of plasma cholesterol and triglycerides (Frzntzyed and hinkelman 
1955; Garattini et al. 1958, 1961; Holmes 1964; tamasi et al. 1968). 
PROCEDURE: 
Male Sprague dawley or wistar weighing 200-350g are starved for 18 h and then 
injected intravenously with 200 mg\kg Triton WR 1399 (isooctyl-polyoxyethylene 
phenol). Serum cholesterol levels increase sharply 2- 3 times after 24h (phase1). The 
hypercholesterolemia decreases nearly to control levels within 24h (phase 2). The test 
drugs employed or the solvent for the controls are administrated simultaneously with the 
Triton injection or 22h thereafter. 
Serum cholesterol analyse are made 6, 24, and 24h after Triton injection. The 
mechanism of the Triton induced hypercholesterolemia in phase 1 is thought to be due to 
increased hepatic synthesis of cholesterol through the ability of Triton too interfere with 
the uptake of plasma lipids by the tissues. Drugs interfering with cholesterol biosynthesis 
were shown to be active in phase 1, while drugs interfering with cholesterol excretion and 
metabolism were active in phase 2. 
EVALUTION 
Mean value standard deviation are calculated for each group and time interval and 
compared statistically with the controls. 
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CRITICAL ASSESSMENT OF THE METHOD 
The method employing Triton hypercholesterolemia is rather simple and rapid for 
detection of the compounds interfering with the synthesis and excretion of cholesterol. 
Since the test is rather artificial, the results have to be validated by other methods. 
2. CHOLESTEROL-DIET INDUCED ATHEROSCLEROSIS IN RABBITS AND 
OTHER SPECIES 
PURPOSE AND RATIONALE  
Rabbits are known to be susceptible to hypercholesterolemia and arteriosclerosis 
after excessive cholesterol feeding, therefore, this approach has been chosen by many 
authors to study the effect of potential ant arteriosclerotic drugs. 
PROCEDURE 
Several modifications of the protocol have been described. Usually, male rabbits 
from an inbred strain, eg, white New Zealand, at an age of 8-10 weeks are used. Body 
weight variation should be as low as possible. At the beginning of the experiment, blood is 
withdrawn from the marginal ear vein for determination of total cholesterol, total 
glycerides and blood sugar. 
Groups of 10 animals are used for treatment with drugs or as controls. The rabbits 
are switched from commercial food to a diet supplemented with 0.3-2% cholesterol and 
kept on this regimen for a period of 10- 12 weeks. One group is kept on normal diet. During 
and at the end of the experiment the blood is taken for analysis. Usually, cholesterol and 
tri glyceride levels increase several- fold over the original values. 
The animals are sacrificed and the thoracic aorta is removed, cleaned of the 
surrounding tissues, and longitudinally cut and opened for fixation with formaldehyde. 
The tissue is stained with oil red. The percentage of the intimal surface covered by the oil 
red positive lesions is calculated with a computerized planimeter. In animals fed normal 
diet, the aorta does not show any staining, whereas in cholesterol- fed rabbits the aorta 
shows severe atherogenic lesion 
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 EVALUATION 
Data are expressed as means standard deviation. Statistical evaluation is 
performed by Dunnett’s or Schefft’s test. A p- value of <0.05 is regarded as statistically 
significant. 
HEREDITARY HYPERLIPEMIA IN RABBITS 
 
Watanabe et al. (1977, 1980) described a strain of rabbits with hereditary 
hyperlipidaemia (WHLL rabbit) which has those observed in humans. This M1. induction 
of experiment atherosclerosis 1100chapter M. Anti-atherosclerosis 1100chapter M. Anti-
atherosclerotic activity animal model is used as background for atherosclerosis research 
and target validation. Walsh et al. (1989) and Rubin et al. 
(1991) integrated human apolipoprotein A-I gene in transgenic mice resulting in an 
increase of HDL levels. 
Linton et al. (1993) described the development of transgenic mice expressing high 
levels of human apolipoprotein B100 which are considered to atherogenic. 
Transgenic mice lacking apolipoprotein E showed severe hypercholesterolemia and 
atherosclerosis (plump et al. 1992; Zhang et al. 1992). 
Overexpression of apolipoprotein E in transgenic mice reduced plasma cholesterol 
hypercholesterolemia and inhibited (Harada et al. 1996) 
FRUCTOSE INDUCED HYPERTRIGLYCERIDEMIA IN RATS 
 
PURPOSE AND RATIONALE 
Rats switched from a diet low in carbohydrates and high in protein to high intake of 
inhibition of this phenomenon afterwards, the animal is offered 20 % fructose.  
Male Sprague Dawley rats weighing 200- 250 g are fred over a period of one 
PURPOSE 
Male Sprague Dawley rats weighing 200- 250 g are fred over a period of one week 
a diet enriched in protein with reduced carbohydrates content eg, altromin C1 080 or C1 009. 
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Groups of 10 animals are treated for 3 days with the test compound or the standard 
(clofibrate 100mg/kg) or the vehicle (polythene glycol) by oral gavage. From the second 
to the third-party water is withheld for a period of 24h. immediatel Solution ad lithium for 
a period of 20h after the last application of the test compound, the animals are anesthetized 
with ether and 1.2 ml blood is withdrawn by retroorbital puncture. The blood is centrifuged 
for 2 min at 16000g. total glycerol is determined in the serum according to Richterlich and 
Lauber (1962) 
EVALUTION 
The average values of total glycerol of the treated groups are compared with the 
control groups using students ‘st- test 
INHIBITION OF ISOLATED ENZYME HMG-COA REDUCTASE IN VITRO 
PURPOSE AND RATIONALE 
For screening purpose, studies on the inhibition of HMG-COA reductase obtained 
from rat liver microsomal fraction can be used (Avigan et al. 1975; Philipp and shapiro 
1979). 
PROCEDURE 
The inhibitory activity of the test compound on HMG CoA reductase is estimated 
with soluble enzyme preparations obtained from the microsomal fraction of rat liver 
(Philipp and Shapiro 1979). 
The enzyme reaction is carried out with 50 ul partially purified HMG CoA 
reductase in buffer containing 25 Mm Tris, 10M EDTA, and 10 mM dithiothreitol at ph. 
7.5, 20 ul of 910 µM HMG- CoA solution containing 100 nCi (3-7KBq) of 14 C- HMG-
CoA and 20 ul of ADPH regenerating system (5.2x 10 -3 M glucose 6- phosphate, 
dehydrogenase, 5.3 x 10-3 M NADP), with the actual concentration of 50 mM NADPH 
The final incubation volume is 200ul. 
The main reaction is preceded by 20 min preincubation with the NAPDH regenerating 
system at 37’c followed by 20 min incubation at 37’c of the completed samples with the 
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test compound or the standard and stopped by addition of 75 µl 2 N HCLO4. After 60 min 
at room temperature, the samples are cooled in an ice bath and neutralized by addition of 
75 ul 3N potassium acetate. Supplementing the volume 500µl, the precipitate is centrifuged 
and 250ul of the clear supernatant are applied to a column (0.6 x 8.0 cm of BIORAD AG 
1-X8 (100-200 mesh) 
Mevalolactone is eluted with water discarding the first 750 µl and collecting the 
next 3500ul. Five hundred ul of the eluate are used for measurement in duplicate, mixed in 
vials with 10 ml Ouickscint(Zinsser) and measured in a liquid scintillation counter 
(Beckman). The assay is generally performed in triplicate. Lovastatin sodium is used as 
standard. 
EVALUATION 
 
The means values with and without inhibitors are compared for the calculation of 
inhibition. IC50 values are calculated, 
EX-VIVO INHIBITION OF CHOLESTROLBIOSYTHESIS IN ISOLATED RAT 
LIVER SLICES PURPOSE AND RATIONALE 
Inhibition of cholesterol biosynthesis in rat livers can be measured in an ex vivo assay 
after oral treatment with HMG-CoA reductase inhibitors by cholesterol synthesis from 
labelled sodium octanoate. 
PROCEDURE 
Male Sprague Dawley weighing 110_ 130 g are kept on a reverse light cycle (lights 
3:00 p.m to 3.00 a.m.) for 14 days prior to use, through the period of adaptation, the rats 
have free access to a low cholesterol diet and tap water. On the day of the experiment, the 
test compounds are given orally between 9:00 and11:00 a.m. as suspension in 0.5% 
methylcellulose. 
After one hour, the rats are sacrificed, the livers removed and transferred to chilled 
oxygenated Krebs-Ringer-bicarbonate buffer (pH 7.4). the livers are then chopped into 
0.8mm2 pieces using a McElwain tissue chopper (eg, Brinkmann Instr., Westbury, USA)  
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N and are suspended in the same buffer. 
Aliquots of the suspension are pipetted, in triplicate, into culture tubes which 
contains (14 c) sodium octanoate (300uM/1,6.67 Ci/M). The assay volume is 1ml. The tubes 
are gassed with 95% O2 /5% CO2 for 10 s, stoppered with a serum cap, and incubated at 
370 Celsius in a metabolic shaker at 150 oscillations/min for 90 min. 
The reaction is stopped by addition of 1ml 15% KOH in ethanol. An aliquot of the 
mixture assayed for protein concentration. An internal standard [3 H] cholesterol (30 000 
dpm) is added to determine recovery, which ranges from 70-80%. 
The tubes are saponified at 75 degrees Celsius for 2 h and then extracted with 10 
ml petroleum ether for 30 min. the lower aqueous phase is frozen in a dry ice/alcohol 
mixture, and the ether phase is removed, washed with 2ml glass- distilled water and then 
evaporated to dryness. 
The cholesterol synthesised is separated by thin layer chromatography on plastic 
silica gel plates using chloroform as eluent, after visualisation with iodine, the cholesterol 
spots are cut out, and radioactivity quantitated by liquid scintillation counting. 
EVALUTION 
Results are expressed as percentage inhibition compared to vehicle -treated control values. 
Using various doses, ED50 values of inhibition can be calculated from dose response 
curves.69 
HYPO GLYCEMIC ACTIVITY 
 
STREPTOZOTOCIN-  INDUCED  DIABETES  STZ (2- deoxy(3methyl 3 nitrosourea) 
1-D – glucopyranose ) is board- spectrum antibiotic, which is produced from Streptomyces 
achromogen. Rakieten et al. first described the diabetogenic property of STZ. 
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Mechanism of causing B cell damage 
 
1) By processes of methylation 
2) Free radical generation and 
3) Nitric oxide production 
PROCEDURE 
STZ induces diabetes in almost all species of animals. Diabetogenic dose varies with species 
and the optimal dose required in various specious are: rats (50-60 mg/kg 
i.p. or i.v.), mice (175-200 mg/kg i.p or i.v) and dogs (15mg/kg for 3 days) the blood 
glucose level shows the same triphase response as seen in the alloxan treated animals, 
hyperglycaemia at 1h, followed by hypoglycaemia, which lasts for 6h, stable 
hyperglycaemia by 24-48h after STZ administration. 
MODIFICATION 
Multiple low dose of STZ also induces diabetes by causing immune mediated 
pancreatic insulitis in rats. It has also been shown to have diabetogenic effect on the golden 
hamsters when given i.p. at a dose of 50mg/kg. cyclosporin-A when given with STZ 
enhances its diabetogenic efficacy. STZ combined with complete Freud’s adjuvant: each 
of CFA, incomplete Freud’s adjuvant. 
Mycobacterium butyricum (component of CFA), Listeria monocytogenes, or 
endotoxin administered 24h prior to STZ (25 mg/kg) and then repeated in the three 
subsequent weeks, all produce hyperglycaemias. Fasting for 48h (24h prior to and 24h 
subsequent to STZ injection) also produces hyperglycaemia. Neither four administrations 
of CFA nor of STZ alone result in persistent hyperglycaemia. 
ADVANTAGES AND DISADVANTAGES 
STZ has almost completely replaced alloxan for inducing diabetes because of: 
 
1) Greater selectively towards β-cells 
2) Lower mortality rate 
3) Longer or irreversible diabetes induction 
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4) However, guinea pigs and rabbits are resistant to its diabetogenic action. 
 
ALLLOXAN INDUCED DIABETES 
 
             Alloxan a cyclic urea analog, was the first agent in this category, which was 
reported to produce permanent diabetes in animal. 
MECHANISM OF ACTION 
The mechanism by which it induces diabetes is not very clear. Alloxan is highly 
reactive molecule that is readily reduced to diuleric acid, which is auto oxidised back to 
alloxan resulting in the production of free radicals. These free radicals damage the DNA of 
β cells and cause cell death. Second mechanism proposed for alloxan is its ability to react 
with protein SH groups, especially the membrane proteins like glucokinase on the b cells, 
finally resulting in cell necrosis. However, there are major species difference in response 
to alloxan. 
CHEMICALLY INDUCED DIABETES 
 
Chemically induced type 1 diabetes is most commonly used animal model of 
diabetes. Chemical agents which produce diabetes can be classified into three categories 
and include agents that 
4) Specifically, damage b cells 
5) Cause temporary inhibition production and/ or secretion 
6) Diminish the metabolic efficacy of insulin in target tissues. 
In general, chemicals in the first category are of interest as they reproduce 
lesions resembling IDDM. 
HORMONE INDUCED DIABETES MELLITUS 
 Dexamethasone, a long acting glucocorticoid is used to produce NIDDM, NIDDM 
form of diabetes is produced when dexamethasone is administered at a dose of 2-5 mg/kg 
i.p twice daily over a number of days in rats. 
 Besides rat models, other experimental models using guinea pigs and rabbts are also 
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reported for the study of diabetes using corticotrophin is used to stimulate adrenal cortex 
that results in hormonal balance causing steroid diabetes. 
INSULIN ANTIBODIES-INDUCED DIABETES 
Giving bovine insulin along with CFA to guinea pigs produces anti- insulin 
antibodies. Intravenous injection of 0.25-1 ml guinea pig anti-insulin serum rats induces a 
dose dependent increase in blood glucose levels up to 300 mg%. this unique effect to guinea 
pig anti-insulin serum is due to neutralization of endogenous insulin by the insulin 
antibodies.It persists as long as the antibodies are capable of reacting with insulin 
remaining in the circulation. Slow i.e. infusion or i.p. injection prolongs the effect for more 
than few hours. However, large doses and prolonged administration are accompanied by 
ketonemia, ketonuria, glycosuria and acidosis and are fatal to the animals. After lower 
doses the diabetic syndrome is reversible after a few hours.70 
ANTI-OXIDANT ACTIVITY 
 
DPPH RADICAL SCAVENGING ACTIVITY 
 
The free radical scavenging activity of methanol extract was measured by 1,1 
diphenyl -2- picryl -hydrazyl (DPPH) using the method of Blois (1958) 0.1 Mm solution 
of DPPH in methanol was prepared and 1ml of this solution was added to 3ml of various 
concentrations of methanol extract and reference compound (125,250,500, and 1000 µg / 
ml). After 30 min, absorbance was measured at 517nm. BHT was used as a reference 
material. 
All the tests were performed in triplicate and the graph was plotted with mean value. 
The percentage of inhibition was calculated of reference compound (control) and samples. 
% of inhibition= {(A blank/A sample)/A blank} multiplied by 100 by comparing the 
absorbance values Where “A blank” is the absorbance of control reaction (containing all 
reagents except the test sample) and A sample is the absorbance of the extracts/standard. 
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HYDROXYL RADICLE SCAVENGING ACTIVITY 
The scavenging capacity for hydroxyl radical was measured according to the 
modified methods of Halliwell et al. (1987). Stock solution of EDTA (1mM), fecl3 (10ml), 
ascorbic acid (10 mM), deoxyribose (10 mM), were prepared in distilled deionized water. 
The assay was performed by adding 0.1 ml EDTA, 0.01ml of Fecl3, 0.1 ml h2o2, 
0.36ml of deoxyribose, 1.0 ml of the extract of the different concentration (125,250,500& 
100 µg/ml) dissolved in distilled water, 0.33 ml of phosphate buffer (50mM, pH 7,9), 0.1ml 
of ascorbic acid in sequence. 
The mixture was then incubated at 37degree C for 1 hour. 1.0 ml portion of the 
incubated mixture was mixed with 1.0 ml of 10 % TCA and 1.0 ml of 0.5 % TBA (in 
0.025 M NaOH containing 0.025 % BHA) to develop the pink chromogen measured at 532 
nm. The hydroxyl radical scavenging activity of the extract is reported as % inhibition of 
deoxyribose degrading is calculated by using the following equation. 
Hydroxyl   radical   scavenging   activity   =   {(A0-    A1)/A0)    *100} where, A0 is 
the absorbance of the control reaction and A1 is the absorbance in presence of all of the 
extract samples and reference. All the tests were performed in triplicates and the result were 
averaged 
SUPEROXIDE RADICLE SCAVENGING ACTIVITY 
Super oxide anion scavenging activity was measured according to the method of 
Roback and Gryglewski (1988) with some modifications. All the solution was prepared in 
100 mM phosphate buffer (pH 7.4) 1 ml of reduced Nicotinamide adenine dinucleotide 
(NADH, 468 µm) 3 ml of the plant extract of different concentration (125, 250, 500&100 
g/ml) were mixed. 
The reaction was initiated by adding 100 ml of phenazine methosulphate (PMS 60 
um). The reaction mixture was incubated at 25-degree C for 5 min, followed by 
measurement of the absorbance at 560 nm. The percentage inhibition was calculated by 
using the following equation superoxide radicle scavenging activiy: {(A0- A1)/A0) *100} 
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Superoxide radicle scavenging activity:  
 
Where, A0 is absorbance of the control reaction and A1 is the absorbance in 
presence of all of the extract samples and reference. All the tests were performed in 
triplicates and the results were averaged. 
ANTIOXIDANT ACTIVITY BY ABTS ASSAY 
The radical scavenging activity of the extract was also analysed by the 2, 2- amino -
bis (3- ethylbenzothiazoline-6-sulfonic acid) assay (TEAC) the total antioxidant activity of 
the samples was measured by ABTS radicle cation decolourization assay according to the 
method of Re et al (1999). 
ABTS was produced by reacting 7mM ABTS aqueous solution with 2.4 mM 
potassium persulfate. This mixture was kept at ambient temperature for 12- 16 hours. Prior 
to assay, this solution was diluted in ethanol (about 1.89 v/v) and equilibrated at 30-degree 
C to given an absorbance at 734 nm of 0.700 +0.02 or – 0.02. 
After the addition of 1 ml of diluted ABTS solution to 10 µl of sample or Trolox 
standard (final concentration 0-15µM) in ethanol, absorbance was measured at 30- degree 
C exactly 30 minutes after initial mixing. 
Appropriate solvent blank was also run. Triplicate analyses were made at each dilution 
of the standard and the percentage inhibition was evaluated at 734nm. The percentage 
inhibition was plotted against Trolox concentration. 
REDUCING POWER ASSAY 
 
Reducing power was estimated according to the method of Oyaizu (1986). An aliquot 
of sample and standard solution was prepared. MeOH (250µ l) that was mixed with 250 ul 
of sodium phosphate buffer (0.25 M, pH6.6) and 250 µl of 1% K3Fe (CN)6 which was 
incubated at 50-degree C for 20 min. 
After adding 250 µl of 10 % trichloroacetic acid, the mixture was centrifuged at 3750 
rpm for10 min. the supernatant (100µl) was then taken out and immediately mixed with 
REVIEW OF LITRATURE 
 
ANTIDYSLIPIDEMIC ACTIVITY OF INDHIRANI MAATHIRAI                  61 
 
100 µl of MeOH and 25µ l and 25µ l of 0.1 % ferric chloride. After 10 min incubation the 
absorbance against blank was taken at 700 nm. Ascorbic acid was taken as standard.71 
3.5. LATERAL RESERCH 
1.PURASU  
Antihyperglycaemic activity 
The antihyperglycaemic activity of the ethanolic extract of Butea monosperma was 
studied in glucose-loaded and alloxan-induced diabetic rats. Single dose treatment 
ofzzethanolic extract of Butea monosperma (200 mg/kg, p.o.) significantly improved 
glucose tolerance and caused reduction in blood glucose level in alloxan-induced diabetic 
rats.72  
Antimicrobial activity 
A new bioactive flavone glycoside was isolated from the methanol soluble 
fraction of the flowers of B. monosperma which was identified as 5,7-dihydroxy-3,6,4'-
trimethoxyflavone-7-O-α -L-xylopyranosyl-(1→3)-O- α -Larabinopyranosyl (1→4)-O-β-
D galacto pyranoside by several colour reactions, chemical degradations and spectral 
analysis. The compound showed antimicrobial activityagainst various fungal species. The 
in vitro antimicrobial efficiency of seed oil of B. monosperma was studied by the filter 
paper disk method against several human pathogenic bacteria and fungi. The oil showed a 
significant bactericidal and fungicidal effect.72 
Antifungal activity 
The petroleum and ethyl acetate extracts of the stem bark from B. monosperma 
displayed antifungal activity against Cladosporium cladosporioides. The active constituent 
of low polarity was isolated by bioassay-monitored chromatographic fractionation, and 
identified as (-)-medicarpin by comparison of physical data. The antifungal activity of (-)-
medicarpin was found to be greater than that of Benlate, a standard fungicide, while (-)-
medicarpin acetate also exhibited significant activity against C. Cladosporiodes.72 
Chemopreventive activity 
The chemopreventive effects of B. monosperma extract on hepatic carcinogenesis 
and on tumor promoter induced markers and oxidative stress in male wistar rats. Treatment 
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of male wistar rats for five consecutive days with 2-AAF i.p. induced significant hepatic 
toxicity, oxidative stress and hyperproliferation. Pretreatment of B.monosperma extract 
(100 and 200 mg/kg body weight) prevented oxidative stress by restoring the levels of 
antioxidant enzymes and also prevented toxicity at both doses.72 
Anthelmintic activity 
The seeds of B. monosperma administered as crude powder at doses of 1, 2 and 3 
g/kg to sheep naturally infected with mixed species of gastrointestinal nematodes exhibited 
a dose and a time-dependent anthelmintic effect. The maximum reduction of 78.4% in eggs 
per gram of feces (EPG) was recorded on day 10 after treatment with 3 g/kg. Levamisole 
(7.5 mg/kg), a standard anthelmintic agent, exhibited 99.1% reduction in EPG (Iqbal et. 
al., 2006). The methanol extract of B. monosperma seeds, tested in vitro, showed 
significant anthelmintic activity.72  
Antidiarrhoeal activity  
The antidiarrhoeal potential of the ethanolic extract of stem bark of  B. monosperma 
has been evaluated using several experimental models in wistar albino rats. The extract 
inhibited castor oil induced diarrhoea and PGE2 induced enteropooling in rats; it also 
reduced gastrointestinal motility after charcoal meal administration. The results obtained 
establish the efficacy and substantiate the use of this herbal remedy as a non-specific 
treatment for diarrhoea in folk medicine.72 
Antiviral activity 
A potential antiviral flavone glycoside has been isolated from the seeds of B. 
monosperma and its structure determined as 5,2' -dihydroxy- 3,6,7-trimethoxyflavone-5-
O-β-Dxylopyranosyl-(1→4) O-β-D-glucopyranoside by various spectral analysis and 
chemical degradations.72 
Anticonvulsant activity 
The bioassay-guided fractionation of dried flowers of B. monosperma was carried 
out to isolate the active principle responsible for its anticonvulsant activity. Further studies 
are required to investigate its usefulness in the treatment of epilepsy.72 
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Anti-giardial and immuno-stimulatory activity 
Pippali rasayana, an Ayurvedic herbal medicine, prepared from Piper longum and 
B. monosperma, and prescribed for the treatment of chronic dysentery and worm 
infestations was tested for antigiardial and immunostimulatory activity in mice, infected 
with Giardia lamblia trophozoites. It produced up to 98% recovery from the infection. The 
rasayana had no killing effect on the parasite in vitro.  It induced significant activation of 
macrophages as evidenced by increased macrophage migration index (MMI) and 
phagocytic activity. Enhancement of host resistance could be one of the possible 
mechanisms contributing towards the recovery of animals from the giardial infection.72 
Anti-implantation activity 
Butin isolated from the seeds of B. monosperma and administered orally to adult 
female rats at the doses of 5, 10 and 20 mg/kg from day 1 to day 5 of pregnancy showed 
antiimplantation activity in 40%, 70% and 90% of the treated animals, respectively. At 
lower doses, there was a dose-dependent termination of pregnancy and reduction in the 
number of implantation sites. In ovariectomized young female rats, the butin exhibited 
estrogenic activity at comparable anti- conceptive doses, but was devoid of antiestrogenic 
activity. Butin is a weak estrogen in that a significant uterotrophic effect was discerned 
even at 1/20th the anticonceptive dose.72 
Antihepatotoxic activity 
An extract from the flowers of B. monosperma, a plant drug used in India for the 
treatment of liver disorders, showed significant activity in different models of liver damage, 
the extract was fractionated by solvent partitioning and HPLC.  The antihepatotoxic 
principles isolated consisted of two known flavonoids, isobutrin (3, 4, 2', 4'-
tetrahydroxychalcone-3, 4' diglucoside), and the less active butrin (7, 3', 4'-
trihydroxyflavanone-7, 3'-diglucoside). For qualitative and quantitative analysis of 
isobutrin and butrin in extracts of B. monosperma flowers a HPLC system was developed.72  
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2.MILAGU  
Anti-bacterial activity 
Piper nigrum leaf and stem assisted green synthesis of silver nano-particles and 
evaluated its antibacterial activity against agricultural plant pathogens and observe that 
these silver nano-particles showed the excellent antibacterial activity against plant 
pathogens. experimented photochemical analysis and antibacterial activity of Piper nigrum 
against human pathogenic bacteria and noted that presence of alkaloids, tannins, 
flavonoids, cardiac and cardiac glycosides shows antibacterial properties against the 
Staphylococcus aureus, Salmonella typhi, Escherichia coli and Proteus sp.73 
Antioxidant activity of black pepper 
Piper species significantly inhibited the atherogenic diet induced increased lipid 
profile and alteration in antioxidant enzymes activities. regenerated tissue of Piper nigrum 
like callus, in vitro shoots, roots, in vitro plantlets, possesses antioxidants activity which is 
probably due to the presence of flavonoids and phenolic contents. Piper species 
significantly inhibited the atherogenic diet induced increased lipid profile and alteration in 
antioxidant enzymes activities.73 
Anti-cancer activity of black pepper 
 Piper nigrum reduced lung cancer by modulating lipid peroxidation and through 
the activation anti oxidative protection enzyme.73 
Digestive activity of black pepper 
Administration of piperine or P. nigrum stimulate the liver to the secrete bile acids 
which in turn play key role in the absorption and digestion of fats.73 
Antidepressant activity of black pepper 
The brainderived neurotrophic factor protein and mRNA levels in the hippocampus 
were also significantly decreased in corticosterone-treated mice. corticosterone induced the 
behavioral and biochemical changes after treatment to animals with piperine. These results 
showed that piperine produces an antidepressant-like effect.73 
Insecticidal properties 
Piperine against insecticide resistant and susceptible strains of Anopheles malaria 
vector mosquitoes and observed that Black pepper and piperine mixtures caused high 
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mortality in the An. Gambiae complex strains, with black pepper proving significantly 
more toxic than piperine. It is concluded that black pepper shows potential as a larvicide 
for the control of certain malaria vector species.73 
Antiplatelet activity 
  Toxic effect of piperine on aggression of platelet in experimental rabbit induced by 
different factors which activate platelet, by collagen and thrombin.73 
Molluscicidal activity 
The effect of piperine on the absorptive function of the intestine. In vitro 
experiments showed an increased rate of lipid peroxidation in the freshly isolated epithelial 
cells of rat jejunum. These results suggested that piperine may interact with the lipid 
environment to produce effect which leads to increased permeability of the intestinal 
cells.73 
3.EUPHORBIA ANTIQUORUM  
Antihyperglycemic and in silico aldose reductase inhibitory activity 
The ethanol extract exhibited a drastic blood sugar level reduction after 1 hour of 
post treatment. This effect was significant compared to standard drug Glibenclamide. The 
petroleum ether extract and aqueous extract also showed a decrease in blood glucose but 
not in a significant manner. Whereas ethanol extract has showed significant 
antihyperglycemic activity on 8th hour of post treatment.74 
Cancer 
Latex of EA has inhibitory effects on several different cancer cell lines. EA induced 
apoptosis, which was characterized by morphological change, DNA fragmentation, 
increased sub-G1 population, and alterations in levels of apoptosis associated proteins.74  
Cytotoxic activity 
The latex can be effectively used along with chemotherapeutic drugs for cancer 
treatment, because the latex by itself is not cytotoxic and when given along with the 
standard chemotherapeutic drug etoposide, it was able to counteract the toxicity of the drug 
in normal chick embryo fibroblasts. The results also suggest its use in combination therapy 
along with chemotherapy to fight cancer.74 
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Hepatoprotective and antioxidant activity 
Aqueous extract of the aerial parts of EA has been reported to have hepatoprotective 
and antioxidant activity. EA extract exerted significant antioxidant activity (at 20 μg, 40 
μg, 60 μg, 80 μg and 100 μg/ml in-vitro) as evidenced by its reducing power, hydroxyl and 
superoxide anion radical scavenging activities. The invitro efficacy was reinforced by a 
significant dose dependent hepato-protection (at 125 mg/kg and 250 mg/kg dose) by 
decreasing the activity of serum enzymes, bilirubin, cholesterol, triglycerides and lipid 
peroxidation while it significantly increased the reduced Glutathione levels of tissue in a 
dose dependant manner. The hepatoprotective and antioxidant activities of the extract have 
been found to be comparable to standards Silymarin and Sodium metabisulphite 
respectively. The hepatoprotective property was attributed to the antioxidant potential and 
the antioxidant principles of the plant which justifies the claim of the native practitioner 
that the decoction of the plant is useful in treating jaundice.74 
Insecticidal activity 
The latex of EA contains insecticidal activity. It was tested against common and 
widely spread pest species of vegetables and rice and also against some of their natural 
enemies. 
These insects or pests are considered to be more resistant to synthetic insecticides. 
Results have revealed that the latex of EA is an effective insecticidal agent because both 
crude extract as well as partially purified extract caused more than 50% mortality of tested 
aphid populations. The observed LC50 of M. persicae with EA latex extract (0.012%) was, 
however,greater than that with Azadirachta seed oil (0.0024%). EA latex extract was not 
effective against insects with thick cuticle covers. Although soft-bodied natural enemies 
like spiders are susceptible to the latex of EA, most common and important natural enemies 
like ladybird beetles are highly resistant.74 
Anti-inflammatory and anti-arthritic activities 
The anti-inflammatory and anti-arthritic potential has been associated with aqueous 
and alcoholic extracts of EA. It showed the presence of triterpenoids in the stem and 
diterpenoids in the latex. It was reported that the anti-inflammatory activity is a common 
REVIEW OF LITRATURE 
 
ANTIDYSLIPIDEMIC ACTIVITY OF INDHIRANI MAATHIRAI                  67 
 
property of many triterpenoids. The anti-inflammatory effects of triterpenes have been 
attributed to various mechanisms including inhibition of lipoxygenase and cyclooxygenase 
activities. Triterpenoids present in the extracts of EA might be responsible for anti-
inflammatory and anti-arthritic effects.74 
 
4. CAESALPINA CRISTA 
Antidiabetic / Hypoglycemic  
Most of the plant from Caesalpinia species shows Antidiabetic and Hypoglycemic 
activity. The ethanolic extract (250mg/kg/day) lowered blood glucose level within 2 weeks 
in the alloxan diabetic albino rats confirming its hypoglycemic activity. β - sistosterol 
isolated from the stem bark was found to posses potent hypoglycemic activity when 
compared to other isolated compounds. 
(1) The seed kernel of Caesalpinia bonducella has significant antidiabetic and 
hypoglycemic effects. Activity may be partly due to a positive effect on glycogen synthesis 
in the liver, skeletal muscle and heart muscle due to an insulin-like action of its constituents 
and partly due to stimulatory action on insulin release. 
(2) The ethanolic and aqueous extracts showed significant blood sugar lowering 
effect of C.bonducella. 
(3) The aqueous extract of C. bonducella seed shell showed very significant blood 
sugar lowering in glucose loaded STZ and alloxan diabetic models.75 
 Anthelmintic activity 
Anthelmintic activity of Caesalpinia crista (L.) against trichostrongylid nematodes 
of sheep,study showed C. crista possess anthelmintic activity in vitro and in vivo, 
supporting its traditional use in Pakistan.75 
Antimalarial activity 
Most of the plant from Caesalpinia species shows antimalarial activity. The isolated 
diterpenes such as 44 cassane- and norcassanetype diterpenes. Most of the tested diterpenes 
showed antimalarial activity, norcaesalpinin E showed the most potent activity, more than 
the drug chloroquine.75 
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Antioxidant activity 
Study showed the methanolic extract of Caesalpinia crista has potent antioxidant 
activity and ROS scavenging activity as well as iron chelating property. Ethyl acetate 
extract showed a maximum of 49% free radical scavenging activity at the end of 1 hr.75 
Antifilarial  
The Caesalpinia bonducella seed kernel extract and fractions showed 
microfilaricidal, macrofilaricidal and female-sterilizing efficacy against L. sigmodontin 
and microfilaricidal and female-sterilizing efficacy against B. malayi in animal models, 
suggesting a potential for its use in new antifilarial drug development.75 
Anxiolytic Activity  
The seed extract of C. bonducella showed a significant and dose dependant 
anxiolytic activity.75 
Antitumor / Antioxidant Activity 
Study of methanol extract of Caesalpinia bonducella showed significant antitumor 
and antioxidant activity in Erllich ascites carcinoma (EAC)-bearing mice.75 
Analgesic Activity:  
The flower extract of Caesalpinia bonducella showed significant antinociceptive 
effect in the inflammatory phase of formalin-induced pain and acetic- induced parietal 
pain.75 
Analgesic / Antipyretic / Anti-Inflammatory 
The seed oil of Caesalpinia bonducella could be a potential source of an anti-
inflammatory, antipyretic and analgesic agent.75 
Immunomodulatory 
The aqueous extract of Caesalpinia bonducella seeds on cell mediated and humoral 
components of the immune system in rats produced an increase in hemagglutinating 
antibody titer and a change in delayed-type hypersensitivity suggesting that the extract 
could be a promising immunostimulatory agent.75 
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Anti-Amyloidogenic / Alzheimer's disease  
Caesalpinia crista leaf aqueous extract has anti-amyloidogenic potential. Study 
showed aqueous extract of C. crista could inhibit the Abeta  aggregration. From monomers 
and oligomers and able to disintegrate the preformed fibrils.75 
Nootropic / Memory Enhancer  
Dried seed kernels of Caesalpinia crista extract have a potential as a learning and 
memory enhancer. Results suggest C. crista can be beneficial in improving cognition in 
disorders like demential and other neurodegenerative disorders.75 
 
5.FERULA ASAFOETIDA 
Relaxant effect 
F. asafoetida or its constituents may bind to muscarinic receptor of tracheal smooth 
muscle and put off the binding of methacholine to this receptor, it suggested the 
competitive antagonistic effect of F. asafoetida at muscarinic receptors.76 
Neuroprotective effect 
In vitro experiments showed that asafoetida is a nerve stimulant and its management 
in neuropathic mice exerted neuroprotecting effects through stimulating axonal 
regeneration and remyelination and decrement of lymphocyte infiltration76. 
Anti-cytotoxicity activity, anti-obesity and fat lowering effect 
To evaluate general cytotoxicity, the brine shrimp (Artemia salina) was employed 
as a model assay system, it provided a suitable in-house pre-screening method. The 
methanol extracts of Ferula species and the oleo-gum resin of F. asafoetida exhibited 
cytotoxic effect with LC50 values in the range of 6e321 mg/mL and showed a dose-
dependent cytotoxicity. The effect of F. asafoetida on weight gain, fat accumulation, liver 
steatosis and leptin level in type 2 diabetic rats. Two treatment groups received F. 
asafoetida oleo-gum resin at doses of 25 or 50 mg/kg. Administration of F. asafoetida 
extensively decreased body weight, abnormal fat and size of epididymal adipocyte 
compared to untreated rats. Serum leptin levels were considerably decreased in treated rats. 
The results revealed that F. asafoetida gum has potent anti-obesity activities, fat lowering 
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and can prevent liver steatosis. F. asafoetida gum can be a good candidate for the treatment 
of diabetes-induced obesity and hepatosteatosis.76 
Spermatic, testicular histopathology and antagonistic effect 
Evaluated the effectiveness of asafoetida on spermatic parameters, blood 
testosterone levels and testis tissue. The asafoetida significantly increased the number and 
viability of sperms. Asafoetida has shown a positive effect on spermatic parameters even 
though the histopathological effects on the testis were observed, particularly at high 
doses.76 
Toxic effect 
A case of methemoglobinemia has been registered after intake of asafoetida in a 5 
week old black male infant. Hewas recovered by the treatment of intravenous methylene 
blue from onset of tachypnea, grunting and cyanosis. Large dose intake of asafoetida can 
lead to swelling of the mouth, digestive illness such as flatulence and diarrhea, anxiety and 
headache. The intake of asafoetida is prohibited during the pregnancy.76 
 
6. ACACIA CATECHU 
Anti-obesity activity 
The bark of Acacia catechu Willd family Fabaceae, maintains healthy fat 
metabolism and reduces the conversion of carbohydrates to fats. In studies of rats fed on a 
diet containing cholesteryl oleate, betel nut extracts significantly lowered cholesterol and 
triglycerides.77 
Hypoglycaemic Activity 
         In eastern traditional medicine Acacia catechu Willd is extensively used in 
management of diabetes in combinations with other medicinal plants. Polar as well as non-
polar components of Acacia catechu Willd shown hypoglycaemic activity. Hypoglycemic 
activity of extract of Khadira (Acacia catechu Willd) is assumed to be due to the presence 
of flavonoids which also show inhibition of cyclooxygenase and regenerate β cells. In an 
experiment, ethyl acetate extract of Acacia catechu Willd at a concentration of 
500mg/kg/day used for 7 days, significantly decreases blood glucose level of normal as 
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well as alloxan induced diabetic albino rats but it was not effective as that of standard drug. 
Studies show that myricetin, quercetin and catechin-gallate inhibit insulin stimulated 
glucose transporters in cells.77 
Antibacterial Activity 
Khadira (Acacia catechu Willd) heartwood extract is found to be an effective 
antibacterial agent. A study conducted in ethanolic and aqueous heartwood extract of 
Khadira, proved its efficacy as a potent anti-bacterial agent. Taxifolin present in heartwood 
of Khadira is found to be responsible for its antibacterial effect. In vitro, Acacia catechu 
Willd is reported to have broad spectrum antimicrobial and antifungal activity. 
Phytochemical studies of Khadira leaves shows the presence of alkaloids, carbohydrates, 
flavones, glycosides, phenolic compounds, saponins, steroids and tannins which may be 
responsible for its antimicrobial activity. Its Methanolic extract having antimicrobial 
activity against pathogenic as well as non-pathogenic bacteria e.g. Bacillus subtilis, 
Staphylococcus aureus, Salmonella typhi, Escherichia coli, Pseudomonas aeruginosa and 
Candida albicans. It is effective against gram positive as well as gram negative bacteria.77 
Antifungal Activity 
Ethanolic extract of Heartwood of Acacia catechu Willd was tested for antifungal 
(antimycotic) activity against Candida albicans, Aspergillus Niger, Aspergillus fumigates, 
Mucor spp and Penicilium marneffei. Disc diffusion technique was followed for screening 
antifungal activity. The discs were loaded with 50μl of ethanolic extracts at different 
concentrations [25ug/disc, 250ug/disc and 500ug/disc]. Positive controls used were 
fluconazole (10 mcg/disc) and amphotericin B (100 units/disc). After incubation at 28oC 
for 48 hours, the zone of inhibition was measured. The extract at different concentrations 
showed varying degree of antifungal activity against the micro organisms tested compared 
to standard. Assay was conducted to check antifungal activity of the aqueous and methanol 
extract of Acacia catechu Willd against fourteen human pathogenic fungi using agar disc 
diffusion method. The methanol extract of Acacia catechu Willd was established most 
promising, and found active against Candida, Dermatophytes and Aspergillus species 
therefore stressing the need to locate the active principle.77 
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Anti-microbial activity 
In vitro Khadira (Acacia catechu Willd) is reported to have broad spectrum anti-
microbial and antifungal activity. Phytochemical studies of Acacia catechu Willd 
leaves shows the presence of alkaloids, carbohydrates,flavones, glycosides, phenolic 
compounds, saponins,steroids and tannins which may be responsible for its anti-microbial 
activity.Its Methanolic extract of has Anti-microbial activity against pathogenic as well as 
nonpathogenic bacteria e.g Bacillus subtilis, Staphylococcus aureus, Salmonella typhi, 
Escherichia coli, Pseudomonas aeruginosa and Candida albicans. It is effective against 
gram positive as well as gram negative bacteria. It was found to be most effective against 
Staphylococcus aureus with about 20mm zone of inhibition at minimum bactericidal 
concentration (MBC) of the crude extract 1,000 l g/ml.Experiments shows that anti-
microbial activity of Khadira (Acacia catechu Willd) depends on nature of solvent used 
for extraction, thus organic solvents used in extraction of leaves are most effective than 
any other.77 
Anti-oxidant Activity 
As the Khadira (Acacia catechu Willd) contain many potent flavonoids such as 
catechin present in this plant plays a vital role as anti-oxidant. Catechins and rutin are most 
important constituents which are free radical scavengers. Antioxidant principles of Acacia 
catechu Willd were analysed by Dot‐blot assay & quantitative analysis by DPPH radical 
scavenging assay with ascorbic acid as standard.77 
Anti-cancer Activity 
The aqueous extract of Acacia catechu has effective on epithelial and stromal cell 
carcinoma in cell line studies.77 
Antidiarrhoeal Activity 
  Ethyl acetate extract of Khadira (Acacia catechu Willd)  has been found to posses 
highly significant antipyretic activity in respect of latent period of onset of  diarrhoea, 
average number of stool passed and purging index.77 
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Hepato protective activity 
 Cyanidanol, an active principle of Acacia catechu Willd, was claimed to be 
effective in treating liver diseases.77 
Anti-pyretic and Anti-inflammatory properties 
The chief major active chemical components of Khadira (Acacia catechu Willd) 
are flavonoids which inhibit Cyclooxygenase and 5-Lipoxygenase and hence decrease 
inflammation. Mixed extract of Scutellaria baicalensis and Acacia catechu inhibit 
Prostaglandin E2 generation in human osteosarcoma cells which express COX-2, and 
leukotriene production is also inhibited in human cell lines, immortalized THP-1 monocyte 
and HT-29 colorectal adenocarcinoma. Baicalin from Scutellaria baicalensis and catechin 
from Acacia catechu Willd are responsible for dual inhibition of Cyclooxygenase and 5- 
Lipoxygenase.[44] Baicalin and catechin are found to in hibit COX1, COX2 and 5-LOX. 
Baicalin also downregulates the expression of cytokines and PGE2, nitric oxide formation, 
and neutrophil invasion in a carrageenan-induced paw edema model.77 
Sore throat 
Khadira (Acacia catechu Willd) is one of most important ingredients used in Paan 
which is also called as beetle leaf. People of different ages use it for healing of sore
 throat, because of its astringent and soothing effect.Tannins present in Acacia 
catechu Willd are responsible for this property. This is very common in Asia especially in 
central Asian countries like Pakistan and India and most common home remedy used for 
sore throat.77 
Anti-secretory and Anti-ulcer Activity 
Study was conducted on antisecretory and antiulcer activity of Khadira (Acacia 
catechu Willd) against indomethacin plus pyloric ligation induced gastric ulcers in rats. 
The results of the study suggested that Khadira(Acacia catechu Willd) causes an inhibitory 
effect on release of gastric hydrochloric acids and protects gastric mucosal damage due to 
presence of flavanoids and tannins in the plant extract. 
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Immunomodulatory Activity 
Immuomodulatory activity of aqueous extract of Acacia catechu Willd after oral 
administration (5 mg/kg and 50 mg/kg). The effect was studied in neutrophil adhesion test, 
mice lethality test, carbon clearance assay, cyclophosphamide induced neutropenia, serum 
immunoglobulin levels and the heamagglutination test. Acacia catechu Willd extract 
showed an increase in the neutrophil adhesion to the nylon fibres produced a significant 
increase in the phagocytic index and a significant protection against cyclophosphamide 
induced neutropenia indicating its effect on cell mediated immunity.77 
Wound healing 
In Asia crushed bark of Acacia catechu Willd is used topical on wounds as it is 
potent wound healing medicinal plant. It has astringent effect and also cause precipitation 
of skin which makes it very good wound healing plant. Furthermore, it also exhibits 
antimicrobial property which prevents growth of microbes on wounds. This activity is due 
to presence of tannins and flavonoids in bark of Acacia catechu willd.77 
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4. MATERIALS AND METHODS 
4.1. PREPARATION OF THE DRUG: 
The trial drug Indhirani Maathirai was prepared as per classical Siddha literature 
sarabendra Siddha maruthuva sudar 4th edition written by Doctor M.Sowrirajan page 
number 336 published by the Saraswati Mahal library, Tanjore.  
INGREDIENTS:  
purasan ver (root of beautea monosperma)     - 17.5 gram 
Milagu (Piper nigrum)       - 17.5 gram 
Kalli ver ( root of Euphorbia antiquorum)     - 17.5 gram 
Kalarchi ver ( root of Caesalpinia bonduc )      - 17.5 gram 
Kadugu (Brassica juncea)       - 17.5 Gram 
Kambiccharam (potassium nitrate)     - 17.5 gram 
Perungayam (ferula asafoetida)     - 17.5 gram 
Karungali kudineer ( Acacia catechu stem decoction) - Sufficient amount 
COLLECTION OF THE DRUG : 
The Pepper( Piper nigrum), Kadugu (Brassica juncea), Asafoeitida (Ferula 
asafoetida), Kambicharam (Potassium nitrate), Karungali Kattai ( Acacia catachu stem) 
were bought from the Ramaswamy Chetty raw drug stores at Parrys Corner. Kalli ver ( the 
root of euphorbia antiquorum), Poovarasan ver ( the root of beautea monosperma) were 
collected from the village mukundaram in Gudiyatham. Kalarchi ver (the root of 
caesalpinia bonduc) was collected from the village Lakshmana Puram in Gudiyattam. 
IDENTIFICATION AND AUTHENTICATION: 
All drugs were identified and authenticated by botanist and experts of gunapadam 
department (pharmacology) in government Siddha Medical College, Chennai. The 
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identified product samples were preserved in the PG gunapadam laboratory for future 
references. 
 METHOD OF PURIFICATION: 
  Milagu,Kadugu,Perungayam are mildly roasted in a pan separately and allowed to 
cool.78  Kalli ver, Kalarchi ver, Purasan ver were washed through water completely and 
allowed to dry.79 Kambicharam is the Vediyuppu which was distilled 6 times.80 The 
Vediyuppu was taken in a pot and dissolved with sufficient amount of water. The salt 
solution was filtered and placed in a stove and allowed to boil until the kuzhambu padham 
was attend. The pot was taken away from the stove and allowed to cool. After sometime 
the potassium nitrate crystals were formed the process was repeated 6 times. Finally got 
the potassium nitrate crystals formed like wire/rods. 
METHODS OF PREPARATION:  
All the above ingredients are crushed and powder by Iron mortar and sieved by th 
a cloth separately. Then the fine powder was collected.  The wood of Karungali (Acacia 
catechu) was crushed in Iron mortar. The crushed pieces are collectod and add sufficient 
amount of water in a pan and subjected to boil and then filter. The karungali Kudi Neer 
was obtained. The fine powder was titrated (ground) with karungali kudineer by stone 
mortar up to attein the mezhugu padham. Then the karkam was collected and rolled into 
Payiralavu Maathirai and allowed to dry.  
PRESERVATION:  
Fully dried pills / tablets was preserved in a clean air tight glass container. 
ADMINISTRATION OF THE DRUG : 
Form of the medicine   -Maathirai 
Route of Administration  -Enteral  
Dose     -Two tablets  
            Time of Administration  - Two times a day  
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Adjuvant    -Water  
Indication    -Adhi Thoola rogam 
4.2. STANDARDIZATION  OF  INDHIRANI MAATHIRAI BY  USING  MODERN 
TECHNIQUES: 
Standardization of drug helps to authenticate and determine its quality and 
efficiency. Standardization of herbal drug is rooted in qualitative and quantitative analysis 
by means of Physico chemical properties and instrumental analysis. The Physico-chemical 
analysis of Indhirani Maathirai was done. The chemical finger print was engaged by using 
modern analytical technique FTIR (Fourier Transform Infra-Red Spectroscopy). The 
particle size and qualitative analysis of chemical elements of Indhirani Maathirai were also 
assessed by Scanning Electron Microscope (SEM). The quantitative and qualitative 
analysis of chemical elements was carried out by using inductively X-Ray Diffraction 
Study (XRD). 
4.2.1. ORGANOLEPTIC EVALUATION: 
The organoleptic characters of the sample drug were evaluated. 1gm of the IM was 
taken and the colour, texture, particle size and other morphological characters were viewed 
by naked eye under natural light.81  
4.2.2. PHYSIO-CHEMICAL INVESTIGATION: 
Physio‐chemical studies like total ash, water insoluble ash, acid Insoluble ash, loss 
on drying at 105°C and pH were done at, The Tamil Nadu Dr. M. G. R. Medical University, 
Guindy, Chennai. 
1.pH value: 
Potentiometrically pH value determined by a glass electrode and a suitable ph 
meter. The pH of the IM was written in results column. 
2.Loss on Drying: 
An accurately weighed 2g of Indhirani maathirai formulation was taken in a tarred 
glass bottle. The crude drug was heated at 1050C for 6 hours in an oven till a constant 
weight. The percentage moisture content of the sample was calculated with reference to the 
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shade dried material  
3.Determination of Alcohol Soluble Extractive: 
2.5 gm of air dried drugs, coarsely powdered was macerated with 50ml alcohol in 
closed flask for 24 hrs. with frequent shaking, it was filtered rapidly taking precaution 
against loss of alcohol. 10ml of filtrate was then evaporated in a tarred flat bottom shallow 
dish, dried at 1000C and weighted. The percentage of alcohol soluble extractive was 
calculated with reference to dried drug. 
4.Solubility: 
 A pinch of sample (IM) was taken in a dry test tube and to it 2ml of the solvent 
was added and shaken well for about a minute and the results are observed. The test was 
done for solvents like distilled water, ethanol, chloroform and results were observed 
individually.82           
4.2.3. PRELIMINARY PHYTOCHEMICAL SCRENNING OF INDHIRANI MAATHIRAI: 
The preliminary phytochemical screening test was carried out for the extract of 
Indhirani maathirai as per standard procedure. 
1. DETECTION ALKALOIDS: 
1. Mayer’s Test: filtrat were treated with Mayer’s reagent (potassium, mercuric 
iodide). Formation of a yellow coloured precipitate indicates the presence of 
alkaloids. 
2. Wagnor’s Test: filtrates were treated with Wagner’s reagent (iodine in potassium 
iodide) formation of brown or reddish precipitate indicates the presence of the 
alkaloids. 
3. Dragendroff’s’ Test: filtrates were treated with Dragendroff’s reagent (solution of 
potassium with bismuth iodide). Formation of red precipitate indicates the presence 
of alkaloids. 
4. Hager’s Test: filtrates were treated with Hager’s reagent (saturated picric acid 
solution) presence of alkaloids conformed by the formation of yellow precipitate. 
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2. DETECTION OF CARBOHYDRATES: 
Extracts were dissolved individually in 5 ml distilled water and filtered. The filtrates 
were used to test the presence of carbohydrates. 
1) Molisch’s Test: To 2ml of a plant sample extract, two drops of alcoholic solution 
of alpha naphthol are added. The mixture is shaken well few drops of concentrated 
sulphuric acid slowly along the sides of the test tube. A violent ring indicates the 
presence of carbohydrates. 
2) Benedict’s Test: filtrates were treated with benedict’s reagent and heated gently 
orange red precipitate indicates the presence of reducing agents. 
3. DETECTION OF GLYCOSIDES: 
Extracts were hydrolysed with dilute HCl and then subjected to the test of 
glycosides. 
1) Modified Bontrager’s Test:Extracts were treated with ferric chloride solution 
and immersed in boiling water for about 5 minutes. The mixture was cooled and 
extracted with equal volumes of benzene. The benzene layer was separated and 
treated with ammonia solution. Formation of rose pink colour in ammonial layer 
indicates the presence of anthranol glycosides. 
2) Cardiac Glycoside (Keller-Killiani Test):Extracts was shaken with distilled 
water (5ml). to this, glacial acetic acid (2ml) containing few drops of ferric 
chloride was added followed by sulphuric acid (1ml) along the side of the test 
tube. The formation of the brown ring at the interface gives positive indication 
for cardiac glycoside and a violet ring may appear below the brown ring. 
4. DETECTION OF SAPONINS: 
1.Froth Test: Extracts were diluted with distilled water to 20 ml and this was 
shaken graduated cylinder for 15 minutes. Formation of 1 cm layer of foam indicates the 
presence of saponins. 
2.Foam Tests: 0. Gm of the extract was shaken with 2 ml of water if foam 
produced persists for ten minutes. It indicates the presences of saponins. 
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4. DETECTION OF PHYTOSTEROLS: 
 Salkowski’s Test: extracts were treated with chloroform and filtered. The 
filtrates were treated with few drops of conc. sulphuric acid shaken and allowed to stand. 
Appearance of golden yellow colour indicates the presence of triterpenes. 
6. DETECTION OF PHENOL FERRIC CHLORIDE TEST: 
Extracts were extracted with 3- 4 drops of ferric chloride solution. Formation of 
bluish black colour indicates the presence of the phenols. 
7. DETECTION OF TANNINS GELATIN TEST: 
The extract is dissolved in 5ml distilled water and 2ml of 1% solution of Gelatin 
containing 10% NaCl is added to it. White precipitate indicates the presence of phenolic 
compounds. 
8. DETECTION OF FLAVONOIDS: 
  1.Alkaline Reagent Test: Extracts were treated with few drops of sodium 
hydroxide solution. Formation of intense yellow colour, which becomes colourless on 
addition of dilute acid, indicates the presence of flavonoids. 
 2.Lead acetate Test: Extracts were treated with few drops of lead acetate solution. 
Formation of yellow colour precipitate indicates the presence of flavonoids. 
9. DETECTION OF PROTEINS AND AMINOACIDS: 
1.Xanthoproteic Test: The extracts were treated with few drops of concentrated 
Nitric acid. Formation of yellow colour indicates the presence of proteins. 
2.Ninhydrin Test: To the extract ,0.25% w/v Ninhydrin reagent was added and 
boiled for few minutes. Formation of blue colour indicates the presence of amino acid. 
10. DETECTION OF DITERPENES COPPER ACETATE TEST: 
Extracts were dissolved in water and treated with 3-4 drops of copper acetate 
solution. Formation of emerald green colour indicates the presence of diterpenes. 
11. GUM AND MUCILAGE: 
To 1ml of extract add 2.5 ml of absolute alcohol and stirring constantly. Then the 
precipitate was dried in air and examine for its swelling properties. Swelling was observed 
that will indicate presence of gum and mucilage. 
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12. Test for Fixed Oils and Fats: 
Spot Test: A small quantity of extract is pressed between two filter papers. Oil 
stain on the paper indicates the presence of fixed oils. 
13.TEST FOR QUINONES:  
Extract was treated with sodium hydroxide blue or red precipitate indicates the 
presence of Quinones.83 
4.2.4. High Performance Liquid Chromatography (HPLC) 
HPLC pumps to pass a pressurized liquid solvent containing the sample mixture 
through a column filled with a solid adsorbent material. Each component in the sample 
interacts slightly differently with the adsorbent material, causing different flow rates for the 
different components and leading to the separation of the components as they flow out of 
the column. In this study, the detection and quantitation were carried out using 515 HPLC 
pumps and 2489 UV/Visible detectors of Waters Company while the software used was 
Empower. 
Two methods using different mobile phases were used for chromatographic 
separation of the research drugs – Method I (binary gradient method of Acetonitrile & 
0.1% Phosphoric acid in Water) and Method II (binary gradient method of Methanol & 
1:25 Acetic acid in Water). Results obtained during Method I have been discussed since 
better separation of compounds was observed during this analysis.  
The chromatographic conditions for Method I are as given below: 
Column : Symmetry C18, 5 µm, 4.6x250 mm Run Time : 30 minutes 
Injection Volume : 20 µl 
Wavelength(Dual) : 272nm&360nm  
Solvent A : Acetonitrile 
Solvent B : 0.1% Phosphoric acid in water 
Flow rate : 1.0 ml/min. 
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Pump Mode : Gradient Processing Method : 
 
Time (min) %A %B 
0 15 85 
12 25 75 
20 25 75 
22 15 85 
30 15 85 
 
                                            Fig No:4.1 HPLC INSTRUMENT 
 
 
 
 
 
 
 
Fig No:4.2 MECHANISM OF HPLC INSTRUMENT 84 
4.2.5. BIO-CHEMICAL ANALYSIS 
 The bio-chemical analysis was done to identify the acid and basic radical present 
in the trial drug Indhirani maathirai. 
Preparation of extract 
5g of  Indhirani maathirai was taken in a 250 ml clean beaker and 50 ml of distilled 
water was added, boiled well and allowed to cool and filtered in a 100 ml volumetric flask 
and made up to 100 ml with distilled water. 
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Preliminary basic and acidic radical studie 
Test for basic radicals 
1. Test for Potassium 
   To a pinch of the Indhirani maathirai 2 ml of Sodium nitrate and 2 ml of Cobalt 
nitrate solution in 30% glacial acetic acid was added and observed for the presence of 
yellow precipitate Test for Calcium 
To 2 ml of Indhirani maathirai extract, 2 ml of 4% Ammonium oxide solution was 
added and observed for the formation of white precipitate. 
2. Test for Magnesium 
To 2ml of Indhirani maathirai extract, drops of Sodium hydroxide solution was added 
and watched for the appearance of white precipitate 
3. Test for Ammonium 
To 2ml of Indhirani maathirai extract few ml of Nessler's reagent and excess of Sodium 
hydroxide solution are added for the appearance of brown colour 
4. Test for Sodium 
Hydrochloric acid was added with a pinch of the Indhirani maathirai, made as paste 
and introduced into the blue flame of Bunsen burner and observed for the appearance of 
intense yellow colour. 
5. Test for Iron (Ferrous) 
The Indhirani maathirai extract was treated with Conc. HNO3 and Ammonium 
thiocyanate and waited for the appearance of blood red colour. 
6. Test for Zinc 
To 2 ml of the Indhirani maathirai extract drops of Sodium hydroxide solution was 
added and observed for white precipitate formation. 
7. Test for Aluminium 
To the 2m1 of the Indhirani maathirai extract sodium hydroxide was added in drops 
and changes are noted. 
 
 
MATERIALS AND METHODS 
 
ANTI-DISLIPIDEMIC ACTIVITY OF INDHIRANI MAATHIRAI     84 
 
8. Test for Lead 
To 2 ml of Indhirani maathirai extract 2ml of Potassium iodide solution was added and 
noted for yellow coloured precipitate. 
9. Test for Copper  
a) A pinch of Indhirani maathirai was made into a paste with con. HCl in a watch 
glass and introduced into the non-luminous part of the flame and noted for blue colour 
appearance. 
b) To 2 ml of Indhirani maathirai extract excess of Ammonia solution was added and 
observed for the appearance of blue coloured precipitate. 
11.Test for Mercury 
To 2m1 of the Indhirani maathirai extract sodium hydroxide solution was added and 
noted for yellow precipitate formation. 
13.Test for Arsenic 
To 2 ml of the Indhirani maathirai extract 2ml of Sodium hydroxide solution was 
added and observed for brown or red precipitate and noted. 
TEST FOR ACID RADICALS 
Test for Sulphate 
             To 2 ml of the Indhirani maathirai extract 5% of Barium chloride solution was 
added and observed for the appearance of white precipitate. 
Test for Chloride 
The Indhirani maathirai extract was treated with Silver nitrate solution and 
observed for the appearance of white precipitate. 
Test for Phosphate 
The Indhirani maathrai extract was treated with Ammonium molybdate and conc. 
HNO3 and observed for the appearance of yellow precipitate. 
Test for Carbonate 
 The Indhirani maathirai extract was treated with conc. HCl and observed for the 
appearance of effervescence  
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Test for Fluoride & Oxalate 
To 2ml of Indhirani maathirai extract 2ml of dil. acetic acid and 2ml calcium 
chloride solution was added and heated and watched for cloudy appearance. 
Test for Nitrate  
To 1 gm of the Indhirani maathirai Copper turnings was added and again 
conc.H2SO4 was added, heated and the test tube was tilted vertically down and observed 
for any changes.85 
4.2.6. Microbial load Availability of bacterial load 
Enumeration of bacteria by plate count – agar plating technique. The plate count 
technique is one of the most routinely used procedures because of the enumeration of 
viable cells by this method. 
Principle 
This method was based on the principle that when a material containing bacterium 
was cultured, every viable bacterium develops into a visible colony on a nutrient agar 
medium. The numbers of colonies were the same as the number of organisms contained in 
the Indhirani maathirai. 
Dilution 
A small measured volume of Indhirani maathirai was mixed with a large volume of 
sterile water called the diluent or dilution blank. Dilution is usually made in multiples of 
ten. A single dilution is calculated as follows: 
Volume of the sample 
                            Dilution=    
                                                            Total volume of the sample and the diluents 
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Requirements 
Sample or Bacterial suspension 
9 ml dilution blanks (7) 
Sterile petri dishes (12) 
        Sterile 1 ml pipettes (7) 
        Nutrient agar medium (200 ml) 
Colony counter 
Procedure 
➢ Label the dilution blanks as 10-1, 10-2, 10-3, 10-4, 10-5, 10-6, 10-7. 
➢ Prepare the initial dilution by adding 1 ml of the Indhirani maathirai extract into a 
9 ml dilution blank labelled 10-1 thus diluting the sample 10 times. 
➢ Mix the contents by rolling the tube back and forth between hands to obtain uniform 
distribution of organisms. 
➢ From the first dilution transfer 1 ml of the suspension while in motion, to the 
dilution blank 10-2 with a sterile and fresh 1 ml pipette diluting the original 
specimen to 100 times. 
➢ From the 10-2 suspension, transfer 1 ml of suspension to 10-3 dilution blank with a 
fresh sterile pipette, thus diluting the original sample to 1000 times. 
➢ Repeat this procedure till the sample has been diluted 10,000,000 times, every time 
using a fresh sterile pipette. 
➢ From the appropriate dilutions transfer 1ml of suspension while in motion, with the 
respective pipettes, to sterile petri dishes. Three petri dishes are to be used for each 
dilution. 
➢ Approximately 15 ml of the nutrient medium is added, melted and cooled to 450c, 
to each petri dish containing the diluted Indhirani maathirai extract. Mix the 
contents of each dish by rotating gently to distribute the cells throughout the 
medium. 
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➢ Allow the plates to solidify. 
➢ Incubate these plates in an inverted position for 24-48 hours at 370c. 
Observation 
Observe all the plates for the appearance of bacterial colonies. Count the number 
of colonies in the plates.Calculate the number of bacteria per ml of the original suspension 
as follows: 
                                                 Number of colonies average (3repleates)86  
Organisms per millimetre =   
                                                                 Amount plated × dilution 
 
4.2.7. SOPHISTICATED INSTRUMENTAL ANALYSIS 
FT IR - Fourier Transform Infra-red Spectroscopy 
FTIR (Fourier Transform Infra-red Spectroscopy) was a sensitive technique 
particularly for identifying organic chemicals in a whole range of applications although  it  
can also characterise some inorganics. Examples include paints, adhesives, resins, 
polymers, coatings and drugs. FTIR was an effective analytical instrument for detecting 
functional groups. 
 
 
Fig No.4.3 FTIR MECHINE 
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Fig No.4.4  FTIR MECHANISM 
APPLICATIONS: 
• Quantitative scans 
• Qualitative scan solids, liquids, gases  
• Organic samples, 
• Inorganic samples  
• Unknown identification 
• Formulation Pharmaceuticals 
Principle: 
Spectrophotometric tests were commonly used in the Identification of chemical 
substances and quantification of polymorphic forms. The test procedures were applicable 
to substances that absorb IR radiation. The IR absorption spectrum of a substance compared 
with that obtained concomitantly for the corresponding reference standard / reference 
substance provide conclusive evidence of the identity of the substance being tested. 
Recording Infrared spectrum of a solid as a disc (as per USP ‹197K›) : 
➢ Triturate about 1 to 2 mg of the substance to be examined with 300 to 400 mg, 
unless otherwise specified, of finely powdered and dried potassium bromide. If the 
substance is a hydrochloride it is preferable to use potassium chloride. 
➢ Carefully grind the mixture and spread it uniformly in a suitable di
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➢ Submit it to the pressure of about 800 mPa (8 tons/cm2 ). 
➢ Examine the disc visually and if any lack of uniform transparency was observed, 
reject the disc and prepare again. 
➢ Record the spectrum between 4000 to 650 cm-1 unless otherwise specified in 
individual standard test procedure. 
➢ When sample and standard were measured for concordance, the transmittance 
obtained at the start of the scan range, should not deviate by more than 10% between 
them (For e.g. If the standard shows a transmittance of 75%, the sample 
transmittance can be between 65% and 85%). 
FT-IR was the most advanced and the major advantage was its 
❖ Speed 
❖ Sensitivity 
❖ Mechanical Simplicity 
❖ Internally Calibrated 87 
ICPOES (INDUCTIVELY COUPLED PLASMA OPTIC EMISSION 
SPECTROMETRY)    
 
                         Fig: 4.5 ICP-OES INSTRUMENT
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Manufacturer: Perkin Elmer 
Model:  Optima 5300 DV ICP-OES Inductively Coupled Plasma Spectrometer (ICP) 
Principle: 
An aqueous sample was converted to aerosols via a nebulizer. The aerosols are 
transported to the inductively coupled plasma which was a high temperature zone (8,000– 
10,000ºC). The analysts are heated (excited) to different (atomic and/or ionic) states and 
produce characteristic optical emissions (lights). These releases are separated based on 
their respective wavelengths and their strengths are measured (spectrometry). The 
intensities are proportional to the concentrations of analyses in the aqueous sample. The 
quantification was an external multipoint linear standardization by comparing the emission 
intensity of an unknown sample with that of a standard sample. Multi-element calibration 
standard solutions are prepared from single- and multi element primary standard solutions. 
With respect to other kinds of analysis where chemical speciation was relevant (such as the 
concentration of ferrous iron or ferric iron), only total essential concentration was analysed 
by ICP-OES. 86 
Application: 
The analysis of major and minor elements in solution IMM. 
Objectives: 
❖ Determine elemental concentrations of different metals. 
❖ Learn principles and operation of the ICP-OES instrument 
❖ Develop and put on a method for the ICP-OES sample analysis 
❖ Enhance the instrumental conditions for the analysis of different   
 elements 
❖ probes the outer electronic structure of atoms  
Mechanism:  
In plasma emwassion spectroscopy (OES), a IMM solution was presented into the 
core of inductively coupled argon plasma (ICP), which generates temperature of 
approximately 8000°C. At this temperature all elements become thermally excited and emit 
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light at their characteristic wavelengths. This light was collected by the spectrometer and 
passes through a diffraction grating that serves to resolve the light into a spectrum of its 
essential wavelengths. Within the spectrometer, this deflected light was then collected by 
wavelength and amplified to yield an strength of  measurement that can be converted to an 
elemental concentration by comparison with standardization values.87 
The Inductively coupled plasma optical emission spectrometric (ICP-OES) analysis 
was done in SAIF, IIT MADRAS, and Chennai-36 using Perkin Elmer Optima 5300 DV. 
                                                                                                                                                                                                  
                                                           
                                                                                                        
                                Fig No.4.6.1 ICP-OES MECHANISM    
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   Fig No:4.6.2  ICP-OES MECHANISM 
Sample preparation: 
Inductively Coupled Plasma Spectroscopy techniques are the so-called "wet" 
sampling methods whereby IMM are introduced in liquid form for analysis. 
100 mg IMM was occupied in a clean, dry test tube. To this, 3 ml Nitric acid was 
added and mixed well and allowed for few minutes untill the reactions were completed. 
And then, 25 ml of Refined water, was added to prepare digested solution. The digested 
IMM solution was shifted into plastic containers and labeled properly. It was completed in 
Bio-chemistry lab, Govt. Siddha Medical College, Chennai-106 
SEM - Scanning Electron Microscope DEFINITION 
Scanning Electron Microscopy (SEM), also known as SEM analysis or SEM 
microscopy, was used very effectively in microanalysis and failure analysis of solid 
inorganic materials. Scanning electron microscopy is performed at high magnifications, 
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generates high-resolution images and precisely measures very small features and objects. 
SEM ANALYSIS APPLICATIONS 
The signals generated during SEM analysis produce a two-dimensional image and 
reveal information about the sample including: 
External morphology (texture) 
➢ Chemical composition (when used with EDS) Orientation of materials making up the 
sample 
The EDS component of the system is applied in conjunction with SEM analysis to: 
➢ Determine elements in or on the surface of the sample for qualitative information 
➢ Measure elemental composition for semi-quantitative results 
Identify foreign substances that are not organic in nature and coatings on metalSEM 
Analysis with EDS – qualitative and semi-quantitative results Magnification – from 5x to 
300,000x 
Sample Size – up to 200 mm (7.87 in.) in diameter and 80 mm (3.14 in.) in height Materials 
analysed – solid inorganic materials including metals and minerals. 
 
 
   Fig No:4.7 SEM INSTRUMENT
MATERIALS AND METHODS 
 
ANTI-DISLIPIDEMIC ACTIVITY OF INDHIRANI MAATHIRAI 93 
 
 
Fig No:4.8 SEM MECHANISM  
THE SEM ANALYSIS PROCESS 
Scanning Electron Microscopy uses a focused beam of high-energy electrons to 
generate a variety of signals at the surface of solid specimens. In most SEM microscopy 
applications, data is collected over a selected area of the surface of the sample and a two-
dimensional image is generated that displays spatial variations in properties including 
chemical characterization, texture and orientation of materials. 
The SEM was also capable of performing analyses of selected point locations on the 
sample. This approach is especially useful in qualitatively or semi-quantitatively 
determining chemical compositions, crystalline structure and crystal orientations. 
The EDS detector separates the characteristic X-rays of different elements into an 
energy spectrum and EDS system software is used to analyse the energy spectrum in order 
to determine the abundance of specific elements. A typical EDS spectrum is portrayed as 
a plot of X-ray counts vs. energy (in keV). Energy peaks correspond to the various elements 
in the sample. 
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Energy Dispersive X-ray Spectroscopy can be used to find the chemical composition 
of materials down to a spot size of a few microns and to create element composition maps 
over a much broader raster area. Together, these capabilities provide fundamental 
compositional information for a wide variety of materials, including polymers. 
In scanning electron microscope high-energy electron beam was focused through a 
probe towards PP. Variety of signals was produced on interaction with the surface of the 
sample. This results in the emission of electrons or photons and it was collected by an 
appropriate detector. 
The types of signal produced by a scanning electron microscope include: 
➢ Secondary electrons 
➢ back scattered electrons 
➢ characteristic x-rays light 
➢ specimen current 
➢ Transmitted electrons. 
➢ This gives the information about the sample and it includes external morphology, 
texture, its crystalline structure, chemical composition and it displays the shape of the 
sample.88 
XRD - X-ray Powder Diffraction (XRD) 
X-ray powder diffraction (XRD) is a rapid analytical technique primarily used for 
phase identification of a crystalline material and can provide information on unit cell 
dimensions. The analysed material is finely ground, homogenized, and average bulk 
composition is determined. 
DEFINITION  
X-ray powder diffraction is most widely used for the identification of unknown 
crystalline materials (e.g. minerals, inorganic compounds). Determination of unknown 
solids is important to studies in geology, environmental science, material science and 
biology. 
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Fig No:4.9 XRD - X-ray Powder Diffraction 
 
 
     
Fig No:4.10 XRD Mechine
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APPLICATIONS: 
• Characterization of crystalline materials 
• Identification of fine-grained minerals such as clays and mixed layer clays that are 
difficult to determine optically 
• Determination of unit cell dimensions. 
With specialized techniques, XRD can be used to: 
• Determine crystal structures using Rietveld refinement 
• Determine of modal amounts of minerals (quantitative analysis) 
• Characterize thin films samples by: 
• determining lattice mismatch between film and substrate and to inferring stress and 
strain 
• determining dislocation density and quality of the film by rocking curve 
measurements 
• measuring super lattices in multi-layered epitaxial structures 
• determining the thickness, roughness and density of the film using glancing 
incidence X-ray reflectivity measurements 
• Make textural measurements, such as the orientation of grains, in a polycrystalline 
sample. 
Strengths and Limitations of X-ray Powder Diffraction: Strengths: 
• Powerful and rapid (< 20 min) technique for identification of an unknown mineral 
• In most cases, it provides an unambiguous mineral determination 
• Minimal sample preparation is required 
• XRD units are widely available 
• Data interpretation is relatively straight forward. 
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Limitations: 
• Homogeneous and 3single-phase material is best for identification of unknown 
• Must have access to a standard reference file of inorganic compounds 
• Requires tenths of a gram of material which must be ground into a powder 
• For mixed materials, detection limit is ~ 2% of sample 
• For unit cell determinations, indexing of patterns for non-isometric crystal systems 
is complicated. 
Sample Collection and Preparation: 
Determination of an unknown requires: the material, an instrument for grinding, and a 
sample holder. 
➢ Obtain a few tenths of a gram (or more) of the material, as pure as possible 
➢ Grind the sample to a fine powder, typically in a fluid to minimize inducing extra 
strain (surface energy) that can offset peak positions, and to randomize orientation. 
Powder less than ~10 µm(or 200-mesh) in size is preferred 
➢ Place into a sample holder or onto the sample surface.89 
4.3. TOXICOLOGICAL STUDY 
4.3.1. ACUTE ORAL TOXICITY STUDY OF INDHIRANI MAATHIRAI(IM) 
(OECD GUIDELINE – 423) 
Introduction: 
❖ The acute toxic class method is a stepwise procedure with the use of 3 animals of 
a single sex per step. 
❖ Depending on the mortality and/or the moribund status of the animals, on average 
2-4 steps may be necessary to allow judgement on the acute toxicity of the test 
substance. 
❖ This procedure is reproducible, uses very few animals and is able to rank 
substances in a similar manner to the other acute toxicity testing methods. 
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❖ The acute toxic class method is based on biometric evaluations with fixed doses, 
adequately separated to enable a substance to be ranked for classification purposes 
and hazard assessment. 
❖ In principle, the method is not intended to allow the calculation of a precise LD50 
but does allow for the determination of defined exposure ranges where lethality is 
expected since death of a proportion of the animals is still the major endpoint of 
this test. 
❖ The method allows for the determination of an LD50 value only when at least two 
doses result in mortality higher than 0% and lower than 100%. 
❖ The use of a selection of pre-defined doses, regardless of test substance, with 
classification explicitly tied to number of animals observed in different states 
improves the opportunity for laboratory to laboratory reporting consistency and 
repeatability. 
Principle of the Test: 
It is the principle of the test that based on a stepwise procedure with the use of a minimum 
number of animals per step, sufficient information is obtained on the acute toxicity of the 
test substance to enable its classification. The substance is administered orally to a group 
of experimental animals at one of the defined doses. 
The substance is tested using a stepwise procedure, each step using three animals of 
a single sex. Absence or presence of compound-related mortality of the animals dosed at one 
step will determine the next step, i.e. 
− no further testing is needed 
− dosing of three additional animals, with the same dose 
− dosing of three additional animals at the next higher or the next lower dose 
level. The method will enable a judgment with respect to classifying the test substance to 
one of a series of toxicity classes. 
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Methodology: 
Selection of Animal Species 
The preferred rodent species is the wistar albino rat, although other rodent species may be 
used. Healthy young adult animals are commonly used laboratory strains should be 
employed. Females should be nulliparous and non-pregnant. Each animal, at the  
commencement of its dosing, should be between 6 to 8 weeks old and the weight (150-
200gm) should fall in an interval within±20 % of the mean weight of any previously 
dosed animals. 
Housing and Feeding Conditions 
The temperature in the experimental animal room should be 22ºC + 3ºC. Although 
the relative humidity should be at least 30% and preferably not exceed 70% other than 
during room cleaning the aim should be 50-60%. 
Lighting should be artificial, the sequence being 12 hours light, 12 hours dark. For 
feeding, conventional laboratory diets may be used with an unlimited supply of drinking 
water. Animals may be group-caged by dose, but the number of animals per cage must not 
interfere with clear observations of each animal. 
Preparation of animals: 
The animals are randomly selected, marked to permit individual identification, and 
kept in their cages for at least 7 days prior to dosing to allow for acclimatization to the 
laboratory conditions 
Test Animals and Test Conditions: 
Sexually mature Female Wistar albino rats (150-200gm) were obtained from 
TANUVAS, Madhavaram, Chennai. All the animals were kept under standard 
environmental condition (22±3°C). The animals had free access to water and standard 
pellet diet (Sai Meera foods, Bangalore). 
Preparation for Acute Toxicity Studies 
Rats were deprived of food overnight (but not water 16-18 h) prior to administration of 
the, Indhirani Maathirai (IM) 
The principles of laboratory animal care were followed and the Institutional Animal 
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Ethical Committee approved the use of the animals and the study design.  
IAEC approved Number: 03/321/PO/Re/S/01/CPCSEA Dated:12/10/2018 
Test Substance : INDHIRANI MAATHIRAI (IM) 
Animal Source : TANUVAS, Madhavaram, Chennai. 
Animals : Wister Albino Rats (Female-3+3) 
Age : 6-8 weeks 
Body Weight on Day 0 : 200-250gm. 
Acclimatization : Seven days prior to dosing. 
Veterinary examination : Prior and at the end of the acclimatization period. 
Identification of animals : By cage number, animal number and individual 
          marking by using Picric acid 
Number of animals : 3 Female/group, 
Route of administration : Oral 
Diet : Pellet feed supplied by Sai Meera foods Pvt Ltd,      
                                                          Bangalore 
Water : Aqua guard portable water in polypropylene            
                                                             bottles. 
Housing & Environment : The animals were housed in Polypropylene cages 
           provided with bedding of husk. 
Housing temperature : between 22ºC + 3ºC. 
Relative humidity : between 30% and 70% 
Air changes : 10 to 15 per hour and  
Dark and light cycle : 12:12 hours. 
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Duration of the study  : 14 Days 
Administration of Doses: 
INDHIRANI MAATHIRAI (IM) was suspended in water and administered to the 
groups of wistar albino rats in a single oral dose by gavage using a feeding needle. The 
control group received an equal volume of the vehicle. 
Animals were fasted 12 hours prior to dosing. Following the period of fasting, the animals 
were weighed and then the test substance was administered. Three Female animals are used 
for each group. The dose level of 20, 40, 60 and 200 mg/kg body weight was administered 
stepwise. After the substance has been administered, food was withheld for a further 3-4 
hours. The principle of laboratory animal care was followed. 
Observations were made and recorded systematically and continuously as per the 
guideline after substance administration. 
The visual observations included skin changes, mobility, aggressively, sensitivity to 
sound and pain, as well as respiratory movements. Finally, the number of survivors was 
noted after 24 hrs and these animals were then monitored for a further 14 days and 
observations made daily. The toxicological effect was assessed on the basis of mortality.90 
Limit test 
The limit test is primarily used in situations where the experimenter has information 
indicating that the test material is likely to be nontoxic, i.e., having toxicity only above 
regulatory limit doses. 
A limit test at one dose level of 200 mg/kg body weight was carried out with three 
animals per step. The test substance-related mortality was not produced in animals, so 
further testing at the next lower level need not be carried out. 
Observations: 
Animals were observed individually after dosing at least once during the first 30 
minutes, periodically during the first 24 hours, with special attention given during the first 
4 hours, and daily thereafter, for a total of 14 days, except where they need to be removed 
from the study and humanely killed for animal welfare reasons or are found dead. 
It should be determined by the toxic reactions, time of onset and length of recovery 
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period, and may thus be extended when considered necessary. The times at which signs of 
toxicity appear and disappear are important, especially if there is a tendency for toxic signs 
to be delayed. All observations are systematically recorded with individual records being 
maintained for each animal. 
a.Mortality 
Animals were observed intensively at 0.5, 2.0, 4.0, 6.0, 12.0, 24.0- and 48.0-hours 
following drug administration on day 1 of the experiment and daily twicethereafter 
for 14 days. 
b.Body weight 
Individual weight of animals was determined before the test substance was 
administered and weights will be recorded at day 1, 7, and 14 of the study. Weight changes 
were calculated and recorded. At the end of the test, surviving animals were weighed and 
humanly killed. 
c. Cage-side observation 
These include changes in skin and fur, eyes and mucous membranes and also respiratory, 
circulatory, autonomic and central nervous systems, somato motor activity and behavioral 
patterns. Attention should be directed to observations of tremors, convulsions, salivation, 
diarrhoea, lethargy, sleep and coma. 
d. Gross necropsy 
All animals (including those which die during the test period are removed from the 
study) will be subjected to gross necropsy. Gross necropsy includes examination of 
the external surface of the body, all orifices, cranial, thoracic and abdominal cavities 
and their contents, brain, eye, thymus, lungs, heart, spleen, liver, kidneys, adrenals, testes 
and uterus of all animals. 
Histopathology 
Microscopic examination will be carried out in organs to show the evidence of any toxicity 
in gross pathology. 
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Data and reporting 
All data were summarized in tabular form, (Table-1-4) showing for each test group 
the number of animals used, the number of animals displaying signs of toxicity, the number 
of animals found dead during the test, description of toxic symptoms, weight changes, food 
and water intake. 
Test substance and Vehicle 
In order to ensure the uniformity in drug distribution in the medium the suspension was 
made by mixing Indhirani maathirai with 2% CMC and it was found suitable for dose 
accuracy. 
Justification for choice of vehicle 
The vehicle selected as per the standard guideline was pharmacologically inert and easy to 
employ for new drug development and evaluation technique.91 
4.3.2. REPEATED DOSE 28-DAY ORAL TOXICITY (407) STUDY OF 
INDHIRANI MAATHIRAI (IM) 
Test Substance : INDHIRANI MAATHIRAI (IM)  
Animal Source : TANUVAS, Madhavaram, Chennai. 
Animals : Wistar Albino Rats (Male -24, and Female-24) 
Age : 6-8 weeks 
Body Weight : 200-250gm. 
Acclimatization : Seven days prior to dose. 
Veterinary examination : Prior and at the end of the acclimatization period. 
Identification of animals : By cage number, animal number a n d  individual 
       marking by using Picric acid 
Diet : Pelletfeedsuppliedby Sai Meera Foods Pvt          
                                                           Ltd,Bangalore 
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Water : Aqua guard portable water in polypropylene bottles. 
                            Housing&Environment : The animals were housed in Polypropylene cages     
                                                                                  provided with bedding of husk 
Housing temperature : between 22ºC±3ºC.  
Relative humidity : between 30% and 70%,  
Air changes : 10 to 15 per hour 
Dark and light cycle : 12:12 hours. 
Duration of the study : 28 Days. 
Justification for Dose Selection: 
The results of acute toxicity studies in Wistar albino rats indicated that Indhirani 
maathirai was non-toxic and no behavioural changes was observed up to the dose level of 
200 mg/kg body weight. On the basis of body surface area ratio between rat and human, 
the doses selected. 
As, per OECD guideline three dose levels were selected for the study. They are low 
dose (5X), high dose (10X). X is calculated by multiplying the acute toxicity dose 200mg) 
and the body surface area of the rat (0.018), 5X dose is (10mg/kg), 10X dose is (20mg/kg) 
The oral route was selected for use because oral route is considered to be a proposed 
therapeutic route. 
Preparation and Administration of Dose: 
Indhirani Maathirai suspended in with water, it was administered to animals at the 
dose levels of 1X, 5X, 10X. The test substance suspensions were freshly prepared every 
two days once for 28 days. The control animals were administered vehicle only. The drug 
was administered orally by using oral gavage once daily for 28 consecutive days. 
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Methodology 
Randomization, Numbering and Grouping of Animals: 
80 Wistar Albino Rats (40M + 40F) were selected and divided into 4 groups. Each 
group consist of 20 animals (Male -10 and Female-10). First group treated as a control and 
other three group were treated with test drug (low, high) for 28 days. Animals were allowed 
acclimatization period of 7 days to laboratory conditions prior to the initiation of treatment. 
Each animal was marked with picric acid. The females were nulliparous and non-pregnant. 
Observations: 
Experimental animals were kept under observation throughout the course of study for 
the following: 
Body Weight: 
Weight of each rat was recorded on day 0, at weekly intervals throughout the course 
of study. From the data, group mean body weights and percent body weight gain were 
calculated. 
Food and water Consumption: 
Food and water consumed per animal was calculated for control and the treated dose 
groups. 
Clinical signs: 
All animals were observed daily for clinical signs. The time of onset, intensity and 
duration of these symptoms, if any, were recorded. 
Mortality: 
All animals were observed twice daily for mortality during entire course of study. 
Functional Observations: 
At the end of the 4th week exposure, ‘sensory reactivity’ to graded stimuli of 
different types (auditory, visual and proprioceptive stimuli), ‘motor reactivity’ and ‘grip 
strength’ were assessed. 
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Laboratory Investigations: 
Following laboratory investigations were carried out on day 29 in animals fasted 
over-night. Blood samples were collected from orbital sinus using sodium heparin 
(200IU/ml) for Biochemistry and potassium EDTA (1.5 mg/ml) for Hematology as 
anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 10 minutes. 
Hematological Investigations 
Blood samples of control and experimental rats was analyzed for hemoglobin 
content, total red blood corpuscles (RBC), white blood corpuscles (WBC) count and 
packed cell volume (PCV). 
Biochemical Investigations 
Serum was used for the estimation of biochemical parameters. Samples of control 
and experimental rats were analyzed for protein, bilirubin, urea, BUN, creatinine, 
triglyceride, cholesterol and glucose levels was carried using standard methods. 
Activities of glutamate oxaloacetate transaminase/Aspartate aminotransferase 
(GOT/AST), glutamate pyruvate transaminase/ Alanine amino transferase (GPT/ALT) and 
alkaline phosphatase were estimated as per the colorimetric procedure. 
Necropsy: 
All the animals were sacrificed by excessive anesthesia on day 29. Necropsy of all 
animals was carried out. 
Histopathology 
Histopathological investigation of the vital organs was done. The organ pieces (5- 
6µm thick) of the highest dose level of 300 mg/kg were preserved and were fixed in 10% 
formalin for 24 hours and washed in running water for 24 hours. 
Samples were dehydrated in an auto technique and then cleared in benzene to 
remove absolute alcohol. Embedding was done by passing the cleared samples through 
three cups containing molten paraffin at 50°C and then in a cubical block of paraffin made 
by the “L” moulds. It was followed by microtome and the slides
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were stained with Hematoxylin-eosin. The organs included heart, kidneys, liver, ovary, 
pancreas, brain, spleen and stomach, of the animals were preserved they were subjected to 
Histopathological examination. 
Statistical analysis: 
Findings such as body weight changes, water and food consumption, 
hematology and blood chemistry were subjected to One -way ANOVA followed by 
Dunnett’s multi comparison test using a computer software program– GRAPH PAD 
VERSION-3 version.93 
4.4. PHARMACOLOGICAL ACTIVITY  
4.4.1. ANTI – DYSLIPIDEMIC ACTIVITY 
TRITON WR 1339 INDUCED HYPERLIPIDEMIA FOR INDHIRANI 
MAATHIRAI 
Experimental protocol 
Total number of groups 4 
Number of animals / groups 6 
Sex : Both 
Strain : Wistar albino rats 
Body Weight : 200 – 250 g 
Surfactant administration 
Surfactant : 10% Triton WR 1339 
Route of administration : intravenously 
Vehicle : Saline 
Test drug administration 
Vehicle : Water 
Route of administration : Oral 
Drug dose : IM - 100 mg/kg b. wt. 
Procedure 
Wistar rats weighing 200–350 g was starved for 18 h and then injected 
intravenously with 10% Triton WR 1 339 (isooctyl-polyoxyethylene phenol). 
Phase I: Serum cholesterol levels increase sharply 2–3 times after 24 h. 
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 Phase II:The hypercholesterolemia decreases nearly to control levels within the next 24 
h. 
The test drugs employed or the solvent for the controls are administered 
simultaneously with the Triton injection or 22 h thereafter. Serum cholesterol analyses are 
made 6, 24, and 48 h after Triton injection. 
Mechanism 
The mechanism of the Triton induced hypercholesterolemia in phase I was thought 
to be due to increased hepatic synthesis of cholesterol through the ability of Triton to 
interfere with the uptake of plasma lipids by the tissues. Drugs interfering with cholesterol 
biosynthesis were shown to be active in phase I, while drugs interfering with cholesterol 
excretion and metabolism were active in phase II. 
Experimental design 
The animals were divided into four groups with six animals in each group. 
Table No:4.1. Experimental design 
 
 
Groups Treatment 
Group I Normal Control 
Group II Diabetic control- STZ (55 mg/kg) 
Group 
III 
Diabetic control- glibenclamide (5 mg/kg) 
Group 
IV 
Diabetic control- Indhirani maathirai 
40mg/kg 
Group V Diabetic control- Indhirani maathirai 
60mg/kg 
All the animals after 72 hours of triton injection (i.e. after inducing hyper lipidemia) the 
respective treatment was continued for 7 days. 
Collection of blood 
On the 8th day the blood was collected by retro orbital sinus puncture, under mild 
ether anaesthesia. The collected samples were centrifuged for 10 minutes. Then serum 
samples were collected and it is used for various biochemical experiments. Then animals 
were sacrificed and collected the liver. 
Biochemical analysis 
▪ Total cholesterol 
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▪ High-density lipoprotein 
▪ Low-density lipoprotein 
▪ Very low-density lipoprotein 
▪ Triglycerides 93  
4.4.2. Hypoglycemic activity of Indhirani maathirai (IM) 
Screening the drug Indhirani maathirai against Streptozotocin (STZ) induced 
Diabetes in Wistar albino Rats. 
Experimental Animals 
The animals were divided into 5 groups each constituting 6 rats. Group I was 
normal rats, Group II were STZ (55 mg/kg b.w., i.p) induced diabetic rats. Group III STZ 
(55 mg/kg b.w., i.p) induced diabetic rats were treated with Glibenclamide 5mg/kg b.w/p.o 
Group IV STZ (55 mg/kg b.wt., i.p) induced diabetic rats were treated with Infhirani 
maathirai 40mg/kg b.w/ p.o Group V STZ (55 mg/kg b.w., i.p) induced diabetic rats were 
treated with Infhirani maathirai 60mg/kg b w/p.o for 28 days. 
Methodology Induction of Diabetes 
Diabetes was induced in male Wistar albino rats aged 2–3 months (180–200 g body weight) 
by intraperitoneal administration of STZ (single dose of 55 mg/kg b.w) dissolved in freshly 
prepared 0.01 M citrate buffer, pH 4.5. 
After injection the animals had food and water ad libitum and were given 5% 
glucose in their drinking water for the first 24 hours to counter any initial hypoglycemia. 
The development of diabetes was confirmed after 72 hours of the Streptozotocin injection. 
After 72 hrs of STZ injection under mild anaesthesia the blood was withdrawn from the tip 
of the tail of each rat and the blood glucose level was analysed. Animals with more than 
250 mg/dl was considered as diabetic. 
Fasting blood glucose levels was measured before the administration of extracts. The 
blood glucose levels were checked on 0th, 7th, 14th, and 21st day of the treatment period. 
Blood was collected from snipping of the rat tail. Blood glucose levels were measured 
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Experimental Design 
Diabetic rats were divided into four groups with six animals in each group. 
Table No:4.2. Experimental design 
 
Groups Treatment 
Group I Normal Control 
Group II Diabetic control- STZ (55 mg/kg) 
Group III Diabetic control- glibenclamide (5 mg/kg) 
Group IV Diabetic control- Indhirani maathirai 40mg/kg 
Group V Diabetic control- Indhirani maathirai 60mg/kg 
 
<All the experimental rats were fasted overnight and the blood was withdrawn through 
puncturing retro orbital sinus on the 5th day,15th day and 20th day of post induction period to 
determine blood glucose level by GOD-POD kit method. The change in the body weight 
was observed throughout the treatment period in experimental animals. 
Statistical Analysis 
All the values were expressed as Mean ± S.D the difference between control and treatment 
groups were tested for significance using ANOVA followed by Dunnett’s test<0.05 were 
considered significant.94 
4.4.3. ANTI-OXIDANT ACTIVITY 
DPPH RADICAL SCAVENGING ASSAY 
The radical scavenging activity of different extracts was determined by using 
DPPH assay according to Chang et al. The decrease in the absorption of the DPPH solution 
after the addition of an antioxidant was measured at 517 nm. Ascorbic acid (10mg/ml 
DMSO) was used as reference. 
PRINCIPLE 
1, 1-diphenyl-2-picryl hydrazyl is a stable free radical with pink colour which turns 
yellow when scavenged. The DPPH assay uses this character to show free radical 
scavenging activity. The scavenging reaction between (DPPH) and an antioxidant (H- 
A) can be written as, 
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DPPH + [H-A] →DPPH-H + (A) 
Antioxidants react with DPPH and reduce it to DPPH-H and as consequence the 
absorbance decreases. The degree of discoloration indicates the scavenging potential of the 
antioxidant compounds or extracts in terms of hydrogen donating ability. 
REAGENT PREPARATION 
0.1mM DPPH solution was prepared by dissolving 4mg of DPPH in 100ml of 
ethanol. 
PROCEDURE 
Different volumes of extracts 1.25μl - 20μl (12.5 - 200µg/ml) from a stock 
concentration 10mg/ml were made up to a final volume of 20µl with DMSO and 1.48ml 
DPPH (0.1mM) solution was added. A control without the test compound, but an 
equivalent amount of distilled water was taken. The reaction mixture incubated in dark 
condition at room temperature for 20 minutes. After 20 minutes, the absorbance of the 
mixture was read at 517nm. 3ml of DPPH was taken as control.95 
CALCULATION 
% inhibition    =                  
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Ingrediants of indhirani maathirai 
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KARUNKALI 
 
 
 
 
 
 
 
 
 
 
 
 
 
VEDIYUPPU 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
 
ANTI-DYSLIPIDEMIC ACTIVITY OF INDIRANI MAATHIRAI 123 
 
Preparation of drug 
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5. RESULTS AND DISCUSSION 
 
There are various modern scientific studies have been carried out to bring the 
potency, efficacy and safety of the drug Inthirani Maathirai. 
This study includes: 
➢ Literary collections 
➢ Organoleptic characters 
➢ Physicochemical analysis 
➢ Phytochemical analysis 
➢ Instrumental analysis 
➢ Toxicological study 
➢ Pharmacological study 
The drug Inthirani Maathirai has been selected for Anti-dyslipidemic activity. 
➢ Literary collections about the drug from various text books were done. Siddha 
literatures related to the drug bring the evidence and importance of its utility in 
treating the dyslipidemia. 
➢ The drug review brings the identification, morphological description of the plants 
and drugs, chemical constiduents and effectiveness of the ingredients present in 
the drug for anti-dyslipidemic, anti-diabetic and anti-oxident property. Also gives 
the medicinal uses of the ingredients.  
➢ Siddha and modern aspect of the drug explains about clinical features and 
treatment aspect of Dyslipidaemia and also explains adverse effect of drugs used in 
modern aspect. 
➢ Pharmaceutical review describes about the purification, preparation, 
administration of trial drug and explains about its shelf-life properties. 
➢ The pharmacological review explains about the methodology of Anti- 
dyslipidemic Activity, Hypoglycaemic Activity and Anti- oxidant activity of the 
drugs used. 
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Standardization of The Test Drug Inthirani Maathirai 
The efficacy and potency of the trial drug was exhibited through standardization. It 
was done by analysing the drug with several modern scientific studies. Physicochemical, 
phytochemical studies and biochemical analysis were done and the results were tabulated. 
Toxicological and pharmacological results of the drug were derived. Its result has been 
tabulated and interpretations were done, thus it gave a comprehensive justification, which 
brings the efficacy of the trial drug. 
Organoleptic Character 
The following organoleptic characters have been noted in Inthirani Maathirai 
Table No.5.1 Results of Organoleptic characters 
 
Colour Sandish Brown 
Odour Pleasant 
Taste Astringent, milld Pungent 
Texture Pills or Tablets 
 Size Payiralavu Maathirai (42mg) 
PHYSICOCHEMICAL ANALYSIS 
Table No.5.2. Results of Physicochemical analysis 
S.NO PARAMETER RESULT 
1 pH 4.9 
2 Total ash 12.8% 
3 Water soluble ash 3.96% 
4 Acid soluble ash        2.47% 
5 Loss on drying (at 105°C) 1% 
6 Water soluble extractive 18.4 % 
7 Alcohol soluble extractive 6% 
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8 Solubility  
I Distilled water Soluble 
II NaOH Soluble 
III Hcl Soluble 
Interpretation 
The Physico chemical results of the drug reveals the pH, total ash, water soluble 
ash, acid insoluble ash, loss on drying, water soluble extractive, alcohol soluble extractive 
and solubility of the trial drug. 
pH: 
PH value reveals the hydrogen ion concentration. It is the measure of the acidic or 
alkaline nature. If the pH of the drug 7.0, it is neutral, above 7.0, it is alkaline and below 
7is acidic. 
Abioavailability and effectiveness. The result concludes that the oral 
bioavailability of the drug Indhirani Maathirai is very high.96 
ASH VALUES: 
Ash content of the drug is generally taken to be the residue remaining after 
incineration at 650-7000 Celsius. It usually represents the inorganic salts naturally 
occurring in the drug and adhering to it. 
Depending upon the concentration and type of minerals existing, the quality of 
the drug was determined. 
The total ash value of Indhirani Maathirai is 12.87% which indicates the purity of 
the drug. 
Acid Insoluble Ash 
Acid insoluble ash value of the drug Indhirani Maathirai is less than 2.47% this 
indicates the good quality of the drug. 
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Water soluble ash 
Water soluble ash value for Indhirani Maathirai is 3.96% which reveals that the 
sample drug has easy facilitation of diffusion and osmosis mechanism. 
Loss on Drying 
The moisture content of a sample was determined by Loss on drying. The moisture 
content of the drug reveals the stability and better shelf life. Loss on drying value of the 
trial drug Indhirani Maathirai is 1% at 105°C. The less value of moisture content could 
prevent bacterial, fungal or yeast growth Solubility 
Solubility is the basic requirement for the absorption of the drug in GIT.The poor 
solubility and low permeability are the causes of low oral availability. Here the water-
soluble nature of Indhirani Maathirai is 18.4% This nature might be helpful for the better 
absorption. The sample drug also soluble in Hydrochloric acid, Sodium hydroxide.97 
PHYTO CHEMICAL ANALYSIS 
Table No:5.3 Results of Phytochemical Analysis 
S.NO Phytochemicals Test name H2O 
Extract 
1. Alkaloids Mayer’s Test - ve 
2. Carbohydrates Molisch’s Test - ve 
3. Glycosides Modified Bontrager’s Test - ve 
4. Saponin Froth Test + ve 
5. Phenols Ferric chloride Test - ve 
6. Tannins Gelatin Test - ve 
7. Flavonoids Alkaline reagent Test + ve 
 8. Proteins Xanthoprotein Test     - ve 
  9. Amino acids Ninhydrin Test - ve 
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10. Diterpenes Copper acetate Test + ve 
11. Gum & Mucilage Extract + Alcohol + ve 
12. Quinones NAOH+Extract - ve 
13. Fat & Fixed Oil Spot Test - ve 
 
Interpretation: 
 All the plants have different Phyto chemical constituents with them. These 
constituents have the definite physiological action on the human body. 
The Phytochemical screening of Indhirani Maathirai shows the presence of 
Saponin, Phenol, Tannins, Flavonoids, Diterpenes, Quinones Gums and Mucilage. 
Flavonoids: 
Flavonoids are poly phenolic molecules containing 15 carbon atoms and are soluble 
in water. They provide health benefits through cell signalling path way and antioxidant 
effects.98 
Flavonoids have the anti-oxidant properties, due to this character it shows the major 
influence on vascular system. They have the anti-atherosclerotic effect, exhibited by the 
oxygen radicals which oxidise LDL, injures the endothelial wall and there by promotes 
anti-atherosclerotic changes.99 
Saponins: 
Saponins are a diverse group of chemicals, which derive their name from their ability 
to form soap-like foams in aqueous solutions. Saponins are the metabolic glycosides 
present in many plants.100 
Saponins have the cholesterol lowering activity. It lowers the cholesterol level by 
blocking the absorption of cholesterol by the body and increases the excretion of the 
cholesterol. 101 
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Diterpenes 
Diterpenes are structurally diverse class of C20 natural compounds widely 
distributed in nature. They are derived from Geranylgeraniol pyrophosphate. Naturally 
occurring diterpenes exert several activities such as anti-spasmodic, anti- inflammatory. 
Diterpenes derived from plants has been used as medication for reducing glucose 
and lipid level. They also possess anti-oxidant activity.102 
Gum & Mucilage: 
Guar gum was significantly effective in comparison with glibenclamide in the 
treatment of hyperlipidemia and hyperglycemia in diabetes rats. Therefore, it may be 
suggested as a reliable fiber in diabetic regimes in diabetic patients.103 
HPLC ANALYSIS 
HPLC is a technique in analytical chemistry which is used to separate the 
components in a mixture, to identify each component, and to quantify each component 
Table No:5.4 HPLC Analysis report of Indhirani Maathirai 
S.no PARAMETERS UNITS RESULTS 
1. Total Polyphenol as gallic acid Equivalent mg/100g 1.68 
2. Total flavonoids as quercetin Equivalent mg/100g       8 
3. Total Alkaloids mg/100g 1.64 
4. Total Tannin as Tannic Acid Equivalent mg/100g 0.78 
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Chart. No:5.1 HPLC Analysis Results of Indhirani Maathirai 
INTERPRETATION 
This HPLC study results, indicating the presence of phenolic compounds such as 
Gallic Acid, Quercetin, Alkaloids and Tannic acid were found in the trial drug Indhirani 
Maathirai. 
Flavonoids as Quercetin 
Flavonoids are group of plant metabolites, having anti-hyperlipidaemic, anti- 
hyperglycaemic and anti-cancerous activities.104 Flavonoids of all sub class have proven 
to have hypoglycaemic properties by the actions like 
1.enhancing insulin secretion via regeneration of pancreatic β cells. 2.enhancing 
insulin mediated glucose uptake by target cells. 
3.inhibitng aldose reductase enzyme. 
4.increasing ca2+ uptake. 105 
High intake of dietary quercetin decreases plasma total cholesterol and increases HDL 
cholesterol. 
Consumption of quercetin reduce thiobarbituric acid reactive substance levels and 
elevated activities of superoxide dismutase, catalase and glutathione peroxidase in the 
liver. Thus, quercetin could be effective in improves hypoglycaemic, dyslipidemic and 
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antioxidant status in type 2 diabetes.106 
Thus, the flavonoids enhance the anti-dyslipidemic, hypoglycaemic and anti- 
oxidant activities. 
BIOCHEMICAL ANALYSIS 
Table No: 5.5Results of Basic radical’s studies 
 
S.no Parameter Result 
1 Test for Potassium Present 
2 Test for Calcium Present 
3.  Test for Sodium Present 
4. Zinc Present 
5. Aluminium Present 
 
Interpretation 
The basic radical test shows the presence of potassium, calcium zinc and 
aluminium. 
Potassium: 
The potassium rich diet has significant reduction in cholesterol ester deposition in 
atherosclerosis 
Calcium: 
Increased intake of calcium produces marked decrease in serum lipids.Calcium 
can bind with bile acids& fatty acids in the gut, leading to mal absorption of fat from the 
digestive tract. Thus, calcium intake has a positive effect on serum lipids. The calcium 
content of the trial drug will support to reduce dyslipidemia. 
Sodium: 
Hypertriglyceridemia may be a factor contributingto abnormal proximal sodium 
handling and sodium retention.107 
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Zinc 
Zinc improved the effectiveness of OHA and may be beneficial in decreasing 
blood glucose, TG, urinary albumin excretion and inflammation in diabetic nephropathy 
patients and thus reducing the risk of complications.  
Zinc supplementation significantly reduced total cholesterol, LDL cholesterol and 
triglycerides. In addition to that, Zinc supplementation in non-healthy patients 
demonstrated a significant elevation of HDL cholesterol. Therefore, it may have the 
potential to reduce the incidence of atherosclerosis related morbidity and mortality 
especially in non-healthy patients who are at risk of atherosclerosis.108 
Aluminium: 
Aluminium mediated drug reactions   participate the lipid metabolism and corrects 
hyperlipidemia.109 
Table No:5.6 Results of Acid Radicals 
 
S.NO Parameter Result 
1.  Sulphate Present 
2. Phosphate Present 
3.   Nitrate Present 
 
Interpretation 
 The acidic radicals test shows the presence of Sulphate and Nitrate. 
Sulphate: 
Sulphate ions attached with oxidised form of cholesterol and it is highly protective 
against fatty streaks and atherosclerosis.110 
Nitrate: 
Dietary nitrate improves glucose tolerance and lipid profile in an animal model 
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REF Existence of these radicals will help the trial drug for its therapeutic effects.111 
Phosphate: 
 The dyslipidemia was accompanied with significantly elevated serum phosphate 
level. On the other hand, no significant difference was evident in the serum lipid or 
phosphate concentrations of subclinical hypothyroid patients compared to euthyroid 
subjects. A significantly reduced serum phosphate level was shown in hyperthyroid 
patients with unaltered serum lipid levels. Significant correlations were evident between 
TSH and T4 levels as independent parameters and the serum concentrations of 
triglyceride, cholesterol and phosphate. The results indicate in hypothyroidism that a 
secondary hyperphosphatemia may aggravate myocardial and arterial abnormalities 
induced by the secondary hyperlipidemia, which may need correction.112 
MICROBIAL LOAD 
Table No.5.7 Bacterial and fungal dilutions 
 
MICROBES DILUTION RESULT 
Bacteria 10-4 5 
Bacteria 10-6 2 
Fungi 10-2 1 
Fungi 10-3 Nil 
Interpretation 
❖ The bacterial load availability in the IM has been performed by Agar plate 
technique. As IM was made from plant materials it is more susceptible to to 
contamination. The contamination of herbal drugs by microorganism not 
only cause bio deterioration but also reduces the effectiveness of drug. The 
toxin produced by microbes makes herbal drugs unfit for human 
❖ consumption because the contaminated drug may develop various disease 
instead of disease being cured. 
RESULTS AND DISCUSSION 
ANTI-DYSLIPIDEMIC ACTIVITY OF INDHIRANI MAATHIRAI 134 
 
❖ The contamination of IM has been examined by bacterial and fungal load. 
❖ Total bacterial load in 10-4 dilution is 5 and 10-6 dilution is 2. 
❖ Total fungal load in 10-2 dilution is 1 and 10-3 dilution is nil. 
This result shows the presence of bacterial and fungal load in the trial drug 
(IM). Load of bacteria and fungi are within the limits of WHO norms 
Fig.No.5.1 FTIR- FOURIER TRANSFORM INFRARED SPECTROSCOPY 
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Table No:5.8 Result of FTIR Spectrum 
 
S.NO 
  PEAK 
  VALUE  
     
INTENSITY 
      STRETCH    FUNCTIONAL GROUP 
1. 3430 Strong O-H Stretch Alcohol 
 2.         3430 Medium N-H Stretch Aliphatic primary amine 
3. 2924 Strong O-H Stretch Carboxylic acids 
4. 2924 Weak O-H Stretch Alcohol 
5. 2924 Strong N-H Stretch Amine salt 
6. 2924 Medium C-H Stretch  Alkane 
7. 2521 Weak S-H Stretch Thiol 
8. 1786 Weak C-H Bond 
Aromatic 
compound (over 
tone) 
  9. 1786 Strong C=O Stretch Anhydride 
10. 1786 Strong C=O Stretch Acid halide 
11. 1786 Strong  C=O Stretch Conjucated acid halide 
12.       1479 Medium C-H Bond Alkane 
13.       1089 Strong C-F Stretch Fluoro compound 
   14.       1089 Strong C-O Stretch Alkyl aryl ether 
 15.      1089 Strong C-O Stretch Vinyl ether 
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   16.      1089 Strong C-O Stretch Aliphatic ether 
 17.       1089 Strong C-O Stretch Secodary Alcohol 
18.       861 Strong C=C Bond Alkene 
19.      782 Medium C=C Bond Alkene (tri substituted) 
20.      712 Strong C=C Bond Alkene (di substituted) 
21.      699 Strong C=C Bond Alkene (di substituted) 
 22.      699 Strong C-Br Stretch Halo compound 
23.      490 Strong C-I Stretch Halide 
Interpretation 
FTIR instrumental analysis was done for the test drug and it was identified that there 
were 11 peaks values. They are the functional groups existing in the trial drug Indhirani 
Maathirai. 
The table shows the presence of alkanes, alkyl halides, alkenes, amines, alcohol, 
carboxylic acid, thiol,aromatic compouds, anhydrides, fluro compound,ether, ketone 
groups which represents the peak value. Existence of this these functional groups will 
intensify the trial drug’s property. 
Carboxylic Acid 
Carboxylic acid is present in the trial drug in the form of per-hydro fluorene which 
is a peroxime proliferator activated receptor. It is a nontoxic one, because of having an 
effect of regulating PPAR, is useful as hypoglycemic and hypolipidemic and preventing 
remedy for metabolic disorders.113 
Ether 
In this trial drug the aromatic ether is present as cyclo heptane. This cycloheptane 
useful in the treatment of various metabolic disorder such as diabetes mellitus, 
dyslipidemia.114 
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Alkane 
In the trial drug the alkanes are present in the form of tridecane, which is found in 
lime oil. It presents in all the spices. The spices having the anti-oxidant property which 
helpful in reducing the oxidative stress in dyslipidemic conditions.115 
ICP-OES-Inductively Coupled Plasma Mass Spectrometry 
It is a technique used to analyse trace levels of a wide range of inorganic elements.it 
identifies and quantifies the metals and inorganic elements. 
Table no.5.9 ICP-OES Interpretation 
S.NO ELEMENTS DETECTED LEVELS 
1. Arsenic BDL (LOQ 0.1) 
2 Cadmium BDL (LOQ 0.1) 
3. Mercury BDL (LOQ 0.1) 
4. Lead BDL (LOQ 0.1) 
 
Interpretation: 
The ICP-OES study results of the trial drug show below detectable values of Arsenic, 
Cadmium, Mercury, Lead. The absence of these heavy metals ensures the quality of the 
drug and the safety of the drug. Thus, the long-term use of the trial drug will not be 
harmful to human beings. 
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XRD (X-Ray diffraction) 
Fig No: 5.2 XRD 
Interpretation 
Dependent on the route of synthesis, the crystalline structure, the size and the shape 
of the particles of the drug are present and also it determines the efficacy of a drug. The 
micro particles may enhance bio absorption of the drug. 
In the XRD analysis results of IM have the major diffraction peaks. They are 
identified and concluded in the range of 27-75 nm is association with organic molecules. 
These molecule plays an important role in making the drug to biocompatible and nontoxic 
at therapeutic doses. Other elements present in IM act as an added supplement and helps 
in increasing the efficacy of the formulation. 
SCANNING ELECTRON MICROSCOPE 
In addition, the particle size and chemical elements were assessed by Scanning 
Electron Microscope SEM is one of the most widely used instruments in research areas. 
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Fig. No:5.3 SEM IMAGE 5µM 
 
 
 
             
 
 
 
Fig. No:5.4 SEM IMAGE 10µM 
The SEM image is done by 500X magnification via 10µm aperture shows 
maximum depth focused. 
Interpretation: 
Biodegradable microparticles have been used frequently as drug delivery vehicles 
due to its grand bioavailability, better encapsulation, control release and less toxic 
properties. The advantages of microparticles are 
The test drug Indhirani Maathirai contains micro particles. 
Micro particles present in the drug results in a better bioavailability and facilitates 
absorption. 
            The particles of micro size show that the drug may easily enter the cells at the   
molecular level to treat the disease rapidly and increase the therapeutic effect.      
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             Micro particles are defined as particulate dispersion or solid particles with a size 
in the range of 100-1000nm in diameter. 
➢ The above SEM studies of microscopic resolution showed objects of sizes ranging 
from 5-10 microns. 
➢ Size and surface of micro particles can be easily manipulated to achieve both 
passive and active drug targeting. 
➢ They control and sustain, the release of drug during the transportation and at the 
site of localization, alters drug distribution in the body and subsequent clearance 
of the drug so as to achieve increased drug therapeutic efficacy thereby bio-
availability and reduced side effects [104] 
➢ Hence Indhirani Maathirai which is prepared biologically contains microparticles 
to enhance the pharmacological action in the target site. 
TOXICOLOGICAL STUDY RESULTS OF Indhirani Maathirai  
As per the OECD guidelines, toxicological studies were very essential in animal 
models in order to establish the safety and efficiency of a new drug. Toxicological studies 
help to make conclusion whether a novel drug should be approved for clinical use or not. 
Toxicity produces the negative, lethal and adverse effects of drugs. 
Some chemical elements present in plants, which may produce weakness 
in general well- being and mortality. 
To avoid the adverse effects, the herbal formulation of Indhirani Maathirai has been 
engaged in to toxicity studies. 
Acute Oral Toxicity Study of Indhirani Maathirai 
Wistar albino rat was treated with the test drug Indhirani Maathirai of single dose of 
200mg/kg in water as suspension. 
The LD50 value of the drug was determined by acute toxicity study to determine 
the immediate toxic effect, single dose of drug given in large quantity. 
This study was conducted as per the OECD guidelines. The result of acute toxicity of 
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Indhirani Maathirai has been tabulated below. 
Table No: 5.10 Observations in Behavioural Signs of Acute Oral Toxicity 
 
S.No Group 
 CONTROL 
  Observation SL      Group 
TEST GROUP 
 Obsevation 
1. Body weight        Normal  1 Body weight    Normally      
    increased 
2. Assessments 
of      posture 
Normal 2 Assessments of 
posture 
      Normal 
3. Signs of 
convulsion  
limb paralysis 
Normal 3 Signs of 
convulsion limb        
paralysis 
      Normal 
4. Body tone Normal 4 Body tone Normal 
5. Lacrimation Normal 5 Lacrimation Normal 
6. Salaivation Normal 6 Salaivation Normal 
7. Change in 
skin color 
       No   
significant    
color change 
7 Change in skin 
color 
        No    
   significant 
Color change 
8. Piloerection Normal 8 Piloerection Normal 
9. Defecation Normal 9 Defecation       Normal 
10. Sensitivity 
response 
Normal 10 Sensitivity     
Response 
Normal 
11. Locomotion Normal 11 Locomotion Normal 
12. Muscle 
gripness 
Normal 12 Muscle gripness Normal 
13. Rearing       Mild 13 Rearing Mild 
14. Urination      Normal 14 Urination Normal 
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Table No:5.11 Dose finding experiment and its behavioural signs of toxicity for 
Indhirani Maathirai 
 
Dose 
200mg/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
A1 
20mg/kg 
+ - - - + + - - - - - - - - - - - - - - 
A2 
40mg/kg 
+ - - - + + - - - - - - - - - - - - - - 
A3 
60mg/kg 
+ - - - + + - - - - - - - - - - - - - - 
1.Alertness 2. Aggressiveness 3. Pile erection 4. Grooming 5. Gripping 6.Touch 
Response 7. Decreased Motor Activity 8. Tremors 9. Convulsions 10. Muscle Spasm, 
11.Catatonia 12. Muscle relaxant 13. Hypnosis 14. Analgesia 15. Lacrimation 16. 
Exophthalmos 17. Diarrhoea 18. Writhing 19. Respiration 20. Mortality. 
(+ Present, - Absent) 
 
Interpretation 
➢ The Acute toxicity result shows no mortality rate up to 200mg/kg. 
➢ The rats did not reveal any observable signs of central nervous system and 
mortality. It does not show any changes in alertness, grooming and touch 
response. The behavioural changes are normal. 
➢ This dose level did not produce signs of toxicity, behavioural changes, and 
mortality in the test groups as compared to the controls when observed during 14 
days of the acute toxicity experimental period. Hence the test drug Indhirani 
Maathirai is a safe herbal drug and can be used for continued administration. 
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Table No:5.12 Body weight of wistar albino rats in acute group exposed to Indhirani 
Maathirai (IM) 
 
 
DOSE 
DAYS 
1 7 14 
CONTROL 218.4±1.24 216.4±1.14 214.2±1.42 
HIGH DOSE 
200mg/kg 
230.2±1.22 232.4±1.44 236.4±3.37 
P value (p)* NS NS NS 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One-
way ANOVA followed by Dunnett’s test) 
Table No:5.13 (Water intake (ml/day) of Wistar albino rats group exposed to 
INDHIRANI MAATHIRAI (IM) 
                 
DOSE 
DAYS 
1 7 14 
CONTROL 1.4±4.34 72.2±3.14 74.4±4.13 
HIGH DOSE 200mg/kg 72.4±3.33 71.53±1.08 52.4±3.20 
P value (p)* NS NS NS 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One-
way ANOVA followed by Dunnett’s test) 
Table No:5.14 Food intake (gm/day) of Wistar albino rats group exposed to 
INDHIRANI MAATHIRAI(IM) 
 
DOSE DAYS 
1 7 14 
CONTROL    66.12±4.24 68.6±1.22 60.6±2.76 
High DOSE 60mg/kg    61.2±1.64 63.3±3.13 64.2±3.1 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are 
mean ± S.D (One-way ANOVA followed by Dunnett’s test. 
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Interpretation 
 The result of the body weight of rats exposed to control and the trial drug of 
Indhirani Maathirai 200mg exhibited overall non-significant changes throughout the 
dosing period of 14 days. This indicates that the tested animals were in the healthy 
condition during the 14 days observation period. 
The quantity of water and food intake taken by the animals from the group and 
the control is comparably normal. 
The results exhibit that the trial drug did not produce any adverse effects up to the 
dose level of 200 mg/kg body weight. 
 
RESULTS OF REPEATED DOSE 28- DAY ORAL TOXIC STUDY OF 
INDHIRANI MAATHIRAI (IM) 
TableNo:5.15Body weight of wistar albino rats group exposed 
to INDHIRANI MAATHIRAI(IM) 
 
DOSE 
                                                            
DAYS 
1 7 14 21 28 
CONTROL 281.2±1.64 282.2 ± 1.04 283.4 ± 1.40 284.4± 1.40 285.2 ± 1.10 
LOW DOSE 
20mg/kg 
281.2 ± 1.25 282.4 ± 1.19 283.3±1 .21 284 ±1.20 285.2± 1.10 
MID DOSE 
40mg/kg 
281.1±1.27 282.3±2.10 283.8±2.71 284.3±3.20 285.1±1.50 
HIGH DOSE 
60mg/kg 
281.2± 1.41 282.4±2.17 283.2 ± 1.64 284.2 ± 1.18 285 ± 2.30 
P value (p)* NS NS NS NS NS 
NS- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One-
way ANOVA followed by Dunnett’s test) 
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TableNo:5.16 Water intake (ml/day) of Wistar albino rats group exposed to 
INDHIRANI MAATHIRAI (IM) 
 
 
      DOSE 
                                      DAYS 
1 7 14 21 28 
CONTROL 61.5 ± 8.95 61±6.23 58.5±6.23 59±8.196 61.5±3.96 
LOW DOSE  72.3±3.41 74.4±1.62 76.4±1.46 75.3±1.04 79.4±1.04 
MID DOSE  67.2±1.15 67.2±2.40 69.2±2.45 67.6±1.28 69.2±2.40 
HIGH DOSE 72.1±1.42 74.2±1.14 75.7±1.14 75.2±1.03 73.2±1.55 
P value (p)* NS NS NS NS NS 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean 
± S.D (One-way ANOVA followed by Dunnett’s test) 
TableNo:5.17 Food intake (gm/day) of Wistar albino rats group exposed to 
INDHIRANI MAATHIRAI (IM) 
 
 
  DOSE 
DAYS 
1 7 14 21 28 
CONTROL 37±5.37 38.5±3.22 39.5±3.37 38.5±3.37 37±3.12 
LOW DOSE  62.6±1.18 64.3±1.62 64.4±1.20 65.4±1.10 66.6±1.42 
MID DOSE  64.8±4.34 65.8±1.14 66.4±1.14 67.4±1.32 67.8±2.49 
HIGH DOSE 65.2±1.04 65.2±1.04 69.2±1.46 69.2±1.34 69.1±1.52 
P value (p)* NS NS NS NS NS 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are 
mean ± S.D (One-way ANOVA followed by Dunnett’s test) 
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TableNo:5.18 Haematological parameters of Wistar albino rats group exposed to 
INDHIRANI MAATHIRAI (IM) 
Parameter Control 20 mg/kg 40 mg/kg 60 mg/kg 
RBC   (x 106/mm3) 7.51 ± 0.16 7.46±0.26 7.69±0.46 7.3±0.43 
PCV (%) 48.2 ± 1.3 46.4±3.2 48.46±4.2 44.6±2.6 
Hb (%) 15.6 ± 0.19 15.3±0.8 15.6±0.4 15.2±1.7 
WBC   (x 103/mm3) 10.12 ± 1.2 10.4±1.2 10.2±2.3 10.6±0.89 
Neutrophils (%) 22 ± 4 24.3±1.6 19.3±0.67 23.6±1.34 
Mononuclear cells (%) 76 ± 2 72.4±2.2 77.6±1.8 73.14±3.2 
Eosinophils(%) 2.4 ± 0.6 2.4±0.12 2.12±0.16 3.2±0.46 
Platelets   (x 103/mm3) 423.2 ± 48.8 433.4±34.3 412.6±23.46 422.68±48.2 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One-
way ANOVA followed by Dunnett’s test) 
 
TableNo:5.19 Biochemical Parameters of Wistar albino rats group exposed to 
INDHIRANI MAATHIRAI (IM) 
 
Parameters Control 20 mg/kg 40 mg/kg 60mg/kg 
Albumin (g/dl) 4.8 ± 0.6 4.4±0.48 4.42±0.6 4.82±0.8 
Total Cholesterol(mg/dl) 91.24 ± 1.35 101.34±1.62 97.56±2.46 96.2±5.8 
Triglycerides  ( mg/dl) 50.15 ± 3.21 52.6±2.8 54.3±3.4 51.5±4.6 
Glucose (mg/dl) 110.16 ±8.62 114.6±3.4 93.6±11.2 97.2±8.2 
Sodium (mEq/L) 138.12 ± 3.14 129.2±4.3 124.2±4.6 132.6±2.3 
Potassium (mEq/L) 7.2 ± 1.34 5.4±0.8 5.6±0.4 6.7±0.6 
 
NS- Not Significant, **(p > 0.01), * (p >0.05), n = 10 values are mean ± S.D (One-
way ANOVA followed by Dunnett’s test) 
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TableNo:5.20 Renal function test of of Wistar albino rats group exposed to 
INDHIRANI MAATHIRAI(IM) 
 
PARAMETERS CONTROL LOW DOSE MID DOSE HIGH DOSE 
BUN (mg/dl) 19.2 ± 1.2 20.6±1.4 21.2±2.1 20.4±0.78 
Urea (mg/dl) 64.24 ± 3.11 64.3±2.6 62.6±4. 59.6±3.14 
Creatinine (mg/dl) 0.82 ± 0.16 0.84±0.02 0.82±0.04 0.73±0.24 
NS- Not Significant, **(p > 0.01), * (p >0.05), n = 10 values are mean ± S.D (One- 
way ANOVA followed by Dunnett’s test) 
TableNo:5.21 Liver Function Test of Wistar albino rats group exposed to 
INDHIRANI MAATHIRAIAM (IM) 
 
NS- Not Significant, **(p > 0.01), * (p >0.05), n = 10 values are mean ± S.D 
(One- way ANOVA followed by Dunnett’s test) 
 
 
 
PARAMETERS CONTROL LOW DOSE MID DOSE HIGH DOSE 
 Total Bilirubin (mg/dl) 0.205 ± 0.04 0.214±0.06 0.31±0.04 0.36±0.04 
SGOT (U/L) 73 ± 2.4 76.4±2.4 69.2±5.6 73.6±3.2 
SGPT(U/L) 28.4 ± 1.2 27.6±4.2 28.25±4.3 29.8±2.2 
Alkaline 
phosphatase(U/L) 
102.4 ± 3.6 95.4±4.3 97.6±3.2 103.4±11.2 
Protein (g/dl) 8.62 ± 1.3 8.2±1.6 8.6±0.85 8.4±1.16 
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FIGURE:5.4  HISTOPATHOLOGICAL SLIDES OF IRM 
NORMAL     HIGH DOSE 
         
     KIDNEY 
NORMAL     HIGH DOSE 
          
     LIVER 
NORMAL     HIGH DOSE 
           
       SPLEEN
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Results Observations 
Overall observations were similar in both male and female rats. 
Clinical signs of toxicity 
No clinical signs of toxicity were observed. 
Mortality 
No mortality was observed after 28 days repeated dose administration of IM. All 
animals survived to study termination period. 
Body weight 
Body weights has slight variations when compared to their initial weight. No 
significant alterations were observed in body weight. 
Food and water consumption   
No effect of treatment was noted.  
Physiological activities 
No changes in the general behaviour 
Blood analysis 
a. Haematology 
No treatment related effects were observed. 
b. Biological parameters 
No treatment related effects were observed. 
c. Histological examination 
Histological examination of organs did not show any pathological changes. 
Discussion 
➢ The acute and repeated 28 days oral toxicity studies of Indhirani Maathirai did 
not produced any toxicity signs in wistar albino rats. Daily administration of IM at 
different doses 20 mg/kg, 40mg/kg, 60mg/kg for 28 days was tolerated by the rats 
without any mortality and morbidity, indicates the drug tolerance. 
➢ Hence the herbomineral formulation of IM was considered to be safe drug for 
long- term use, as revealed by toxicological studies. 
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PHARMACOLOGICAL ACTIVITY 
Pharmacological activity explained the efficacy of the drug. Each activity is carried 
in animal model and the corresponding results were tabulated. These results reveal the 
potency of the test drug Indhirani Maathirai and its effectiveness in treating the diseases. 
ANTI-HYPERLIPIDEMIC ACTIVITY RESULTS 
Table: 5.22 Effect of INDIRANI MATHIRAI   on lipid profile of Triton induced 
hyperlipidemia in rats 
Lipid 
parameters 
Group-I 
Normal 
control 
Group-II          
Triton 
control 
rats 
Group-III 
Hyperlipide
mic +  
Simvastatin 
Group-
IV 
Hyperlipi
demic + 
IM 40mg 
Group-V 
Hyperlipi
emic + 
IM60mg 
Cholesterol(mg/
dl) 
72.80±1.20 172.81±7.
43*** 
58.13±7.3** 72.90±8.4
** 
64±6.4** 
HDL (mg/dl) 33.23±1.25 28.30±0.9
7** 
63.90±1.59*
* 
73.80±2.4
9** 
84.63±2.5
2** 
LDL (mg/dl) 57.43±2.2 127.80±0.
90** 
50.40±6.10*
* 
52.10±3.2
0** 
46.21±3.7
** 
VLDL 
(mg/dl) 
19.74±0.60 81.50±3.5
5*** 
41.50±4.082
** 
51.25±4.8
7** 
41.22±2.1
1** 
TGL (mg/dl) 65.02± 1.88 127.50±1.
70*** 
48.50±2.04*
* 
56.25±2.4
0** 
50.42±1.1
0** 
Values were expressed as Mean±SEM, n=6, Hyperlipidemic control was 
compared with normal control rats - Values are statistically significant at +P<0.05, 
++P<0.01, +++P<0.001 Experimental groups(III & IV) were compared with 
hyperlipidemic control rats - Values are statistically significant at *P<0.05, **P<0.01, 
***P<0.001 
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Chart no:5.2 Anti-Hyperlipidemic activity of IM 
 
INTERPRETATION 
Anti-dyslipidemic activity of the test drug Indhirani Maathirai was conducted by 
Triton WR 1339 induced hyperlipidemia in animal model Wistar albino rats. In this study 
the triton induced group shows the levels of total cholesterol, triglycerides, LDL, VLDL 
which are significantly increased when compared to control groups. While HDL groups 
were significantly decreased in level when compared to control groups. 
Triton WR-1339 (tyloxapol) is a non-ionic surfactant being widely used to explore 
possible mechanism of lipid lowering drugs. It causes drastic increase in serum TG and TC 
level due to increase in 3 hydroxy, 3 methyl glutaryl Co A (HMG Co A) reductase activity 
and by inhibition of lipoprotein lipase responsible for hydrolysis of plasma lipids.116 
The test drug Indhirani Maathirai of 100mg/kg b. wt. showed significant changes in 
the lipid level. There is a significant decrease in the level of LDL, VLDL, TGL. There is 
a significant increase in the HDL also noted. The standard drug Lovastatin also showed the 
significant decrease in the LDL, VLDL, TG. But there is no significant increase in the 
HDL. This outcome of the trial drug may be due to the presence of flavonoids, saponins, 
diterpenes, gums and mucilage. 
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Disorders of lipid metabolism are associated with increased oxidative stress and over 
production of oxygen free radicals. Free radicals implicated in aetiology of several life 
style disorders such as atherosclerosis, stoke, diabetes and cancer.117 
Consuming plant phytosterol containing products reduces LDL levels, greatly in 
individual with high baseline LDL level compared with those with normal to borderline 
baseline LDL levels118 
The presence of flavonoids, alkaloids and polyphenols in the test drug reveals it has 
the anti-oxidant property, which will reduce lipid peroxidation119 
The lipid lowering drugs such as Fibrates, Statins, bile acid sequestrants does not 
possess anti-oxidant property. Therefore, a drug having dual property of anti- 
dyslipidemic as well as anti-oxidant property activate from the natural product is the most 
preferred one. The trial drug Indhirani Maathirai may achieve the requirement. 
Hypoglycaemic activity of Indhirani Maathirai 
Fasting blood glucose levels was measured before the administration of extracts. 
The blood glucose levels were checked on 0th, 7th, 14th, and 21st day of the treatment 
period. Blood was collected from snipping of the rat tail. Blood glucose levels were 
measured and body weight was taken on day 0 and 28th day. 
Table no 5.23  Animal groups and its dosage 
 
Groups Treatment 
Group I Normal Control 
Group II Diabetic control- STZ (55 mg/kg) 
Group III Diabetic control- glibenclamide (5 mg/kg) 
Group IV Diabetic control- Indhirani Maathirai 40mg/kg 
Group V Diabetic control- Indhirani Maathirai 60mg/kg 
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Table no 5.24: Effect of INDIRANI  MATHIRAI   on blood sugar level in 
Streptozotocin induced diabetic rats  
Gro
ups 
Treatments Blood glucose level (mg/dl) on post induction days 
Initial 5th day 10th day 15th day 
I Normal 
control 
70.50 ±9.23 66.45± 9.56 68.00 ±7.45 
 
64.25 ±5.24 
II Diabetic 
Control 
261.27±1.73*
* 
270.36±1.59**
* 
264.75±1.24*
** 
259.80±1.10*
** 
III Diabetic rats 
+ 
Glibenclamid
e 
264.50± 1.70 252.86± 3.63 140.67±3.20* 71.54±3.65** 
IV Diabetic rats 
+ IM-
40mg/kg 
272.34±3.46 
 
266.45± 2.65 
 
164.28±2.70* 
 
148.68±3.38*
* 
 
V Diabetic rats 
+ IM-
60mg/kg 
284.29±2.34 274±2.42 172.18±1.54* 116.20±2.20*
* 
Control rat - Values are statistically significant at *P<0.05, 
**P<0.01,***P<0.001. Experimental groups(III & IV) were compared with diabetic 
control rats - Values are statistically significant at *P<0.05, **P<0.01, ***P<0.001 
Chart no 5.3 Blood glucose level of  IM 
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Table no 5.25: Effect of INDIRANI  MATHIRAI   on body weight in Streptozotocin 
induced diabetic rats 
Group 
No. 
Treatment Body weight (g) on post induction days 
Initial  5th day 15th day 20th day 
I Normal 
control 
166.25±2.52 168.89±3.21 169.47±2.58 170.45±2.45 
II Diabetic 
Control 
164.49±2.78 162.80± 
3.34 
135.80±2.10++ 124.30±2.33++ 
III Diabetic rats + 
Glibenclamide 
161.40±3.26 164.10 ± 
2.77 
169.8±3.26* 177.30 ± 
2.37** 
IV Diabetic rats + 
IM-40mg/kg 
166.40±5.78 170.60 ± 
4.23 
174.80 ± 4.86* 176.40± 
5.89** 
V Diabetic rats + 
IM-60mg/kg 
220.32±5.21 200.31±2.72 204.71±2.91* 214.31±1.82** 
Control rat - Values are statistically significant at *P<0.05, 
**P<0.01,***P<0.001. Experimental groups (III & IV) were compared with diabetic 
control rats - Values are statistically significant at *P<0.05, **P<0. 
Chart no:5.4 Body Weight Changes Hypolipidemic Activity of IM 
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Fig no 5.5: Histopathology of Pancreas 
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Interpretation Hypoglycemic activity 
The hypoglycemic Activity of the test drug Indhirani Maathirai has been estimated 
in the streptozotocin induced diabetes in Wistar albino rat. 
Administration of the streptozotocin effectively induces diabetes mellitus in the 
animal model which is known by the increased glucose level. 
STZ, slightly cytotoxic agent of pancreatic beta cells, selectively destroys the 
pancreatic insulin secreting beta cells, thus leaving less active cells and resulting in 
diabetes mellitus. Thus, it is widely used to induce diabetes in animal models. It also 
interferes with cellular metabolic oxidative mechanisms 120 
Oral administration of the test drug Indhirani Maathirai taken in the dose of 
20mg/kg showed significant decrease in the sugar level. 
The possible mechanism by which the test drug Indhirani Maathirai brings about a 
decrease in the blood sugar may be by potentiation of the insulin effect of plasma by 
increasing either the pancreatic secretion of insulin from β-cells of the islets of 
Langerhans or its release. 
Body weight changes 
Body weight of the animal models in this study was also observed. There is decrease 
in the body weight of the animal treated with the control. Whereas the animal treated with 
Indhirani Maathirai shows a significant improvement in the body weight. Thus, the trial 
drug not only reduced the sugar level but also sustains the body weight in Diabetes 
Mellitus. 
Histopathology slides of pancreas did not exhibit any pathological changes when 
compared to the control group. 
Discussion on anti dyslipidemic and hypoglycemic effects of Indhirani Maathirai 
Anti-dyslipidemic activity of the test drug Indhirani Maathirai was conducted by 
Triton WR 1339 induced hyperlipidemia in animal model Wistar albino rats. The results 
were tabulated above. 
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The test drug Indhirani Maathirai of 200mg/kg b. wt showed significant changes in 
the lipid level. There is a significant decrease in the level of LDL, VLDL, TGL. There is 
a significant increase in the HDL also noted. The standard drug also showed the 
significant decrease in the LDL, VLDL, TG. But there is no significant increase in the 
HDL. 
In dyslipidemic conditions, hyperlipidemia is always accompanied by 
hyperglycemia representing risk factor for coronary heart disease and other 
complications. Hyperlipidemia may lead to insulin resistance. The enzymes used in 
biosynthesis of cholesterol was inhibited by insulin. Therefore, deficiency of insulin 
results in the increased level of LDL, VLDL, TG, cholesterol and decrease in HDL. 
Hyperlipidemia produces further vascular complications and increases the severity of 
diabetes. 
The drug showed significant decrease in the LDL which is almost equal to the 
standard and marked increase in the HDL than the standard drug. Hence this anti- 
dyslipidemic activity supports the hypoglycemic activity of the drug Indhirani Maathirai, 
in giving an effective treatment as a whole. 
ANTIOXIDANT ACTIVITY: (IN VITRO STUDY) 
 Antioxidants are substances that can prevent or slow down the damage to 
cells caused by free radicals, unstable molecules that the body produces as a reaction to 
environmental and other pressures. They are sometimes called "free-radical scavengers." 
 Antioxidants support to deactivate free radicals in our body and they thought 
to enhances overall health. 
 The cell damage caused by free radicals known as oxidative stress. 
Antioxidants can protect the cell against this oxidative stress. 
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Free radicals and their actions: 
➢ Free radical is a molecular species, which has the capable of independent 
existence that contains an unpaired electron in an atomic orbital. The presence of 
an unpaired electron results in certain common properties that are shared by most 
radicals. 
➢ Radicals are weakly attracted to a magnetic field and are said to be paramagnetic. 
Many radicals are highly reactive and can either donate an electron to or extract 
an electron from other molecules, therefore behaving as oxidants. As a result of 
this high reactivity most radicals have a very short half- life (10−6 seconds or less) 
in biological systems, although some species may survive for much longer. 
➢ Oxidative stress has been linked to heart disease, cancer, arthritis, stroke, 
respiratory diseases, immune deficiency, emphysema, Parkinson's disease, and 
other inflammatory or ischemic conditions.121 
Antioxidant Action in Dyslipidemia 
In dyslipidemia, there is an elevated concentration of malondialdehyde, which is 
an end product of poly unsaturated fatty acid peroxidation. The increased level of 
malondialdehyde will produce excess of free radicals and leads to lipid peroxidation and 
cell oxidative injury. Free radicals adversely alter lipids, proteins and trigger number of 
diseases. 
A balance between free radicals and anti-oxidant is necessary for proper physiological 
functions of the body Thus, anti-oxidant reduces lipid peroxidation rate and restore the 
anti-oxidant’s capacity, which possibly prevent or delay the development of 
dyslipidemia.122 
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Result: 
Table no. 5.26 DPPH assay on Indhirani Maathirai 
 
 
*µg/ml: microgram per millilitre. Drug:  IM (1.25-20µg/µl). Standard: 
Ascorbic acid (10mg/ml DMSO)  
Chart No:5 DPPH assay on Indhirani Maathirai 
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Control 0.3547 1.7983 0 0.00 
12.5 0.3119 1.4044 12.07 21.90 
25 0.2600 1.0782 26.70 40.04 
50 0.1744 0.7121 50.83 60.40 
100 0.1487 0.2921 58.08 83.75 
200 0.0521 0.0692 85.31 96.15 
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Discussion on Antioxidant activity in DPPH assay: 
The values of DPPH free radical scavenging activity of the IM extract was given in 
(Table) expressed in the percentage. The extract of IM showed the highest DPPH 
scavenging activity (75.64%) at 200µg/ml and the lowest percentage of inhibition 
(12.80%) at 12.5µg/ml. Ascorbic acid (Standard) showed highest percentage of inhibition 
(96.15%) at 200µg/ml and the lowest percentage of inhibition (21.90%) at 12.5µg/ml. So, 
the trial drug has antioxidant property and it will supportive to the dyslipidemia condition. 
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6. CONCLUSION 
The drug Indhirani Maathirai was selected to validate the safety and its efficacy 
for Anti-Dyslipidemic Activity in animal model (Wistar albino rats). 
The ingredients of the drug were identified and authenticated by Gunapadam 
experts. The drug was prepared as per classical Siddha literary procedure and 
subjected to various studies to reveal the potency and efficacy of the drug. 
The Organoleptic character and physico chemical studies were made to 
standardization of the drug Indhirani Maathirai. From the above studies, the 
Indhirani Maathirai was standardised as per AYUSH guidelines. 
The analysis of biochemical, instrumental was made to know the presence of 
active ingredients in the drug which is responsible for its activity. 
Here, the biochemical analysis showed the presence of Potassium, calcium, 
sodium, zinc, sulphate, nitrate by its synergistic effect, the drug as activity against 
the dyslipidemic condition. 
In instrumental analysis, FTIR showed the peak values represents the functional 
groups responsible for its activity. SEM picture explained the particle size of the 
drug. In ICP-MS described about the absence of heavy metals and its permissible 
limits which showed the safety of the drug. The XRD results reveals the organic 
molecules present in the trial drug. 
Toxicity studies revealed about the acute and sub-acute toxicity effect of the 
Indhirani Maathirai in rat models. The drug showed no toxicity and mortality in both 
acute and sub-acute toxicity. 
According to OECD guidelines, the haematological, biochemical parameters 
were investigated. There were no significant changes in the functional behaviour and 
in the normal values. Thus, it was established the safety of the drug while 
administrated for prolonged time. 
Pharmacological studies were done on the rat model for Anti-dyslipidemic, 
hypoglycaemic activity and in vitro study for Anti- oxidant activity. 
 
CONCLUSION 
 
ANTI-DYSLIPIDEMIC ACTIVITY OF INDHIRANI MAATHIRAI 166 
 
In Dyslipidaemia the main pathophysiology is the increased oxidative stress which 
results in the tissue damage and it is the main reason for other complications. The anti-
oxidant property of this drug is mainly due to the presence of phytochemicals and other 
active ingredients which involve in scavenging the free radicals and prevents tissue 
damage and other complications. 
In Anti dyslipidemic activity, showed significant decreased LDL, VLDL, TGL, TC 
levels and marked increased HDL level in the triton WR-1339 induced dyslipidemic in 
Wistar albino rat models. 
In Dyslipidemic conditions, hyperlipidaemia is always accompanied with the 
hyperglycaemia. The increase in level of LDL, VLDL, TGL, cholesterol and decrease 
in HDL will lead to insulin resistance. Dyslipidaemia produces further vascular 
complications and increases the severity of Diabetes. The drug showed significant 
decrease in the LDL and marked increase in the HDL than the standard drug. 
In hypoglycaemic activity, there was significant decrease in blood glucose level and 
slightly increased body weight in the Streptozotocin induced Wistar albino rats. 
In Anti-oxidant activity, there was significant effect of drug when compare to 
standard in DPPH assay. 
Thus, by surviving all the above factors, it is concluded that the drug Indhirani 
Maathirai is safe and potent drug with Anti-dyslipidemic and hypoglycaemic activity 
with rich Anti-oxidant activity. This will support the treatment and management of 
dyslipidaemia and its complications. In treating, the dyslipidemic condition with this 
drug it has a synergistic effect of controls on lipid profile, blood sugar level and also 
reduces the oxidative stress and gives a complete treatment for dyslipidemic condition 
and its complications 
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7. SUMMARY 
The herbal drug Indhirani Maathirai was taken as a test drug for Dyslipidaemia 
from the classical Siddha literature Sarabenthirar Siddha Maruthuva Sudar, 4th edition 
was edited by Dr.M.Sowrirajan and it was exposed to validate the safety and its efficacy 
for treating Anti-dyslipidemic, Hypoglycemic and anti-oxidant activity in animal 
model. The trial drug was subjected to various studies through which the efficacy of 
the drug is proved. 
The preparation of trial drug was standardized by physico chemical and bio 
chemical analysis. 
The bio chemical analysis of the drug shows the presence of zinc, calcium. 
phosphate. These elements are responsible for anti-dyslipidaemic activity. HPLC 
analysis disclose the percentage of elements presence in the drug 
FTIR analysis revealed the presence of C=O groups, -C=C group, which indicates 
functional groups present in the sample. XRD Interprets the molecular structure of the 
sample. 
SEM analysis showed the size of the drug in micro particles which denotes that 
the trial drug could have potent drug delivery. ICP-MS study reveals safety of the drug. 
The acute and sub-acute toxicological studies proved that the drug is nontoxic and 
safe. 
The pharmacological studies conducted by in vivo method revealed that the drug 
has effective results in Anti-dyslipidaemic, Hypoglycaemic and anti-oxidant activity. 
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8. FUTURE SCOPE 
The trial drug Indhirani Maathirai was taken from the classical Siddha literature 
Sarabenthirar Siddha Maruthuva Sudar, 4th edition was edited by Dr.M.Sowrirajan. Its 
validation for Anti-dyslipidaemic, Hypoglycaemic and anti-oxidant activity was 
completed at preclinical level. The results showed the assurance of Anti-Dyslipidaemic 
activity against hyperlipidaemia. Clinical trials are required to understand the exact 
molecular mechanism of action and it would be a safer drug for Dyslipidaemia in 
worldwide. 
 
 
BIBILIOGRAPHY 
 
ANTI-DYSLIPIDEMIC ACTIVITY OF INDIRANI MAATHIRAI 169 
 
BIBILIOGRPHY 
1- Shanmugavelu M, Noi naadal noi muthal naadal thirattu-1, Indian medicine and 
homoeopathy department puplications, 2014, 359-63. 
2- Thiyagarajan R, Gunapadam thathu jeeva vaguppu, Indian medicine and homoeopathy 
department puplications, 2013, 1. 
3- Uththanaraayan K S, Siddhar aruvai maruthuvam, Indian medicine and 
homoeopathy department puplications, 2009, 34-5. 
4- Sudhaparimala S, Kodi CM, Gnanamani A, Mandal AB. Quality assessment of 
commercial formulations of tin based herbal drug by physico-chemical fingerprints. 
Indian Journal of Science and Technology. 2011 Dec 1;4(12):1710-4.  
5- Chaudhary A, Singh N. Herbo mineral formulations (rasaoushadhies) of ayurveda an 
amazing inheritance of ayurvedic pharmaceutics. Ancient science of life. 2010 
Jul;30(1):18. 
6- Thanigavelan V, Kaliyamurthi V, Lakshmanakumar V, Elansekaran S, Kumar MP. 
Physicochemical characterization for the quality assessment of a Siddha herbomineral 
pill–Karpoora chindhamani mathirai. Journal of Applied Pharmaceutical Science. 
2013 Mar;3(03):133-8.  
7- Coyne T, Hughes R, Langi S. Lifestyle diseases in Pacific communities. Noumea: 
Secretariat of the Pacific Community; 2000.  
8- https://www.ncbi.nlm.nih.gov.in 
9- https://www.ncbi.nlm.nih.gov.in 
10- https://www.webmed.com 
11- Kuppusamy Muthaliyar K M, Siddha maruthuvam pothu, Indian medicine and 
homoeopathy department puplications, 2012, 511. 
12- Kuppusamy Muthaliyar K M, Siddha maruthuvam pothu, Indian medicine and 
homoeopathy department puplications, 2012,497. 
13- Kuppusamy Muthaliyar K M, Siddha maruthuvam pothu, Indian medicine and 
homoeopathy department puplications, 2012,506-7. 
14- Shankar Narayanan S, Medical taxonomy of angiosperms, Harishi publications, 2009, 
371. 
15- Murugesa Muthaliyar K S, Gunapadam mooligai vaguppu, Indian medicine and 
homoeopathy department puplications, 2008, 646. 
BIBILIOGRAPHY 
 
ANTI-DYSLIPIDEMIC ACTIVITY OF INDIRANI MAATHIRAI 170 
 
16- Murugesa Muthaliyar K S, Gunapadam mooligai vaguppu, Indian medicine and 
homoeopathy department puplications, 2008, 645. 
17- Murugesa Muthaliyar K S, Gunapadam mooligai vaguppu, Indian medicine and 
homoeopathy department puplications, 2008, 645. 
18- Shankar Narayanan S, Medical taxonomy of angiosperms, Harishi publications, 2009, 
371. 
19- Arangarasan S, Panjakaaviya nigandu, Sarasvathi mahal library publications, 2003, 
221-22. 
20- Murugesa Muthaliyar K S, Gunapadam mooligai vaguppu, Indian medicine and 
homoeopathy department puplications, 2008, 760. 
21- Shankar Narayanan S, Medical taxonomy of angiosperms, Harishi publications, 2009, 
721. 
22- Murugesa Muthaliyar K S, Gunapadam mooligai vaguppu, Indian medicine and 
homoeopathy department puplications, 2008, 761. 
23- Murugesa Muthaliyar K S, Gunapadam mooligai vaguppu, Indian medicine and 
homoeopathy department puplications, 2008, 761. 
24- Murugesa Muthaliyar K S, Gunapadam mooligai vaguppu, Indian medicine and 
homoeopathy department puplications, 2008, 761. 
25- Murugesa Muthaliyar K S, Gunapadam mooligai vaguppu, Indian medicine and 
homoeopathy department puplications, 2008, 761. 
26- Shankar Narayanan S, Medical taxonomy of angiosperms, Harishi publications, 2009, 
721. 
27- Shankar Narayanan S, Medical taxonomy of angiosperms, Harishi publications, 2009, 
721-22. 
28- Arangarasan S, Panjakaaviya nigandu, Sarasvathi mahal library publications, 2003, 
192. 
29- Shankar Narayanan S, Medical taxonomy of angiosperms, Harishi publications, 2009, 
392. 
30- Murugesa Muthaliyar K S, Gunapadam mooligai vaguppu, Indian medicine and 
homoeopathy department puplications, 2008, 262. 
31- Murugesa Muthaliyar K S, Gunapadam mooligai vaguppu, Indian medicine and 
homoeopathy department puplications, 2008, 262. 
BIBILIOGRAPHY 
 
ANTI-DYSLIPIDEMIC ACTIVITY OF INDIRANI MAATHIRAI 171 
 
32- Shankar Narayanan S, Medical taxonomy of angiosperms, Harishi publications, 2009, 
735. 
33- Shankar Narayanan S, Medical taxonomy of angiosperms, Harishi publications, 2009, 
736. 
34- Shankar Narayanan S, Medical taxonomy of angiosperms, Harishi publications, 2009, 
392. 
35- Shankar Narayanan S, Medical taxonomy of angiosperms, Harishi publications, 2009, 
393. 
36- Murugesa Muthaliyar K S, Gunapadam mooligai vaguppu, Indian medicine and 
homoeopathy department puplications, 2008, 251. 
37- Murugesa Muthaliyar K S, Gunapadam mooligai vaguppu, Indian medicine and 
homoeopathy department puplications, 2008, 252. 
38- Murugesa Muthaliyar K S, Gunapadam mooligai vaguppu, Indian medicine and 
homoeopathy department puplications, 2008, 252. 
39- Shankar Narayanan S, Medical taxonomy of angiosperms, Harishi publications, 2009, 
392. 
40- Shankar Narayanan S, Medical taxonomy of angiosperms, Harishi publications, 2009, 
393. 
41- Arangarasan S, Panjakaaviya nigandu, Sarasvathi mahal library publications, 2003, 
223-24. 
42- Shankar Narayanan S, Medical taxonomy of angiosperms, Harishi publications, 
2009,239. 
43- Murugesa Muthaliyar K S, Gunapadam mooligai vaguppu, Indian medicine and 
homoeopathy department puplications, 2008, 196. 
44- Murugesa Muthaliyar K S, Gunapadam mooligai vaguppu, Indian medicine and 
homoeopathy department puplications, 2008, 196. 
45- Murugesa Muthaliyar K S, Gunapadam mooligai vaguppu, Indian medicine and 
homoeopathy department puplications, 2008, 196. 
46- Murugesa Muthaliyar K S, Gunapadam mooligai vaguppu, Indian medicine and 
homoeopathy department puplications, 2008, 197. 
47- Sambasivam Pillai T V, Siddha medical dictonory, Indian medicine and homoeopathy 
department puplications, 2016,  
BIBILIOGRAPHY 
 
ANTI-DYSLIPIDEMIC ACTIVITY OF INDIRANI MAATHIRAI 172 
 
48- Thiyagarajan R, Gunapadam thathu jeeva vaguppu, Indian medicine and homoeopathy 
department puplications, 2013, 433. 
49- Thiyagarajan R, Gunapadam thathu jeeva vaguppu, Indian medicine and homoeopathy 
department puplications, 2013, 434. 
50- Arangarasan S, Panjakaaviya nigandu, Sarasvathi mahal library publications, 2003, 
51- Shankar Narayanan S, Medical taxonomy of angiosperms, Harishi publications, 2009, 
484. 
52- Murugesa Muthaliyar K S, Gunapadam mooligai vaguppu, Indian medicine and 
homoeopathy department puplications, 2008, 710. 
53- Shankar Narayanan S, Medical taxonomy of angiosperms, Harishi publications, 2009, 
485. 
54- Shankar Narayanan S, Medical taxonomy of angiosperms, Harishi publications, 2009, 
403. 
55- Murugesa Muthaliyar K S, Gunapadam mooligai vaguppu, Indian medicine and 
homoeopathy department puplications, 2008, 232. 
56- Murugesa Muthaliyar K S, Gunapadam mooligai vaguppu, Indian medicine and 
homoeopathy department puplications, 2008,232. 
57- Murugesa Muthaliyar K S, Gunapadam mooligai vaguppu, Indian medicine and 
homoeopathy department puplications, 2008, 233. 
58- Murugesa Muthaliyar K S, Gunapadam mooligai vaguppu, Indian medicine and 
homoeopathy department puplications, 2008, 233. 
59- Shankar Narayanan S, Medical taxonomy of angiosperms, Harishi publications, 2009, 
404. 
60- T V Sambasivam Pillai Siddha Medical Dictionary Edition 2011 Dept. Of Indian 
Medicine & Homoeopathy, Chennai-106, Vol I, Page No:240. 
61- U. Sathya Narayana, U. Chakrapani Biochemistry, Edition III, Arunabha Sen Books 
& Allied (p) Ltd, Kolkata, 28-29. 
62- Frederickson classification of lipid disorders available online from 
https:||www.cmecorner.com|…PDF|Frederickson – classification pdf. 
63- U. Sathya Narayana, U. Chakrapani Biochemistry, Edition III, Arunabha Sen Books 
& Allied (p) Ltd, Kolkata, 317-320. 
64- Vinay kumar, Abdul K Abbas Robbin’s Basic Pathology, Edition VIII, Published by 
Elsvier Inc, 347 
BIBILIOGRAPHY 
 
ANTI-DYSLIPIDEMIC ACTIVITY OF INDIRANI MAATHIRAI 173 
 
65- Marahatta SB, Multi-drug resistant tuberculosis burden and risk factors: an update, 
Kathmandu univ Med J (KUM J), 2010 Jan-Mar 8 (29): 116-25 
66- T.V.Sambasivam pillai, Tamil agarathi, Government of Tamilnadu, Edition-1994, 
pg.no 776 
67- http://en,wikipedia.org/wiki/tablet 
68- David jones,2008 
69- H. Gerhard Vogel (ed) Drug Discovery and Evaluation, Springer-Verlag Berlin 
Heidelberg, 2002, Edition II, 1106. 
70- SK Gupta Drug Screening Methods Edition III Jay Pee Brothers Medical Publishers, 
NewDelhi-002, 614-616. 
71- Antioxidant Assays Research / Science Topic available online from 
https://www.researchgate.net/topic Antioxidant Activity Assay 
72- Rana F, Avijit M. Review on Butea monosperma. Int. J. of Research in Pharmacy and 
Chemistry. 2012; 2:1035-9.  
73- Srivastava AK, Singh VK. Biological action of Piper nigrum-the king of spices. 
European Journal of Biological Research. 2017 Sep 30;7(3):223-33  
74- Prashant Y, Kritika S, Anurag M. A review on phytochemical, medicinal and 
pharmacological profile of Euphorbia antiquorum. IJPPR Human. 2015; 4:56-67.  
75- Suryawanshi HP, Patel MR. Traditional uses, medicinal and phyto-pharmacological 
properties of Caesalpinia crista Linn–An overview. Int J Res Pharm Chem. 
2011;1(4):1179-83.  
76- Amalraj A, Gopi S. Biological activities and medicinal properties of Asafoetida: A 
review. Journal of traditional and complementary medicine. 2017 Jul 1;7(3):347-59.  
77- Parle M, Kadian R, Sharma K. Phytopharmacology of acacia catechu wild: A review. 
World J Pharm Pharm Sci. 2014;3(3):1380-9.  
78- Sarakku Sei Suththi Muraigal (Tamizh Maruththuva Nool Varisai- 8) Edition- 2008, 
Commissionerate of Indian Medicine & Homoeopathy, Chennai-106, Page No:9 
79- Sarakku Sei Suththi Muraigal (Tamizh Maruththuva Nool Varisai- 8) Edition- 2008, 
Commissionerate of Indian Medicine & Homoeopathy, Chennai-106, Page No:56. 
80- Sambasivam Pillai T V, Siddha medical dictonory, Indian medicine and homoeopathy 
department puplications, 2016,  
81- Lohar DR. Protocol for testing: Ayurvedic, Siddha and Unani Medicines. 
Pharmacopoeia Laboratory for Indian Medicine, Ghaziabad 
BIBILIOGRAPHY 
 
ANTI-DYSLIPIDEMIC ACTIVITY OF INDIRANI MAATHIRAI 174 
 
82- WHO guidelines 
83- Prashant diwari et al, phytochemical screening and extraction: A review IPS Jan-
March 2011 vol 1(1) 
84- Mradu Gupta et al, Pharmacognetics and Chemical Standardisation of vaginal herbal 
Formulation Extracts Using Spectroscopy (UV-VIS& FTIR) and Chromatography 
(HPTLC, HPLC, GC-MS) Methods, IJPPR, 2017 May, Vol- 9, Issue-2. 
85- Anonymous, 1998, Bio chemical Standards of Unani formulations, Part3, CCRUM, 
New Delhi, P.no.58-60 
86- Anija et al, Text Book of Microbiology, Volume:2, Page No:197 
87- FTIR available at: 
https://www.lpdlabservices.co.uk/analytical_techniques/chemical_analysis/ftir.php 
88- Scanning Electron Microscope available online from: 
https://serc.carleton.edu/research_education/geochemsheets/techniques/SEM.h tml 
89- X-ray powderdiffraction available from: 
https://serc.carleton.edu/research_education/geochemsheets/techniques/XRD.h tml 
90- Organization for Economic Cooperation Development (OECD) Guideline, 423, 2000. 
Guideline Document on Acute Oral Toxicity. Environmental Health and Safety 
Monograph Series on Testing and Assessment No. 24. 
91- Schlede E et al, Justification for Choice of Vehicle, 1992, 66, 455-470 
92- OECD Guidelines for the Testing of Chemicals (No. 407, Section 4: Health Effects) 
"Repeated Dose 28-Day Oral Toxicity in Rodents" (Adopted on 12 May 198 1 and 
Updated on 27 July 1995.) 
93- Rohman, A., Riyanto, S., 2Yuniarti, N., 1Saputra, W. R., 1Utami, R. and 1Mulatsih, 
W. International Food Research Journal 17: 97-106 (2010). 
94- P.K. Senthil Kumar and D. Reetha International Journal of Pharmaceutical & 
Biological Archives 2011; 2(5):1534-1538. 
95- CHANG et al. Free radical scavenging activity of Phellinus merrillii 415 1,1- diphenyl-
2-picrylhydrazyl radical. Chem. Pharm. Bull. 37: 2016-2021. H 
96- David T. Manallack et.al, The Significance of Acid/Base Properties in Drug Discovery, 
Chem Soc Rev.2013 Jan 21; 42(2): Page no: 485-496 
97- Ajazuddin et al, Evaluation of physico chemical and Phyto chemical properties of 
Safoof-E-Sana, an Unani Polyherbal Formulation, Pharmacognosy research 2 (5), 318, 
2010.  
BIBILIOGRAPHY 
 
ANTI-DYSLIPIDEMIC ACTIVITY OF INDIRANI MAATHIRAI 175 
 
98- What are Flavonoids? – Live Science available from https:// 
www.livescience.com>52524-flavonoids, html 
99- A.D. Agarwal et al, Pharmacological Activities of Flavonoids: A Review, International 
Journal of Pharmaceutical Science &Nanotechnology, Volume 4: Issue 2, Sep 11, Page 
No: 1394-1398 
100- Saponins – an overview | Science Direct… Available online from 
https://www.sciencedirect.com >topics 
101- N>K>War ditinani et al, Antidyslipidemic activity of Katuk leaves Saponins 
Fractions in rats withinduced with fat rich diet, Research Gate, jan 2016. 
102- Diterpenes – A Review on therapeutic uses with special emphasis on anti- diabetic 
activity, journal of pharmacyresearch2012,5(8),4530-4540.  
103- Saeed S, Mosa-Al-Reza H, Fatemeh AN, Saeideh D. Antihyperglycemic and 
antihyperlipidemic effects of guar gum on streptozotocin-induced diabetes in male 
rats. Pharmacognosy magazine. 2012 Jan;8(29):65.  
104- What are flavonoids? –live science available from 
https://www.livescience.com>52524-flavonoids, html 
105- Saritha Marella, Flavonoids – The most potent poly phenol as antidiabetic agents:an 
overview, Mod Appro Drug Des, 1(3), MADD000513 2017. 
106- Soo-Mi-jeong et al, Quercetin ameliorates hyperglycemia and dyslipidemia and 
improves antioxidant status in type 2 diabetic rats, Nutrition research and practice, 
6(3), 201-207, 2012. 
107- Stenvinkel P, Ottosson-Seeberger A, Alvestrand A. Renal hemodynamics and 
sodium handling in moderate renal insufficiency: the role of insulin resistance and 
dyslipidemia. Journal of the American Society of Nephrology. 1995 Apr 1;5(10):1751-
60. 
108- Ranasinghe P, Wathurapatha WS, Ishara MH, Jayawardana R, Galappatthy P, 
Katulanda P, Constantine GR. Effects of Zinc supplementation on serum lipids: a 
systematic review and meta-analysis. Nutrition & metabolism. 2015 Dec;12(1):26. 
109- Rizk MZ, Borai IH, Ezz MK, El-Sherbiny M, Aly HF, Matloub A, Fouad GI. 
Possible therapeutic role of grape (Vitis vinifera) leaves polyphenolic extract in the 
regression of aluminium-induced Alzheimer's disease in rats. J Mater Environ Sci. 
2018;9(7):2098-108. 
BIBILIOGRAPHY 
 
ANTI-DYSLIPIDEMIC ACTIVITY OF INDIRANI MAATHIRAI 176 
 
110- Stephanie Senef et al, Could Sulphur deficiency be a Contributing Factor in 
Obesity,Heart disease, Alzeimer’s and chronic fatigue syndrome? 
People.(sail.mit.edu/seneff/Sulphur-obesity-alzeimer’s-muscle 
111- Saeedeh Khalifi et al, Dietary Nitrate Improves glucose Tolerence and lipid profile 
in an animal model of hyperglycemia,44c:24-30 nov 2014. 
112- Al-Tonsi AA, Abdel-Gayoum AA, Saad M. The secondary dyslipidemia and 
deranged serum phosphate concentration in thyroid disorders. Experimental and 
molecular pathology. 2004 Apr 1;76(2):182-7. 
113- Carboxylic derivative and a pharmaceutical composition containing the derivativd 
as active ingredient at https://www.google.com>patents 
114- Cycloheptane available at https://patents.google.com/ 
115- Tridecaneavailableat 
https://pubchem.ncbi.nlm.nih.gov/Compound/Tridecane#Section=Top 
116- Mechanisam of increase of hepatic cholesterol synthesis and serum cholesterol level 
in WR Triton 1339 induced rats, Biochem Biophys Acta 489(1), 119-125. 
117- Studies of antidyslipidemia effect of Morinda citriforte fruits in lipids by calyh and 
dis 
118- Suhad et al, Plant sterols as cholesterol lowering agents A metabolic analysis of 
randomaised controlled trials, Food and nutrition research, 2008, 52, 10.3042 
119- ASE possess antioxidant property asit invitro generation of oxygen and OH, 
IJCPR, may-july,2011, 2(2), 115. 
120- D.Mathe et al, Dyslipidemia and Diabetes in animal model, Diabetes and 
metabolism, 21(2), 106-111, 1995. 
121- Megan Ware, how can Anti-oxidants benefit our health, Newsletter (29 May 2018) 
AT: https://www..phpmedicalnewstoday.com/articles/301506.php 
122- Rui-Li-Yang et al, Increasing oxidative stress with Progressive Hyperlipidemia in 
Human: Relation between Malondialdehyde and Atherogenic index, Journal of 
Clinical biochemistry and Nutrition, https://www.ncbi.nlm.nih.gov/pmc/articles/pmc 
2581765 
 
Government Siddha Medical College 
Arumbakkam, Chennai – 600 106   
 
 
 
 
 
 
 
CERTIFICATE 
 
 
 
Certified that the samples submitted for identification by 
Dr.P.Gnanavel PG Scholar, Department of Gunapadam, Government Siddha 
Medical College, Arumbakkam, Chennai-600 106, were identified as: 
Ingredients of Indhirani maathirai: 
 
1. Butea monosperma (Purasan ver) 
 
2. Euphorbia antiquorum (Kalli ver) 
 
3. Caesalpinia crista (Kalarchi ver) 
 
4. Brassica juncea (Kadugu) 
 
5. Ferula asafoeitida (Perungayam) 
 
6. Piper nigrum (Milagu) 
 
7. Acacia catechu (Karungali kattai) 
 
8. Potassium nitrate (Vediyuppu) 
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